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SUMMARY 
Coffee is one of the most widely consumed beverages worldwide. Epidemiological 
data suggest that there is an inverse association between coffee consumption and the 
incidence of reactive oxygen species (ROS) related diseases (such as diabetes, 
neurodegenerative diseases, cancer). Also animal studies and in vitro experiments provide 
evidence for antioxidant activity of coffee and coffee components. However, data from 
human intervention trials are scarce and partly controversial.  
Aim of the present thesis was to investigate the impact of coffee consumption on DNA 
stability and on the redox status in humans. Therefore, intervention trials were carried out and 
different parameters of oxidative stress were determined. DNA stability monitored in single 
cell gel electrophoresis (SCGE or comet) assays was one of the main parameters. To design 
an optimal study plan the results of earlier SCGE assays were critically evaluated and the 
outcomes published in form of a review. So far 84 studies have been conducted with different 
food items and in about half of them protective effects were found. 
In the first human intervention trial the impact of a mix of metal and paper-filtered 
coffee (n=8, 600 ml/P/day, 5 days) on DNA stability was studied. The results indicate that 
coffee consumption leads to a significant decrease of oxidised purines (by 68 %) and 
pyrimidines (by 48 %) (detection with DNA lesion specific enzymes). Furthermore, DNA 
damage caused by reactive oxygen radicals (H2O2 treatment) and by the heterocyclic aromatic 
amine 3-amino-1-methyl-5H-pyrido [4,3-b] indole acetate (Trp-P-2), a carcinogen found in 
fried meats, was significantly reduced (by 17 % and 35 %, respectively). Furthermore, an 
increase of the activity of the antioxidative enzyme superoxide dismutase (by 38 %) was 
detected; whereas the activity of glutathione peroxidase was not significantly altered.  
The second trial was conducted with a new type of instant coffee (n=29, 800 ml/P/d, 5 
days), which is rich in chlorogenic acids (CAs). CAs are well absorbed and it is assumed that 
they contribute substantially to the antioxidant properties of coffee. In this clinical 
intervention trial results of 15 different oxidative parameters (including endpoints of oxidative 
DNA damage, lipid peroxidation and antioxidant enzymes) as well as gene expression profiles 
were analysed. The results obtained with the comet assay indicate a decrease of oxidised 
DNA bases (oxidised purines by 6,7 %, oxidised pyrimidines by 9,8 %) and reduced 
sensitivity towards ROS induced DNA damage (6.1%). However, only the decrease of 
oxidised purines in female volunteers reached significance. Furthermore, F2-isoprostane 
levels in the urines of the volunteers (which is one of the most reliable marker for lipid 
peroxidation) and also protein nitrosation (3-nitrotyrosin levels) were significantly reduced 
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(by 14.9 % and 17.2 %, respectively) after coffee intake. Interestingly, the decrease of these 
two parameters was more pronounced in female volunteers. Other markers of oxidative stress 
were not affected by coffee consumption.  
The third article (paper III) describes human intervention studies with unfiltered and 
paper filtered coffee in which the impact of coffee consumption on glutathione-S-transferase 
(GST) activities were monitored in saliva and plasma. GSTs are detoxifying enzymes and 
possess also antioxidant properties. The first part describes a study with unfiltered coffee 
(n=10, 1L/P/d, 5 days). The results show that coffee increased the levels of the isoenzyme 
GSTP (3-fold) but not of GSTA. Furthermore, no increase of the overall GST activity was 
found. Also other investigated biochemical parameters (creatinine, alanine aminotransferase, 
aspartate aminotransferase, alkaline phosphatase) were not altered. A slight but not significant 
increase of cholesterol levels was observed after the intervention. In the second trial, GSTP 
levels after consumption of unfiltered and paper filtered coffees, which differ in their levels of 
coffee specific diterpenoids (cafestol and kahweol), were compared. Again, a significant (3-
fold) induction of GSTP was observed, regardless the type of coffee consumed. Since GST 
plays a key role in the detoxification of polycyclic aromatic hydrocarbons (PAHs), we 
conducted a further trial in which the impact of coffee intake on the sensitivity of peripheral 
lymphocytes towards (±)-anti-B[a]P-7,8-dihydrodiol-9,10-epoxide (BPDE) induced DNA 
damage was monitored. BPDE is the reactive metabolite of benzo(a)pyrene, which is a model 
compound for PAHs. We detected a significant reduction of BPDE-induced comet formation 
(by 45 %) after the intervention due to coffee consumption. 
The results of our experiments suggest that coffee protects humans against adverse 
health effects caused by DNA damage. This finding provides a possible explanation for the 
results obtained in epidemiological studies indicating that coffee intake is inversely related 
with the incidence of diseases associated with cellular damage by reactive oxygen species and 
DNA instability. 
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ZUSAMMENFASSUNG 
Kaffee ist eines der am häufigsten konsumierten Getränke weltweit. Epidemiologische 
Studien ergaben einen inversen Zusammenhang zwischen Kaffeekonsum und der Inzidenz 
von Krankheiten, an deren Auslösung reaktive Sauerstoffspezien beteiligt sind (z.B. Diabetes, 
neurodegenerative Erkrankungen, Krebs). Auch Tierstudien und in vitro Experimente zeigen, 
dass Kaffee und dessen Inhaltsstoffe antioxidativ wirken, allerdings liegen nur wenige, 
teilweise widersprüchliche Ergebnisse von Humanstudien vor. 
Das Ziel der vorliegenden Arbeit war die Klärung der Frage, ob Kaffeekonsum beim 
Menschen einen Einfluss auf den oxidativen Status und auf die DNA Stabilität hat. Es wurden 
humane Interventionsstudien durchgeführt und verschiedene Parameter des oxidativen 
Stresses bestimmt, die Biomarker für antioxidative Effekte sind. Einer der Hauptparameter 
war die Messung der DNA Stabilität mittels dem Einzelzellgelelektrophorese Test (Komet 
Assay). Um ein optimales Studiendesign zu entwickeln, evaluierten wir die bis dato 
vorhandenen Interventionsstudien die mit dem Komet Assay durchgeführt wurden und 
verfassten einen Übersichtsartikel, der die Resultate dieser Studien zusammenfasst. Bisher 
wurden 84 Studien mit verschiedenen Nahrungsmitteln durchgeführt und in etwa der Hälfte 
wurden Schutzeffekte gefunden.  
In der ersten humanen Interventionsstudie wurde die Auswirkung des Konsums eines 
Gemisches von metallgefiltertem und ungefiltertem Kaffee (n=8, 600 ml/Person/Tag, 5 Tage) 
auf die DNA Stabilität untersucht. Die Resultate zeigen, dass Kaffeekonsum zu einer 
signifikanten Reduktion von oxidierten Purinen (68 %) und Pyrimidinen (48 %) (detektiert 
mittels läsionsspezifischen Enzymen) und auch zu einer erniedrigten Sensitivität gegenüber 
H2O2 induzierter DNA Schädigung (17 %) führt. Weiters konnten wir zeigen, dass durch 
Kaffeekonsum die Aktivität eines antioxidativ wirksamen Enzyms (Superoxid dismutase) 
steigt. Im Gegensatz dazu war die Aktivität der Glutathioneperoxidase nicht verändert.  
Bei der zweiten Arbeit handelte es sich ebenfalls um eine Interventionsstudie (n=29, 
800 ml/P/T, 5 Tage), die allerdings mit „cross-over“ Design durchgeführt wurde. Die 
verwendete Kaffeesorte war ein neu entwickelter Instantkaffee, der einen besonders hohen 
Gehalt an Chlorogensäuren aufwies. Chlorogensäuren werden sehr gut über den Magen-
Darmtrakt aufgenommen und es wird angenommen, dass sie in besonderer Weise für die 
antioxidativen Eigenschaften von Kaffee verantwortlich sind. In dieser klinischen Studie 
wurden DNA Stabilitätsparameter wie in der ersten Studie gemessen, sowie zusätzlich 
Parameter des oxidativen Status (Lipidperoxidation und diverse antioxidativ wirksame 
Enzyme), weiters wurden auch Genexpressionsprofile bestimmt. In der Gruppe der 
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Kaffeetrinker wurde eine Reduktion der oxidierten Basen (oxidierte Purine - 6,7 % und 
oxidierte Pyrimidine - 9,8 %) detektiert und auch die Sensitivität gegenüber ROS-induzierten 
Schäden war erniedrigt (6.1 %), diese Effekte erreichten jedoch nur im Falle der oxidierten 
Purine bei den weiblichen Probanden statistische Signifikanz. Auch die F-2 Isoprostane im 
Urin und die 3-Nitrotyrosin Konzentrationen im Plasma waren deutlich nach dem 
Kaffeekonsum reduziert, die anderen biochemischen Parameter veränderten sich jedoch nicht. 
Die protektiven Eigenschaften des Kaffees waren in dieser Studie bei den weiblichen 
Probanden deutlich höher. 
Die dritte Arbeit betrifft humane Interventionsstudien die mit gefiltertem und 
ungefiltertem Kaffee durchgeführt wurden und in denen die Auswirkungen auf die 
Glutathione-S-Transferase (GST) Aktivität im Speichel und Plasma untersucht wurde. GST 
ist an der Detoxifizierung von Umweltgiften (z.B. polyzyklischen aromatischen 
Kohlenwasserstoffen) beteiligt und ist auch antioxidativ wirksam. Im ersten Teil der Arbeit 
wurde eine Studie mit ungefiltertem Kaffee (n=10, 1L/P/Tag, 5 Tage) durchgeführt und die 
Ergebnisse zeigten eine signifikante Erhöhung (3-fach) der Konzentration des Isoenzyms 
GSTP. Im Gegensatz dazu waren die GSTA Gehalte, die gesamte GST Aktivität und auch 
diverse klinische Parameter (Creatinin, Alanin-Aminotransferase, Aspartat-Aminotransferase, 
Alkalische-Phosphatase) nicht verändert; der Cholsesterinspiegel war nach Kaffeekonsum 
leicht jedoch nicht signifikant erhöht. In der zweiten Studie tranken die Teilnehmer 3 Tage 
lang ungefilterten oder papiergefilterten Kaffee (n=7, 1L/P/T), die sich im Gehalt von 
kaffeespezifischen Diterpenoiden (Cafestol und Kahweol) unterschieden. Unabhängig von der 
Art des konsumierten Kaffees waren die gemessenen GSTP Aktivitäten nach Kaffeekonsum 
deutlich erhöht (3-fach). Wir führten nachfolgend eine weitere Interventionsstudie durch 
(n=7, 1L/P/Tag, 5 Tage), in der wir die Auswirkung von ungefiltertem Kaffeekonsum auf die 
Empfindlichkeit peripherer Lymphozyten gegenüber (±)-anti-B[a]P-7,8-dihydrodiol-9,10-
epoxid (BPDE) untersuchten. BPDE ist der reaktive Metabolite von Benz(a)pyren und ist eine 
Modelsubstanz der polyzyklischen aromatischen Kohlenwasserstoffe. Die Ergebnisse zeigen, 
dass nach Kaffeekonsum die Zellen weniger empfindlich gegenüber dieser Substanz 
reagierten.  
Die Ergebnisse der Interventionsstudien deuten darauf hin, dass Kaffeekonsum einen 
positiven Einfluss auf die DNA Stabilität hat. Die Resultate untermauern die Befunde von 
epidemiologischen Studien die zeigen, dass Kaffeekonsum vor Krankheiten schützt, die mit 
reaktiven Sauerstoffspezien und DNA Instabilität in Zusammenhang stehen. 
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LIST OF ABBREVIATIONS 
AP-1  activator protein 1 
ARE  antioxidative response element 
BPDE (±)-anti-B[a]P-7,8-dihydrodiol-9,10-epoxide 
CA  chlorogenic acid 
C+K  cafestol and kahweol 
ELISA   enzyme linked immunosorbent assay 
FPG  formamidopyrimidine DNA glycosylase 
FRAP  ferric ion reducing antioxidant parameter 
GPx  glutathione peroxidase 
GSH  glutathione 
GST  glutathione-S-transferase 
HNE  4- hydroxy- 2 nonenal 
IL-1  interleukin-1 
LDL   low density lipoproteins 
LP    lipid peroxidation 
MAPKs  mitogen activated protein kinases 
MDA malondialdehyde 
MN  micronucleus 
NFκB  nuclear factor kappa-B 
NOS  nitric oxide synthetases 
Nrf2  nuclear factor erythroid 2-related factor 2 
ORAC  oxygen radical absorbance capacity test 
oxLDL  oxidised LDL 
RNS  reactive nitrogen species 
ROS  reactive oxygen species 
SCGE  single cell gel electrophoresis 
SOD  superoxide dismutase 
TAC  total antioxidant capacity 
TEAC  trolox equivalent antioxidant capacity 
TNF-α  tumour necrosis factor-alpha 
TRAP  total radical trapping antioxidant parameter 
3-NT  3-nitrotyrosine 
4-HNE 4-hydroxy-2-nonenal 
8-OHdG  8-hydroxydeoxyguanosine 
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It is well documented that oxidative stress has a substantial impact on human health. It 
has been estimated by Blomhoff that around ten scientific articles are published every day 
which concern the effects of reactive oxygen species (ROS) [1], and strong attempts have 
been made to identify dietary compounds which protect humans against the adverse 
consequences of oxidative damage. A broad variety of food compounds has been identified, 
which inactivate radicals directly and/or induce antioxidant defence systems. Apart from 
vitamins, also many secondary plant constituents have been identified as antioxidants, which 
are contained in foods. These compounds are often by-products of the primary metabolism 
and play a role in the protection of plants against radical induced damage caused by light or 
by tissue damage and also protect them against pests. The discovery of ROS protective 
compounds in human foods has lead to dietary recommendations and also to the production of 
food supplements and production of foods, which contain such compounds [2].  
The uptake of antioxidants via coffee consumption is relatively high, since coffee is a 
frequently consumed beverage. Some investigations indicate that the total intake of phenolic 
antioxidants via coffee intake is substantially higher than via fruits and vegetable 
consumption and other beverages [3]. Furthermore, evidence from epidemiological studies 
indicates that coffee consumption is inversely related to the incidence of specific forms of 
cancer (i.e. in the liver and colon), liver cirrhosis and fibrosis and diseases such as diabetes, 
Alzheimer and Parkinson [4]. It is possible that these protective effects are due to inactivation 
of ROS (which play a role in the etiology of these diseases) by coffee components. Results of 
a number of in vitro experiments show that specific coffee components such as 
hydroxycinnamic acids, Maillard reaction products, caffeine and coffee itself possess 
antioxidant properties [5,6]. However, at present the evidence for effects of coffee in humans 
is scarce and partly controversial (for details see literature overview, chapter 3). 
The concentration of coffee constituents, which possess antioxidant properties 
depends on the selection of the cultivars used (Coffee arabica and/or robusta), on the roasting 
process and also on the preparation method. This offers the possibility to optimise the 
antioxidant properties of coffee. During the roasting process, the levels of chlorogenic acids 
decline and Maillard products are formed. A number of investigations indicate that the 
chlorogenic acids play a key role in the antioxidant properties of coffee [7-9].  
The present thesis consists of a literature overview and origial articles presented in the 
publication section. The literature overview provides information on the general mode of 
action of radicals, their formation and the molecular mechanisms of antioxidants (chapter 1). 
Furthermore, the methodological principles of antioxidant measurements used in human 
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intervention trials and their advantages and limitations are disscused (chapter 2). Furthermore, 
the results of human intervention trials, which have been carried out with coffee so far are 
described and disscused in chapter 3. This information provides the basis for the design of the 
human intervention studies, which are described in the publication section. 
The main parameter used in all trails was DNA migration, which was determined in 
single cell gel electrophoresis (SCGE) assays. SCGE assays are based on the determination of 
DNA migration in an electric field. DNA damage leads to comet shaped images, therefore this 
technique is also termed “Comet assay”. Different parameters of DNA migration were 
measured, namly endogenous formation of single and double strand breaks, endogenous 
formation of oxidised purins and pyrimidines which can be monitored by use of lesion 
specific enzymes and alterations of the sensitivity of the cells towards damage caused by ROS 
(H2O2 treated) or genotoxic carcinogens contained in the human diet (such as polycyclic 
aromatic hydrocarbons or heterocyclic aromatic amines).  
The first article (paper I) describes a small intervention trial (n=8), in which the impact 
of consumption of a mix of paper- and unfiltered coffee was investigated with the SCGE 
assay and also antioxidant enzymes have been determined (paper I, page 79).  
The second intervention is a large comprehensive multiple endpoint study with cross-
overdesign (n=29) in which the influence of instant coffee consumption on different 
parameters of oxidative damage was investigated (paper II, page 91). Beside of DNA stability 
(determined with the SCGE assay) also isoprostane levels were determined in the urine with 
GC-MS, which is regarded as the most reliable method to determine the isoprostanes and 
several other parameters such as malondialdehyde (MDA), oxidised low-density lipoproteins 
(oxLDL), total antioxidant capacity (TAC), glutathione-S-transferase (GST), cellular 
glutathione (GSH) levels, reactive oxygen species (ROS), levels of antioxidant enzymes 
(superoxide dismutase, glutathione peroxidase) and geneexpression profiles were measured.  
The third article concerns the impact of coffee consumption on the activity of 
glutathione-S-transferase (GST) activities (paper III, page 121). This enzyme is involved in 
the detoxification of environmental pollutants and has also antioxidant properties [10,11]. 
Therefore, the impact of coffee on the sensitivity of peripheral lymphocytes towards (±)-anti-
B[a]P-7,8-dihydrodiol-9,10-epoxide (BPDE) induced DNA damage was monitored. BPDE is 
the reactive metabolite of benzo(a)pyrene, which is a model compound for PAHs. 
The review article (page 135) gives an overview on the current state of knowledge of 
the use of single cell gel electrophoresis (SCGE) assays in human intervention trials.  
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1.1 Introduction 
Oxidative stress has been defined by Blomhoff [1] as a “condition that is characterised 
by the accumulation of non-enzymatic oxidative damage to molecules that threaten the 
normal functions of a cell or the organism”. Oxidative stress is involved in the aetiology of a 
number of human diseases (for review see Valko et al. [12]). Therefore, strong attempts have 
been made over the last decades to identify components that protect humans against the 
consequences of oxidative damage. This chapter gives a brief overview of the formation of 
different types of reactive oxygen species (ROS) and describes their interactions with 
different types of macromolecules. Furthermore, the consequences of oxidative damage, 
cellular defence mechanisms, and the mechanisms underlying the protective effects of dietary 
compounds are described.  
1.2 Formation of reactive oxygen species (ROS) 
“Reactive oxygen species” is a collective term that includes not only radicals, but 
also non-radical derivates of oxygen (O2), for example hydrogen peroxide (H2O2), 
hypochlorous acid (HOCl), and ozone (O3) (for details see Table 1) [13]. Radicals, which are 
characterised by their high reactivity (except O2), contain unpaired electrons in atomic or 
molecular orbitals. Therefore, they donate or receive other electrons to obtain stability. O2 
itself is a bi-radical and rather unreactive, but its univalent reduction leads to the formation of 
more reactive species. ROS in the cells undergo a cascade of reactions, which leads to 
conversion into other molecular forms and furthermore to oxidation of macromolecules. 
These processes and some important representatives of ROS are depicted schematically in 
Figure 1. 
Table 1: Chemical structures of different ROS (modified from [13]) 
Radicals Non radicals 
Name Chemical structure Name Chemical structure 
Superoxide  O2·- Hydrogen peroxide  H2O2 
Hydroperoxyl  HO2 Peroxynitritea ONOO- 
Hydroxyl OH- Peroxynitrous acida ONOOH 
Peroxyl  RO2 Nitrosoperoxycarbonate  ONOOCO2- 
Alkoxyl RO Hypochlorous acidb HOCl 
Carbonate CO3 - Hypobromous acid, c HOBr 
Carbon dioxide CO2 - Ozone O3 
Singlet oxygen O2 1Σg+ Singlet oxygen O2 1 ∆g 
 
can also be designated as a “reactive nitrogen species”, b “reactive chlorine species”, c “reactive bromine 
species” 
The one electron reduction product of oxygen is the superoxide radical (O2·-). It is a 
by-product of the respiration chain in the mitochondria of the cells produced by NADPH 
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oxidases and formed as a consequence of reduction of oxygen required for ATP production.  
O2·- forms at low pH hydroxyperoxyl radicals (HO2) which cross membranes due to their 
uncharged nature. Due to the pH of most body tissues, the ratio of [O2·-]/[HO2·] is rather large 
(e.g., 1000/1 at pH 7.8), but the HO2 radicals are more reactive [13,14]. Under stress 
conditions, O2·- acts as an oxidant of [Fe–S] cluster-containing enzymes (e.g., metalloproteins) 
and facilitates hydroxyl radical (OH-) production from H2O2 by making Fe2+ available for the 
Fenton reaction [15].  
If two electrons are transferred (e.g., enzymatically via superoxide dismutase), the 
product is H2O2, which can be detoxified enzymatically (catalase, glutathion peroxidase). 
H2O2 is a source of more deleterious species such as HOCl and OH-. The enzyme 
myeloperoxidase catalyses the production of HOCl by interaction between H2O2 peroxides 
and chlorides [16]. H2O2 itself is a poor oxidant and reacts to a less extend with [Fe-S] 
clusters and metallo enzymes. The highly reactive OH- radicals with a very short in vivo half-
life of approx. 10−9 s [17] react very close to its side of formation. It can be formed in vivo 
via the Haber-Weiss Reaction (•O2- + H2O2 → •OH + OH- + O2), which combines a Fenton 
reaction and the reduction of Fe3+ by O2· -, yielding Fe2+ and oxygen (Fe3+ + O2· - → Fe2+ + O2) 
[18].  
The different ROS have distinct biological properties, which include their high 
chemical reactivity, their short half-live and their lipid solubility. Moreover it is notable that 
“reactive” is a relative term; O2·- and H2O2 are highly selective in their reactions with 
biological molecules, leaving most of them unscathed, whereas OH- attacks all types of 
biomolecules (see Figure 1, grey box) [13].  
20
  
 
 
 
Figure 1: ROS sources and biochemical properties (adapted from D'Autreaux et al. [19]). 
 
Also reactive nitrogen species (RNS) belong to ROS; one of the most important is 
nitric oxide (NO•). It is produced by oxidation of the terminal guanidine-nitrogen atoms of 
arginine [20,21]. This reaction is catalysed by nitric oxide synthetases (NOS, i.e. neuronal 
NOS, endothelial NOS and inducible NOS). NO• can react with different radicals, the most 
important reaction under physiological conditions is the formation of peroxynitirite (ONOO2) 
in which O2 is involved [21,22]. ONOO2 can cause damage similar to that induced by OH• 
[20].  
1.3 Sources of ROS  
Beside of exposure to exogenous sources, ROS are produced by normal cellular 
functions, in particular during respiration in the mitochondria. It has been estimated that the 
average person encounters approximately 10,000–20,000 free radical attacks per cell per day. 
In well trained athletes this number can increase by 50 % [23]. 
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Figure 2: Schematic overview on exogenous and endogenous sources of ROS exposure 
(adapted from Kohen and Nyska [24]). 
 
Several exogenous factors can contribute to oxidative stress. Air pollutants such as 
cigarette smoke [25,26] and car exhausts [27], drugs (e.g., bleomycin, doxorubicine) [28] as 
well as pesticides and herbicides [29] and industrial chemicals [30] are sources of ROS that 
can attack the organism [24]. Ionising radiation (caused by e.g., medical applications such as 
radiation therapy, X-rays, natural sources such as cosmic and solar radiation) may cause toxic 
effects in organisms primarily via ionisation of intracellular water [31]. Even exposure to non-
ionizing irradiation such as UV-C (< 290 nm), UV-B (290–320 nm), and UV-A (320–400 
nm) can indirectly produce a variety of ROS including 1O2, H2O2, and O2.- radicals; also 
hemolytic cleavage of H2O2 by UV radiation yields OH- Radicals [24]. Also O3 can be formed 
in the presence of UV light. In the upper atmosphere it is required to scavenge UV-C 
radiation, but on the other hand it is a powerful oxidising agent [32]. Also infections by 
pathogenic microorganisms may produce ROS either by direct release from the pathogen or as 
a consequence of endogenous responses of phagocytes and neutrophils.  
Probably the most relevant external source is nutrition. Most of the foods we consume 
are oxidised and contain oxidants such as peroxides, aldehydes, fatty acids and transition 
metals [33,34]. Although the exogenous exposure of the organisms to ROS can be high, the 
ROS formation due to endogenous sources is more extensive, because it is a continuous 
process of every cell in the organism during life time [24].  
The most important endogenous source is the respiration processes in the mitochondria 
and it was shown, that the massive continuous production of radicals is even increased in 
ageing cells [35,36]. Also enzymes are a source of ROS, most of them produce ROS as a by-
product (e.g., xanthine oxidase), but there are also enzymes which are designed to produce 
ROS (e.g., NOS). There are also some diseases which are related to an excess of ROS (for 
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reviews see [12,37]), but ROS are not only the cause but also the consequence of certain 
diseases [13,38]. More than 200 clinical disorders have been described in which ROS are 
involved either in the beginning of the disease and/or produced during its course.  
1.4 Oxidative damage of DNA, Lipids and Proteins 
Continuous exposure of the organism to ROS results in oxidative damage of cell 
components and leads to alterations of many cellular functions. Three main categories of 
macromolecules namly proteins, lipids and DNA are targets of oxidative damage. Some of 
these changes can be used as markers of oxidative stress. 
Oxidative DNA damage by ROS can induce mutations, which lead to genomic 
instability and furthermore to formation of aberrant cells (cancer cells). DNA is a rather stable 
molecule, thus ROS can interact with it and various different types of damage (e.g., 
modification of DNA bases, loss of purines, single and double strand breaks, damage to the 
deoxyribose sugar, DNA protein crosslinkage and damage to the DNA repair system) can be 
formed [23,24]. The major portion of DNA damage is attributable to the highly reactive OH- 
radical. OH- reacts with all parts of the DNA, damaging the DNA bases (purines and 
pyrimidines) and also the deoxyribose backbone. The formed reaction products are various 
(e.g., 5-hydroxycyteine, uracil glycol) depended on different factors (e.g., absence or presence 
of oxygen and or transition ions). The most extensively investigated product is 8-hydroxy-
desoxyguanosine (8-OHdG) [13,39]. 8-OHdG is very easily formed and it is mutagenic and 
therefore a potential biomarker of carcinogenesis [23]. DNA damage can occur also indirectly 
through lipid peroxidation (LP) products. Lipid radicals during the chain reaction can cause 
adduct formation, strand breaks and DNA protein crosslinks (for review see [40]). Also NO• 
can damage DNA indirectly via formation of peroxinitrite [41,42]. 
Proteins can undergo direct and indirect damage due to interactions with ROS. The 
consequences are fragmentation, degradation, changes in their tertiary structure, peroxidation 
and damage of specific amino acid residues. Within the proteins, the peptide bonds or the 
sidechains may be targeted, and it has been shown that many of the reactions triggered by 
ROS are site-specific [43]. Radicals react in particular with nucleophilic amino acids for 
example with tryptophane, histidine and cysteine [44,45]. The major products are aldehydes, 
keto compounds and carbonyls. The formation of the latter is due to oxidation of specific 
amino acid residues (e.g., lysine, arginine, and proline residues), cleavage of the peptide 
backbone or cleavage due to oxidation of glutamyl residues. An important marker of 
oxidative protein damage is the carbonyl derivate 4- hydroxy- 2 nonenal (4-HNE) which is 
formed due to reaction of some amino acid side chains with lipid oxidation product [46]. 
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Another important marker of oxidative damage is 3-nitrotyrosin (3-NT). It is produced via 
interaction of ONOO- and other nitrogen reactive radicals with the amino acid tyrosine [43]. 
The NO. radical reacts in particular with Fe-S centers of proteins which transport electrons 
and this affects the functions of mitochondria [47]. Another important feature is its reaction 
with thiol groups of proteins; a typical example is the S-nitrosylation of caspases, which are 
part of cell signalling processes [48]. 
Also Lipids can be damaged by ROS, which leads to their oxidation, which occurs in 
three steps. The first step of the lipid peroxidation (LP) reaction (“initiation step”) is 
characterised by the attack of radicals to double bonds of the fatty acids, which leads to 
formation of fatty acid radicals. In the second step (“propagation”) the chain reaction takes 
place, lipid radicals are formed continuously. The last stage (“chain determination”) occurs 
because of the interactions of ROO• (peroxyl radical) or with other radical types and/or 
antioxidants (for details see [13,49]). A schematic overview of the LP process is given in 
Figure 3. 
 
 
Figure 3: Schematic overview of the lipid peroxidation (LP) process. (1) Initiation phase: 
attack of radicals to the double bound (2) formation of hydroxyperoxides (adapted from Dotan 
et al. [50]). 
 
All cellular membranes are vulnerable to oxidative damage because of their high 
content of unsaturated fatty acids. Important markers of LP are aldehyds and ketones, such as 
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malondialdehyde (MDA), which forms DNA adducts [51], the family of isoprostanes,  which 
is excreted via the urine and 4-HNE, formed via reaction with amino acid residues.  
Oxidative modification of low density lipoproteins (LDL) is one of the earliest 
events in atherosclerosis. LDLs are responsible for the transport of cholesterol and triglycerids 
from the liver to the peripherie. Oxidised LDL (oxLDL) represents a variety of modifications 
of both lipid and apolipoprotein B (apoB) components by LP [52]. OxLDL particles are taken 
up by macrophages inside the aterial walls and form foam cells, which cause artherosclerotic 
plaques [53].  
A detailed overview of the interaction of different forms of ROS with macromolecules 
described above is given in Figure 4. 
 
 
Figure 4: Oxidative damage of different macromolecules caused by ROS (adapted from 
Kohen and Nyska [24]). Non-continuous arrows indicate the ultimate macromolecule 
damaging pathways. 
 
1.5 Antioxidant defence system 
In the course of the evolution, pro- and eukaryotic organisms developed a variety of 
antioxidant defence mechanism, which can be grouped into two main categories namely: (a) 
the synthesis of molecules which are able to inactivate ROS by direct scavenging (b) indirect 
defence systems which are based on the activation of transcription factors via signalling 
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pathways leading to induction of antioxidant enzymes. In this context, it is notable that 
besides of the antioxidant mechanisms, which are described in this chapter in detail, the 
organism possesses additionally other defence mechanisms against free radical induced 
oxidative stress for example complex repair mechanisms [12]. 
1.5.1 Direct scavenging mechanisms 
Direct scavenging of ROS might take place due to antioxidants contained in foods or 
via substances synthesised in the organisms. The most important endogenous formed 
antioxidants are uric acid, hämoglobin and the tripeptide glutathione (GSH). GSH is present 
in a high concentration in the cell and beside its function as co-substrate of glutathione 
peroxidase (GPx) and –transferases (GST) it is a direct scavenger of ROS.  
Also plants contain highly potent antioxidants, which are often termed “secondary 
constituents” as they are not directly involved in their primary metabolism. These components 
comprise flavonoids and other phenolic components and fulfill an important biological role as 
they protect plants against ROS, caused by cellular damage or light. Furthermore, they may 
act as “natural pesticides” and possess potent toxic activities. 
Dietary antioxidants and vitamins differ strongly in regard to their tissue distribution 
and scavenging spectrum. In the case of phenolics, it is assumed that the radicals are trapped 
by the molecules and become resonance-stabilised. Phenoxy radical intermediates are stable 
and are unlikely to participate in the initiation of new radical chain reaction (see Figure 5). 
Important antioxidants, which are either synthesised by higher organisms or taken up via 
foods are vitamin C, E and A; the latter can be also formed by cleavage from certain 
carotenoids which also possess potent ROS protective properties per se. 
 
 
Figure 5: Stabilisation of the phenoxyradical due to delocalisation of the unpaired electron in 
the aromatic ring (adapted from Shahidi and Wanasundara [54]) 
 
1.5.2 Activation of transcription factors  
Activation of transcription factors and complex signalling chains, which control these 
factors, is the concern of numerous investigations published in the last years. The general 
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characteristic of these defence processes is induction of cytosolic proteins (mainly enzymes 
such as mitogen activated protein kinases- MAPKs), which cause transcription of genes 
encoding for ROS defence mechanism. ROS themselves are involved in these processes, but 
also dietary factors can interact with the processes related to alteration of transcription. ROS 
have an impact on cell signalling via two different mechanisms, namely receptor- or non-
receptor mediated pathway. Growth factors or cytokine receptors activate intracellular 
receptor mediated signalling which affect MAPKs. Also non-receptor proteins can be 
activated by ROS (e.g., Src, Ras –family)[55], which, as a consequence, trigger MAPK 
signalling (see Figure 6). In general, MAPKs relay signals generated by exogenous or 
endogenous stimuli to the intracellular space via phosphorylation of proteins [56]. The kinases 
interact also during this process with downstream mediators including transcription factors 
[57]. It has been shown that these processes are type and stimuli specific and it is interesting 
that endogenously produced H2O2 (e.g., by respiratory burst) induces extracellular signal-
related kineases (ERK) but not p38, while exogenous peroxide treatment activates the latter 
enzyme [2,58,59]. The activation of the transcription factor, which controls the expression of 
protective genes, arrests division of damaged cells and induces apoptosis (programmed cell 
death) is one of the most significant effects of ROS on MAPKs. ROS activate several 
transcription factors, such as AP-1 (activator protein 1), NFκB (nuclear factor kappa-B), Nrf2 
(Nuclear factor erythroid 2-related factor 2). Furthermore, they have also an impact on 
additional factors, for example on p53, also termed a “tumour suppressor” since it arrests cell 
cycle and induces apoptosis [60] (for detail see [2]). The complex interaction between ROS 
and signalling pathways is depicted in Figure 6. 
Phytochemicals, such as quercitin, cumarin, genistein, and resveratrol can interact with 
signalling pathways [61-63]. The molecular mechanisms by which phytochemicals interact 
with signal transmission cascades are not fully understood. One possible mechanism is that 
the down regulation of transcription factors may be due to the direct scavenging of ROS [2].  
A wide variety of chemopreventive phytochemicals is described in the literature. They 
prevent carcinogenesis either by enhancing cellular antioxidative and detoxification enzymes 
via activation of Nrf2 or by suppressing induction or overamplification of proinflammatory 
and growth promoting gene expression driven by NFκB or AP-1 [63]. In the subsequent 
section the most important transcription factors are described, which are affected by dietary 
factors or can be activated/inhibited via ROS. 
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Figure 6: Reactive oxygen species (ROS) and their impact on signalling pathways (adapted 
from Knasmüller et al. [2]) 
 
NFκB (nuclear factor kappa-B) is a ubiquitous redox-regulated transcription factor 
that remains sequestered in the cytoplasm as an inactive complex with its inhibitory 
counterpart IκB. Exposure to oxidative and inflammatory stimuli leads to phosphorylation of 
IκB and subsequently to proteasomal degradation of IκB, thereby releasing free NFκB 
dimmers for translocation to the nucleus [63]. Hereby, ROS have been implicated as second 
messengers involved in the activation of NFκB via TNFα and IL-1 [64,65]. It is generally 
accepted that the degradation of IκB is important for the activation of NFκB, but there are 
also studies which show that the activation is independent of IκB [66,67]. In the nucleus, the 
transcription factor activates genes involved in inflammatory processes, transformation and 
angiogenesis [68]. A number of investigations demonstrated that the activation can be blocked 
by antioxidants including N-acetylcysteine, cysteine, vitamin E, thiols and green tea 
polyphenols [12].  
AP-1 (activator protein 1) regulates the expression of genes, which are involved in 
cellular adaptation, differentiation and proliferation. It consists of either homo- or 
heterodimers between members of the JUN and FOS families, which interact via a leucine-
zipper domain. This transcription factor is also regulated by the MAPK-signalling cascade 
[62]. Bioactive substances, e.g. curcumin, capsaicin, genistein and resveratrol (for detail 
review see [62]) have an impact on the AP-1 and NFκB transcription factors. [62]. 
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Nrf2 (Nuclear factor erythroid 2-related factor 2) controls the expression of phase 
II enzymes, which are involved in the detoxification of carcinogens and protect against 
oxidative stress. A number of investigations showed, that dietary factors induce phase II 
enzyme expression via Nrf2. The induction of these genes is mediated by the antioxidative 
response elements (ARE) within the promoter regions of genes encoding for these enzymes. 
Nrf2, which belongs to the CNC (cap ´N´-collar) basic leucine zipper family, is the key 
mediator of ARE dependent activation. Nrf2 is sequestered in the cytoplasm by an actin 
binding protein Keap1 (Kelch-like ECH associating protein 1). Oxidative stress, as well as 
chemopreventive agents, leads to dissociation of Nrf2 from Keap1. As a consequence, Nrf2 
translocates to the nucleus and binds to AREs. Numerous upstream signalling pathways (e.g., 
mitogen-activated protein kinases, protein kinase C) are involved in the regulation (for details 
see Figure 7). Chemopreventive agents can act for example via activation of signalling 
factors, direct disruption of Nrf2 –Keap1 complex or inhibition of proteasomal degradation 
[62,69]. 
 
 
 
Figure 7: Induction of phase 2 detoxifying and antioxidant enzymes through activation of the 
Nrf2/ARE (modified after Jeong et al. [69]). 
 
1.5.3 Antioxidant enzymes: properties and biological implications 
The organism possesses a number of different enzymatic detoxification systems and it 
is well documented that dietary components can induce some of them. The most efficient 
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enzymatic antioxidants include superoxide dismutase (SOD), catalase and glutathione 
peroxidase (GPx) [70].  
Superoxide dismutase (SOD) catalyses the dismutation of the highly reactive 
superoxide anion to O2 and to the less reactive species H2O2. The reaction product (H2O2) can 
be destroyed via catalase and glutathione peroxidase (GPx). In humans there are three main 
forms of SOD, namly mitochondrial Mn-SOD, cytosolic Cu/Zn-SOD and extracellular SOD 
[70]. Mn-SOD is a homotetramer and contains one manganese atom per subunit, which cycles 
from Mn (III) to Mn (II) during the dismutation reaction. The major source of free radicals is 
the respiration chain in the mitochondria. It has been shown that cytokines have an impact on 
induction or depression of Mn-SOD, whereas oxidants influence Mn-SOD only moderately 
[71]. There is also evidence that the transcription factors NFκB and AP-1 have impact on the 
expression of Mn-SOD [72]. Mn-SODs are more labile to denaturation by heat, organic 
solvents or detergents than Cu/Zn-SODs. In most animals and yeast, Mn-SOD is usually 
entirely located in the mitochondria [73]. The Cu/Zn-SODs have two identical subunits of 
about 32 kDa and each of them contains a metal cluster [70]. Investigations on the distribution 
of SODs demonstrated that Cu/Zn and Mn-SOD had the highest contents in the liver. Among 
various tissues Mn-SOD contents were half as large as the Cu/Zn-SOD [74]. Extracellular 
superoxide dismutase (EC-SOD) contains also Cu and Zn and was found in the interstitial 
spaces of tissues and extracellular fluids. It accounts also for the SOD activity in the plasma, 
lymph and synovial fluid [75].  
Catalase promotes the conversion of H2O2 to water and molecular oxygen. It has a 
very high turnover rate (1 molecule of catalase converts 6 millions of H2O2 molecules into 
water within 1 minute) [76]. The catalase is present in all organs, high amounts are found in 
the liver. The enzyme is mainly located in the peroxisomes [13,76].  
Glutathione peroxidase (GPx) contains selenium and catalyse the reduction of 
adifferent hydroperoxides (e.g., ROOH and H2O2) using GSH as a substrate. Oxidised 
glutathion (GSSG) can be reduced via glutathione reductase. In mammals at least five 
isoforms of GPx are known which are located in different parts of the cell (e.g., cytosol, 
membrane, mitochondria). Although their expression is ubiquitous, the levels of each isoform 
vary, depending on the tissue type [77]. Figure 8 depicts the impact of different antioxidant 
enzymes in the detoxification of ROS. 
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Figure 8: Important antioxidant enzymes and their impact on the detoxification of ROS 
(modified after Mates et al. [70]). CAT; catalase, GPx; glutathione peroxidase, GR; 
glutathione reductase, GSH; glutathione (reduced form), GSSG; glutathine (oxidised form), 
MPO; myeloperoxidase, SOD; superoxide dismutase. 
 
Furthermore the organism also possesses enzymes (e.g., NADPH: quinone 
oxidoreductase and glutathione S- transferases) that catalyse metabolic detoxification of 
xenobiotics, drugs and carcinogens and, thus, protect the cells against oxidative stress [77]. 
GSH is not only involved in the detoxification catalysed by GPx, but involved in the 
metabolism of xenobiotics.  
Many compound are metabolised by conjugation with GSH, catalysed by glutathion-
S-transferases (GST) [13]. The GST family of enzymes comprises a long list of cytosolic, 
mitochondrial, and microsomal proteins that are capable of multiple reactions with a 
multitude of substrates and especially the liver is rich in GSTs. In mammals the alpha, mu and 
pi class are most abundant [13]. GSTs, like GPx, are involved in the detoxification of 
secondary products of ROS damaged macromolecules; this is mandatory to prevent further 
intracellular damage, degradation of cell components and eventual cell death and thus have 
antioxidant properities [11,78].  
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1.6 Conclusion: some remarks 
ROS play an important role in living organism. They are essential in regard to the 
functioning of the immune system, and are continuously generated in the cause of energy 
metabolism. Excess in formation leads to adverse effects, including numerous diseases and it 
shortens the life span. In this case it is notable that excess production of SOD, and high 
intrinsic levels of antioxidants such as uric acid are associated with a longer life expectancy in 
vertebrates and invertebrates [79,80]. Therefore it is likely that an improvement of the ROS 
protection system via dietary strategies; i.e. via consumption of components which act as 
direct scavengers or which activate transcription factors controlling antioxidative enzymes 
may have beneficial effects in humans. Numerous antioxidants have been detected in the diet. 
However it has been stressed that in many cases evidence for protection is restricted to results 
from in vitro experiments, which do not enable to draw firm conclusions if beneficial effects 
can be expected in man [13]. 
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CHAPTER 2 
METHODS FOR THE DETERMINATION OF ANTIOXIDANT 
EFFECTS IN HUMAN INTERVENTION TRIALS  
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2.1 Introduction 
A broad variety of different approaches has been developed, which are applied to 
monitor the redox status in humans. The research of antioxidants in human nutrition has 
increased considerably over the last few decades and many intervention trials have been 
performed to elucidate if dietary factors cause antioxidant effects in vivo. Several individual 
antioxidants, combination of several antioxidants and antioxidant rich foods and other plant 
constituents (e.g., gallic acid, green tea polyphenols) have been studied in human intervention 
trials. Also under disease conditions (e.g., cardiovascular disease, diabetes) intervention 
studies have been performed with antioxidative food components. The most frequent 
materials used in human studies are body fluids and blood cells (e.g., plasma, erythrocytes, 
lymphocytes, monocytes, granulocytes). The present chapter will describe methods, which are 
applied in human intervention trials. 
Basically, the different methods can be divided into two main categories namely a) 
direct markers and b) indirect markers of antioxidant activity. A short overview based on the 
different markers is given in Figure 9. 
2.2 Direct markers of antioxidant activity 
2.2.1 Total antioxidant capacity (TAC) 
To measure the TAC, two main techniques have been developed. One measures the 
ability of a substance to transfer one electron (electron transfer). Due to this property 
radicals, carbonyls or metals are reduced. The most common tests, which belong to this 
category, are the trolox equivalent antioxidant capacity (TEAC), the ferric iron reducing 
antioxidant parameter (FRAP) and the diphenyl-1-picrylhydrazyl test (DPPH). The other one 
comprises methods are described which are based on the ability to quench free radicals by 
hydrogen donation (hydrogen atom transfer). A variety of test systems, such as the total 
radical trapping antioxidant parameter (TRAP) and the oxygen radical absorbance capacity 
test (ORAC), as well as methods measuring the inhibiton of linoleic acid or LDL oxidation 
fall into this category.  
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Figure 9: Biomarker of oxidative stress (adapted from Wood et al. [81]) 
 
The measurement of TAC can be used in human and animal studies (determination of 
TAC in plasma/serum), but to a great extent, these measurements are used to determine the 
antioxidant potential of foodstuffs. The pitfalls and limitations of each method are described 
in more detail in recent reviews [2,81-83].  
The principle of the electron transfer (ET) methods is, that the sample itself is an 
oxidant that abstracts an electron from an antioxidant. The total antioxidant capacity indicates 
therefore the total reducing capacity.  
For example, the TEAC assay measures the antioxidant capacity of plasma compared 
with the activity of a strong Vitamin E analogue (“Trolox”) [84]. The TEAC assay is based on 
the ability of antioxidants to scavenge blue-green colored 2,2´-azinobis (3-
ehtylbenzthiazoline-6-sulfonic acid) radicals (ABTS-). This chromophore has the advantage 
of being soluble in organic solvents and aqueous conditions and its reactivity is not affected 
by ionic strength, therefore it can be applied to determine lipophilic and hydrophilic 
antioxidants [83]. The concentration of the amount of ABTS- which accumulates within a 
fixed time period is used to quantify the antioxidant capacity, which is calculated as Trolox 
equivalents [85].  
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In the FRAP assay the reduction of 2,4,6-tripyridyl-s-triazine (TPTZ) to a colored 
product is determined. In order to maintain the solubility of Fe, this approach is conducted at 
acidic conditions (pH of 3.6) [86]. This assay (similar to other “reducing assays”) does not 
enable to monitor compounds that quench radicals, for example thiolic compounds such as 
glutathione or proteinsm, therefore the antioxidant capacity of the samples may be 
underestimated. A modified version is the copper reducing assay (CUPRAC) in which iron is 
replaced by Cu (Cu 2+ is reduced to Cu 1+). The advantage of this protocol is that thiol type 
antioxidants can be determined (such as GSH), Cu has a lower redox potential (more 
selective) and high stability. 
Another assay developed by Brand Williams et al. [87] uses the 2,2 diphenyl-1-
picrylhydrazyl radical, which is commercially available. Compared to ATBS-, the DPPH 
measurement is carried out under nearly physiological conditions (i.e. pH 7.0) [88]. The 
different compounds used for the TAC assays described above are depicted in Figure 10.  
 
 
Figure 10: Substrates, which are used to determine the total antioxidant capacity based on 
electron transfer reactions. ABTS.- - 2,2´- azinobis(3-ethylbenzthiazoline-6-sulfonic acid); 
DPPH - 2,2 diphenyl-1-picrylhydrazyl radical; [Fe(III) (TPTZ)2] (TPTZ; 2,4,6-tripyridyl-s-
triazine), [Cu(II)-Nc2]2+ (Nc- Neocuprine, 2,9-dimehtyl-1,10-phenantroline). 
 
The majority of the hydrogen atom transfer methods uses a reaction scheme, in which 
antioxidant and substrate compete for thermally generated peroxyl radicals through 
decomposition of azo compounds. The first TAC method was the TRAP assay developed by 
Wayner et al. [89] using 2,2´- azobis (2,4-amidinopropane) dihydrochloride, a hydrophilic 
azo-compound which generates peroxyl (ROO-) radicals. Meanwhile, different other 
approaches have been developed which differ from each other in terms of substrates, reaction 
ABTS. - DPPH
[Fe(III) (TPTZ)2]3+ [Cu(II)-Nc2]2+
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conditions and quantitation methods [90]. In general, the samples react with ROO- radicals at 
low concentration and a significant spectroscopic change occurs between the native (original) 
sample and the oxidised sample. Only when antioxidants have been depleted the ROO- 
radicals will attack lipids and cause lipid peroxidation. A modification of the TRAP assay is 
the chemiluminescence (CL) assay, which is based on reactions with oxidants that emit CL 
(for details see [91]). 
Also the ORAC assay based on inhibition of ROO- induced oxidation by antioxidants. 
The radical reacts with a fluorescent probe thereby forming a non-fluorescent product which 
can be quantified. In the first version developed by Cao et al. [92], ß-phycoerythrin was used 
as a fluorescent agent, but due to shortcomings and inconsistencies of the results, fluorescein 
or dichlorofluorescein are currently used. These fluorescent agents are less reactive and more 
stable [83]. One advantage of the ORAC assay is that it can be easily automated [93] and 
excellent results have been obtained with well plates coupled with a microplate reader [94]. A 
disadvantage of this method and for TRAP is interference of proteins which contribute by ≥ 
80% to the total antioxidant capcity [83,90]. In order to obtain reproducible data, trolox can 
be used as internal standard or the samples must be deproteinized prior to the measurements. 
Other hydrogen atom transfere methods are the Crocin bleaching assay, inhibited oxygen 
uptake (IOU) measurements or approaches, which detect the inhibition of linoleic acid 
oxidation. 
Several critical reviews (e.g. [82,83]) emphasize, that no single test reflects the overall 
antioxidative capacity and the situation even becomes more complex, if we want to measure 
the redox status in in vivo studies. It is notable, that the different TAC assays do not provide 
information on bioavailability, in vivo stability, retention of antioxidants in tissues and 
reactivity in situ [82]. Additionally to the assay validity, special attention has to be paid to 
confounding factors such as matrix effects. Also clinical, metabolical, or physical conditions, 
which are not necessarily related to oxidative stress may influence the antioxidant capacity. 
For example, in human plasma, the TRAP values are around 103 µmol ROO- and it is known, 
that the major contributors are urate (35-65%) and plasma proteins (10-50%), followed by 
ascorbate (up to 24%) and vitamin E (5-10%). Due to pathologies, the urate levels can raise 
because of alterations in the purine metabolism, therefore in some studies an increase of 
plasma TAC was observed in diseased people. In some studies, males had higher TAC values 
than females, which may be due to higher urate levels [13]. It can be seen in Table 2 that the 
TAC values differ strongly when different methods are used. These differences appear 
because of the sensitivity of the chemical reactions on which the measurements are based and 
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the specific experimental designs (e.g., the duration of the measurements). Some assays run to 
completion (e.g., ORAC) while others run only for a fixed time period (e.g., the ATBS- assay) 
and in some a lag period is determined.  
Also the anticoagulants used to prepare plasma may affect the outcome. The use of 
heparinized tubes is better than EDTA tubes, because heparin stabilizes plasma against loss of 
TAC [95]. It has also be seen that the TAC values are general higher in males than in females 
[95,96]. 
 
Table 2: Total antioxidant capacity in human body fluids by various assays (modified after 
Halliwell and Gutterdige [13]) 
Method Principle Representative results (µM) Ref. 
ABTS- assay ET ~ 2000 [97] 
FRAP ET 1030 ± 220 [86] 
TRAP HAT ~ 1000 [13] 
Enhanced chemiluminescence HAT 829 ± 77 [98] 
ORAC HAT 3100 ± 490 [99] 
Crocin assay HAT ~ 2000 [13] 
 
Abbreviations: ABTS; 2,2´- azinobis(3-ethylbenzthiazoline-6-sulfonic acid), FRAP; ferric reducing anti-
oxidant power of plasma, TRAP; the total radical trapping antioxidant parameter, ORAC; oxygen radical 
absorbance capacity test, ET; electron transfer, HAT; hydrogen atom transfer. 
 
2.2.2 Determination of the concentrations of selected antioxidants 
Measurements of dietary antioxidants such as vitamin C [100], vitamin E [101,102], 
carotenoids (e.g., α- and β-carotene, lycopene, lutein, zeaxanthin and β-cryptoxanthin) 
[102,103] and flavonoids (e.g., quercetin, epicatechin, proanthocyanidins) are usually 
performed with high performance liquid chromatography (HPLC) linked with various 
detection systems (e.g., UV spectra, fluorescence, electrochemical detection).  
HPLC is a sensitive and highly accurate technique, however due to the expensive 
equipment, the requirement of a high degree of technical expertise, and the time consuming 
sample preparation procedures this technique is not available in all laboratory settings. 
Furthermore some technical difficulties may arise due to the fact that certain antioxidants are 
instable. Precautions include for example, protection of samples from fluorescent and direct 
light, cool temperatures during extraction and processing of the samples, and the storage of 
the samples at –80°C.  
Humans possess an endogenous defense system against ROS, which includes 
antioxidative enzymes catalysing the enzymatic detoxification of ROS as well as 
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endogenously formed compounds (e.g., glutathione, uric acid, plasma proteins), which act as 
radical scavangers. The activation of antioxidant enzymes, such as superoxide dismutase 
(SOD), catalase (CAT) and gluthatione peroxidase (GPx) are usually determined 
spectrophotometrically and commercial kits are available for this assays [104-106]. Specific 
isoenzymes can be monitored with enzyme linked immunosorbent assay (ELISA) kits. 
The reduced or oxidised form of glutathione can be determined with HPLC or with 
spectrophotometric assays [107,108]. The measurement of plasma proteins (e.g., albumin) is 
often carried out with HPLC but for protein measurements also enzymatically methods are 
available, which makes analyses for more laboratories accessible [109,110].  
2.3 Indirect markers of antioxidant activity 
2.3.1 Measurements of free radicals  
An indirect approach to determine the antioxidant properties (in body fluids) is the 
measurement of free radicals. However, this determination is difficult due to the highly 
reactive nature of ROS. The electron spin resonance spectroscopy (ESI) method measures 
the absorption of energy, which results from the interaction of ROS with an applied external 
magnetic field. For this method, spin trapping agents are required to form spin adducts, which 
are more stable than the original ROS. Because of the toxicity of the trapping agents, these 
methods have limitation in regard to their in vivo application [111]. Another indirect approach 
to determine ROS is based on chemiluminescene, which needs highly specialised equipment. 
The consequence of electron transfer reactions, initiated by a probe is the emission of light (in 
the wavelengths of near-infrared and infrared regions). The two major probes used in human 
samples are lucingenin, which detects superoxide anions and luminol, which is a more general 
detector for ROS [112,113]. Intracellular ROS can also be determined fluorometrically, with 
the dichlorofluorescein (DCFH-DA) assay using a flow cytometric analysis system. DCFH-
DA is deacetylated by cytosolic esterases, this metabolite is trapped within the cytoplasm 
where it is oxidised in the presence of ROS to 2,7 dichlorofluorescein (DCF). Furthermore 
also a number of colorimetric and fluorometric assays exist to determine H2O2, which are 
rather simple to perform, but the instability of the molecule remains problematic [114,115]. 
2.3.2 Measurement of oxidised biomolecules: DNA, proteins, lipids 
With these approaches not the quantity of antioxidants or ROS is measured, but the 
damage, which is caused by ROS. Biomarkers of oxidative damage are important in human 
trials since alterations of biologically relevant molecules have an impact on the health status. 
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The oxidation products are used to determine oxidative stress; therefore they can provide 
information about the antioxidant capacity of different compartments. 
DNA is highly susceptible to radical-induced damage. Oxidative alterations are 
measured in many laboratories since it is assumed that such damage is involved in the 
etiology of many diseases, including cancer. The incidence of most cancers rises with the 
fourth of fifth power of age in animals and about 35% of humans have cancer by the age of 
85. Since the beginning of the 80ties it has been hypothesized that aging is due to a lifetime of 
attack by ROS [116]. It is notable, that oxidative adducts occur at a frequency of 1 or more 
orders of magnitude higher than non-oxidative adducts [37]. However, so far it has been not 
proven that oxidised DNA is a valid biomarker for cancer risks [117]. In the following 
section, several measurements are described which are used in dietary human intervention 
studies to determine the oxidative state of the DNA.  
The most important oxidation product formed as a consequence of ROS mediated 
damage is 8-hydroxydeoxyguanosine (8-OHdG), which can be monitored with different 
methods in urine and peripheral lymphocytes of humans. Most frequently used methods are 
based on chromatography such as gas chromatography coupled with mass spectrometry 
(GC/MS), liquid chromatography prepurification followed by gas chromatography coupled 
with mass spectrometry (LC-GC/MS), liquid chromatography coupled with tandem mass 
spectrometry (LC-MS/MS) and others [2]. Recently also attempts have been made to develop 
enzyme linked immunosorbent (ELISA) kits [118]. It is known that guanine is prone to 
oxidation if precautions are not taken during the preparation of samples for analysis [119], 
therefore also artefacts might be measured. There are also large discrepancies between results 
obtained with different methods for the determination of 8ohdG (for details see [2]). For 
example, GC/MS estimates of DNA oxidation are consistently higher than HPLC estimates by 
a factor of 10 [120]. The cause of these differences is artificial oxidation with GC-MS vs. an 
underestimate due to inefficient enzymatic digestion with HPLC-ECD [121]. Also the results 
obtained with ELISA are different to those of chromatographic methods. Attempts have been 
made by the European Standards Committee on Oxidative DNA Damage (ESCODD) to 
compare different groups in several countries to clarify methodological questions and to 
develop optimal protocols [122-124]. So far, more than 20 studies have been published, in 
which the impact of dietary factors on 8-OHdG was measured [125,126]. 
The single cell gel electrophoresis (SCGE) assay is based on the determination of the 
migration of DNA in an electric field. DNA damage leads to comet shaped images, therefore 
this technique is also called “Comet assay” (see Figure 11). The first experiments were carried 
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out under neutral conditions, which allowed only the detection of double strand breaks [127], 
subsequently a modified protocol was developed by Singh et al. [128] and Tice et al. [129] in 
which the DNA is unwinded under alkaline conditions (pH>13). This version enables also the 
determination of single strand breaks, DNA protein crosslinks and apurinic sites. The target 
cells used in most human studies are peripheral lymphocytes, only few investigations were 
carried out with exfoliated epithelial cells from the buccal cavity [130-133]. The use of 
epithelial cells is problematic due to their low viability. Recently, a human intervention trial 
was published in which bioptic material from the colon was used to investigate the influence 
of fried meat consumption on DNA stability [134]. More information concerning human 
intervention trial and the application of the SCGE assay is provided in a review which is part 
of the present thesis (page 135) [135]. 
 
 
Figure 11: High (A), moderate (B) and undamaged (C) cell nuclei (examined with the SCGE 
technique) 
 
The cytokinesis block micronucleus (CBMN) method developed by Fenech et al. 
[136,137] allows to monitor micronucleus (MN) formation in peripheral blood cells in vitro 
and can be also used in dietary human studies with lymphocytes. This assay is one of the most 
important techniques to assess structural and numerical chromosome damage and has widely 
replaced conventional chromosomal aberration (CA) analyses as the MN experiments are less 
time consuming and laborious. The procedure is based on the use of the mitogen 
phytohaemagglutintin (which stimulates nuclear division), in combination with cytochalasin 
B (which stops cytokinesis). Treatment of the cells with these chemicals leads to formation of 
binucleated cells, which are a signal of replication. The CBMN assay can be evaluated using 
simple morphological criteria. Additionally other endpoints of genotoxicity and cytotoxicity 
can be determined, such as chromosome breakage, chromosome loss, chromosome 
rearrangement (nucleoplasmic bridges), cell division inhibition, necrosis and apoptosis (see 
Figure 12). Only few studies have been performed to investigate the impact of nutritional 
factors in humans with the MN assay. Examples are interventions with red wine [138-140] 
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and vitamin C [141], a comparative study of vegetarians and non-vegetarians [142] and 
experiments concerning the role of folic acid and vitamin B12 [143]. 
 
 
Figure 12: Examples of different endpoints, which can be evaluated with the cytokinesis 
block micronucleu (CBMN). A: cell with two micronuclei, B: nucleoplasmatic bridges, C: 
nuclear buds, D: apoptotic cell, E: necrotic cell 
 
Cell membranes are highly susceptible to lipid peroxidation (LP) due to their specific 
composition, which is characterized by their high content of polyunsaturated fatty acids 
(PUFAs). PUFAs are sensible to oxidation, as the presence of a double bond weakens the C-H 
bonds on the adjacent carbon atoms, facilitating H+ removal. Free radicals (e.g., hydroxyl 
radical- OH-, alkoxyl radical- RO- and peroxyl radical- ROO-) initiate LP in mitochondrial 
and microsomal membranes rich in PUFAs. LP oxidation is a chain reaction and leads to 
alterations of the membrane properties, which include inactivation of membrane-bound 
receptors and enzymes, disturbance of the membrane fluidity, increase of the permeability and 
also rupture the membranes, which leads to a release of the cell organelle contents [81]. 
Oxidative damage of membrane PUFAs leads to formation of numerous products, most of 
them are unstable and degrade rapidly (e.g., shortchain alkanes and aldehydes). Some of the 
intermediates or endproducts are used for in vivo measurements of LP, for example 
conjugated dienes, malondialdehyde (MDA), F2-isoprostanes, exhalation of the alkanes 
pentane and ethane gases and cytotoxic aldehydes [144]. The most important parameters are 
described below.  
Determination of malondialdehyde (MDA) and thiobarbituric acid-reacting 
substances (TBARS) in body fluids is one important and widely used parameter of PUFA 
peroxidation [2]. The derivatisation of MDA with thiobarbituric acid (TBA) results in 
formation of a pink MDA-TBA adduct, which is quantified using a spectrophotometer [111]. 
There are several concerns regarding the validity and specificity of this method [111,145]. It 
has been stressed, that the presence of iron in the assay reagents may lead to false results. 
Other sources of uncertainties are the rapid metabolism of MDA and the fact that MDA 
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represents less than 1% of lipid peroxide [111]. Also heating of the samples with TBA at low 
pH is far from physiological conditions and not only free MDA in the original sample is 
measured but also the aldehyde generated during this procedure by decomposition of lipid 
peroxides [146]. Also other compounds like haemoglobin, sugars or amino acids present in 
the sample can interact with TBA. HPLC separation of these compounds before to the acid 
heating can increase the sensitivity of the assay. The harsh conditions of the sample 
preparation and the cross reactivity with other aldehydes might be an explanation of the 
overestimation of MDA levels by commonly used TBAR measurements (more than 10-fold) 
[147]. Furthermore, MDA is not only formed during LP but is also a byproduct of 
cyclooxygenase activity in platelets [148]. Attempts are made to refine the techniques for the 
measurement of MDA, but the clinical relevance of this approach as an index of LP is 
questionable. Nevertheless it is notable that it has been shown by a large number of studies 
that increased levels are found in patients with ROS related diseases, such as cancer, diabetes 
and cardiovascular disease [149]. 
Isoprostanes are isomers of enzymatically formed prostaglandins [150]. The 
advantages of their use as marker of isoprostanes are that they are structurally stable, they are 
produced in vivo and are present in relatively high amounts [151]. Morrow et al. [152] 
discovered in the 1990s the formation of prostaglandin F2-like compounds in humans by non-
enzymatic free radical-induced peroxidation of arachidonic acid. At present, the measurement 
of isoprostanes is regarded as one of the most reliable markers of oxidative stress. It has been 
postulated that the measurement of 8-iso-PGF-2α is 20 times more sensitive than the 
determination of thiobarbituric acid-reactive substance (TBARS) [151]. A large number of 
endproducts are generated but interest has focused mainly on F-2-Isoprostanes in particular, 
on 8-iso-prostaglandin F-2α (PGF-2α) (sixty-four different F-2-isprostanes exist) [13]. One 
important consideration to ensure reliable isoprostane measurements is to prevent the 
autooxidation of the samples, therefore the probes should be stored immediately after 
collection at –80°C and addition of antioxidants (e.g., butylated hydroxytoluene (BHT) and 
triphenylphosphine (TPP)) during sample processing is recommended [81,153]. Several 
approaches are available for the detection of F-2 isoprostanes in biological fluids (e.g., urine, 
plasma) including radioimmunoassay (RIA), enzyme immunoassay (EIA), high performance-
liquid chromatography (HPLC), liquid chromatography-tandem mass spectrometry (LC-
tandem MS), gas chromatography-mass spectrometry (GC-MS) and GC-tandem MS. The first 
results were obtained by use of the MS technique, which allows the structural identification of 
several isoprostanes, isoprostane esters and isoprostane metabolites [153]. Mass spectrometric 
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methods are expensive and time consuming, but they are highly specific and sensitive. More 
recently also radio- and enzyme immunoassays have been developed for isoprostane 
measurement [154,155]. The results obtained with these techniques correlate quite well with 
the findings of GC-MS measurements [155], however some discrepancies can occur due to 
the cross reactivity of the antibodies with other prostaglandin metabolites, especially in 
plasma samples [156]. Therefore purification methods before using immunoassays should be 
applied to improve specificity. Although the measurement of F-2-Isoprostanes by mass 
spectrometry is regarded as the most reliable method [157], the use of immunoassays might 
be appropriate in intervention studies with various samplings from the same subject, if the 
results are not focused on the absolute levels but on the relative change [2]. Several human 
intervention studies showed that intake of antioxidants can suppress the levels of isoprostane 
formation. For example, in an intervention study with high doses of antioxidants (including 
vitamin C, vitamin E and ß-carotene) the participants had a reduced level of isoprostane by 
25-55% after 2 weeks of supplementation and also the application of vitamin E for 2 weeks in 
a human trial resulted in a decrease of isoprostane formation by 37% [81]. 
After peroxidation of ω-6 and ω-3 polyunsaturated fatty acids (PUFAs), the relatively 
unstable fatty acid hydroperoxides are converted into more stable aldehydes. The main 
aldehydes formed after peroxidation of ω-3 PUFAs are propanol and 4-hydroxyhexenal and 
whereas the peroxidation of ω-6 leads to the formation of 4-hydroxynonenal (4-HNE) and 
hexanal [158,159]. These LP products are the most frequent formed aldehydes in biological 
tissues [160]. The most common used method to determine the aldehyde concentrations are 
based on GC-MS [161]. Experiments with mammalian cells indicate that 4-HNE causes acute 
cytotoxicicity [159], furthermore it induces also rapid depletion of GSH, inhibition of DNA, 
RNA and protein synthesis, LP and inhibition of respiration and glycolysis which precede the 
cell death [160]. The in vivo concentrations of “free” aldehydes are low, because of their 
conjugation to proteins. This fact, makes the assessment of their true levels based on HPLC or 
GC methods difficult. A wide range of antibody-based methods for the determination of 
aldehyde-protein conjugates are available [13]. The antibodies which are available have 
variable specificity; for example the preferred antigen recognized by monoclonal anti-HNE 
antibody Ig4 is an HNE histidine adduct [162]. 
The measurement of breath hydrocarbons is a non-invasive method which is based 
on the determination of LP through exhaled breath by determination of trace volatile 
hydrocarbons [163]. The end products of ω-6 fatty acid peroxidation are pentane and its 
isomer isopentane while from ω-3 fatty acid peroxidation ethane is formed. ω-6 PUFAs 
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predominate in the human body, so that pentane would be formed predominantly if all PUFAs 
would peroxidize equally. Both gases are measured by use of GC [164]. The expired breath is 
passed through an adsorbent, which concentrates the hydrocarbons, which are then desorbed 
and assayed. These approaches have some disadvantages; the hydrocarbons are minor 
endproducts of peroxidation and their formation depends on the presence of transition metals 
and oxygen concentrations [165], also bacteria present in the skin, colon and/or cavity 
produce hydrocarbons in significant amounts. Furthermore, the air in large cities is 
contaminated with hydrocarbons due to combustion processes (e.g., motor vehicle, 
environmental smoke) [13] and analytical problems were encountered in the past to separate 
pentane from isoprene, resulting in high levels of breath pentane. As a consequence, attempts 
have been made to improve these techniques. Some human studies indicate increased levels of 
hydrocarbon exhalation with age, smoking, hyperoxia, scleroderma, diabetes and some lung 
disease [13,166-169]. 
The oxidation of lipoproteins, in particular of low density lipoproteins (LDL) 
cholesterol plays an important role in the development of artheriosclerosis [170]. Beside of 
analytical methods (GC/MS, HPLC/MS) an enzyme-linked immunosorbent assay (ELISAs) 
kit is available to detect oxidised LDLs (oxLDL) in a quick and simple manner. The 
antibodies are directed against the oxidative modifications of LDL. This technique provides 
an in vivo marker of protein or lipid peroxidation.  
Proteins can be damaged directly via ROS or via LP products (e.g., 4-HNE). The 
oxidative damage leads to alterations of the function of biomolecules such as transport 
proteins, receptors and enzymes. Modification of membrane proteins might lead to a 
disturbance of the ionic balance. Markers of protein oxidation are in general less frequently 
used than LP parameters and are mainly used in combination with them [2]. Protein 
carbonyls are formed as a consequence of the oxidation of amino acid side chains can be 
detected with the “carbonyl assay”. To determine protein carbonyls a conventional 
colorimetric assay with 2,4-dinitrophenylhydrazine is used [171]. Other methods to determine 
protein carbonyls are atomic absorption spectroscopy, fluorescence spectroscopy, HPLC [81] 
and spectrophotometrically by ELISA techniques. The detection of protein carbonyls is 
widely used in different laboratories. However, there are considerable variation reported in 
the baseline levels of protein carbonyls, depending on the assay performance [13].  
The attack of tyrosine leads to formation of 3-nitrotyrosin (3-NT), which can be 
measured by GC/MS [172], HPLC [173] and also with immunological methods [174].  
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2.4 Conclusions and outlook 
The assumption that there is no individual biomarker, which can be used for the 
characterisation of oxidative stress, is due to the complexicity of the reactions of different 
ROS. Dotan et al. found in a recent evaluation only weak correlations of commonly used 
parameters of oxidative stress [50]. The authors analysed the results of studies in which two 
or more methods were used under identical conditions and conclude that relationships 
between peroxidation products such as malondialdehyde, F-2 isoprostans, and carbonyls exist 
but not with concentrations of antioxidants and DNA migration. Inconsistent findings were 
also seen in human intervention trials where multiple endpoints were determined. For 
example in a study where the participants (n=18) were asked to consume 
anthocyanin/polyphenolic rich fruit juices the DNA migration in lymphocytes was decreased 
and increased levels of reduced GSH was observed, while other parameters of oxidative stress 
(e.g., MDA in plasma, excretion of isoprostanes in urine) were not affected. –Omics based 
approaches (genomics, proteomics, metabolomics) are increasingly used to study the impact 
of dietary antioxidants on human health. A detailed review about the advantages and 
shortcomings of the different methods has been published recently by Knasmüller et al. [2]. 
The authors conclude that the new high throughput techniques do not allow to establish 
antioxidant specific patterns of gene transcription and protein alterations, but stress that these 
approaches can provide evidence for protective effects of antioxidants in specific 
experimental settings and reversions of gene and protein expression patterns caused by ROS 
related diseases. 
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CHAPTER 3 
 
ANTIOXIDANT EFFECTS OF COFFEE CONSUMPTION 
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3.1 Introduction 
Coffee is one of the most widely consumed beverages worldwide. Its production 
(about 70 % Arabica and 30 % Robusta) varies annually and has increased by about 15-20% 
in the last 20 years from 5.2 million tons per year in 1984 to 5.9-6.4 million nowadays [175]. 
Besides of caffeine, which is well known for its stimulant effects, coffee contains numerous 
other bioactive substances. These compounds include, purine derivatives, polyphenolics 
including chlorogenic acid and its degradation product caffeic acid, Maillard reaction 
products and diterpenes such as cafestol and kahweol (C+K) [176]. Pellegrini et al. [177] 
demonstrated that coffee itself possesses a higher antioxidant activity compared to other 
beverages (e.g., 5 fold higher than green tea and 3 fold higher than red wine). Besides of 
antioxidant properties seen in in vitro studies there is also evidence from animal experiments 
and human studies. The consequences of coffee consumption on human health have been 
studied during the last decades and a series of epidemiological studies have associated coffee 
consumption with beneficial health effects, such as reduction of the risks of certain forms of 
cancer [178], diabetes type 2 [179], Parkinson and Alzheimer diseases [180] and it is 
conceivable that these protective effects are partly due to inactivation of ROS by coffee 
components.  
This chapter concerns the antioxidant properties of coffee and its constituents with 
particular emphasis on human intervention trials, which have been conducted so far including 
studies, which have been carried out in course of the present thesis (see publications). 
3.2 Bioactive constituents of coffee 
Coffee is a complex mixture and contains a broad variety of substances [176]. In the 
volatile fraction more than 1400 different substances, which are responsible for its smell and 
flavour. The most intensely studied substances in the volativle fraction are shown in Figure 1. 
Some of them possess antioxidant properties and/or alter drug metabolizing or DNA repair 
enzymes (for details see [181]).  
Caffeine (1,3,7, trimethylxanthine) is a purine alkaloid and antagonizes the adenosine 
receptor [182,183]. This results in stimulatory effects, such as elevation of blood pressure, 
increased metabolic rate, diuresis and stimulation of the central nervous system [184]. The 
alkaloid is almost completely and rapidly absorbed in the stomach and in the small intestine, 
thereafter it is distributed to all tissues including the brain [185]. A number of low dose in 
vitro experiments provide evidence that caffeine may contribute substantially to the 
antioxidant effects of coffee [186-188]. 
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The coffee specific diterpenoids cafestol and kahweol (C+K) are responsible for the 
cholesterol raising effects of coffee [189]. They are present in unfiltered coffee, therefore 
Scandinavian boiled coffee, Turkish coffee and French press coffee contain high levels of 
C+K, whereas filtered coffee and instant coffee contain low levels [189,190]. Animal studies 
indicate that C+K induce phase II enzymes and inhibit phase I enzymes which activate 
carcinogens [191] and recent findings of Higgins et al. [192] indicate that they are responsible 
for the induction of the transcription factor Nrf2, which regulates enzymes involved in the 
antioxidant defence system. 
A number of investigations indicate that hydrocinnamic acids, e.g. chlorogenic acid 
(CA) and caffeic acid, which are the major phenolic compounds found in coffee, play a key 
role in the antioxidant effects of coffee [7-9]. It has been shown that CA and caffeic acid are 
well absorbed in humans, but so far it is still unclear if the effects of seen in in vitro studies 
are relevant for humans, because they are extensively metabolized and metabolites of 
phenolics have often lower antioxidant capacities [4].  
During the roasting process trigonelline in coffee beans is demethylated and forms 
nicotinic acid (niacin). It has been reported that coffee contains 1-3 mg of niacin per cup 
[193]. Niacin is an important watersoluble vitamin and is converted to nicotinamide and then 
to NAD and NADP in vivo, which play essential roles in living cells. Another degradation 
product of trigonelline is N-methylpyridinium, which possess antioxidative properties 
(induction of GST, elevated TAC levels in an animal feeding study) [194].  
The bioactive substances in coffee, which possess antioxidant properties, are listed in 
Table 3. 
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Figure 13: Structures of bioactive constituents of coffee (adapted from Faustmann et al. [181]) 
 
The antioxidant capacity of instant coffees (e.g., [177,195-198]) and also for filtered 
coffees (e.g., [199-201]) has been demonstrated in a number of in vitro studies. In this context 
it is notable that also adverse effects have been observed, for example induction of mutations 
in the Salmonella/microsome assay, which were attributed to formation of hydrogen peroxide. 
However, addition of a metabolic activation mix (S9) diminished these effects [202]. 
Also animal studies indicate antioxidative effects of coffee (for details see [203]). For 
example, in a study with instant coffee (8 days, 0.146-0.351 g coffee) which was given to 
CCl4 treated Sprague-Dawley rats a increase of the TAC levels and a decrease in MDA levels 
was detected [204]. Furthermore also induction of GST levels attributable to coffee 
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consumption was observed in the study of Huber et al. (treatment with Turkish coffee) [205] 
and Somoza et al. (treatment with filter coffee) [194].  
 
Table 3: Antioxidant properties of individual coffee components in vitro (adapted from [181]) 
Test compound Results and comments 
Caffeine ↓ formation of OH• and 1O2; protection against oxidative damage of calf 
thymus DNA and of radical induced migration in human lymphocytes 
 
Hydroxycinnamic acids 
CGAs, CA, FA & 
p-CMA 
numerous investigations showed inactivation of peroxides (t-BOOH, 
H2O2), scavenging of DPPH-radicals, inhibition of LP and reduction of 
radical induced DNA damage in bacterial and mammalian cells; the 
antioxidant activity of CGA and CA was higher than of Trolox 
 
Cafestol & Kahweol no antioxidant effects were found in in vitro experiments with human 
lymphocytes, Induction of Nrf2 and antioxidant enzymes in mice 
  
Maillard products 
Melanoidins 
most studies were conducted with “model mixtures”, only in one, 
melanoidins from coffees with different degrees of roasting were tested, 
antiradical effects were found to ↓ with roasting time but prevention of 
LA peroxidation ↑ with roasting 
 
Guaiacol  
& derivatives 
fat-soluble phenolic compounds were found to possess high antioxidant 
activity in MDA experiments 
 
Trigonelline & niacin  were found to possess lower antioxidant properties than CGA and 
caffeine (measurement of deoxyribose degradation) 
 
Caffeoyltryptophan & 
protocatechuic acid 
 
caused similar effects as CA and CGA (DPPH-radical scavenging) 
Pyrolysis products of 
caffeic acid  
 
different components were found protective at low doses 
Heterocyclic compounds  strongest effects were seen with 2-acetylpyrrole and 1-methylpyrrole 
(measurement of conversion of hexanal to hexanoic acid) 
 
Abbreviations: CA; caffeic acid, CGA; chlorogenic acid, DPPH; diphenyl-1-picrylhydrazyl, FA; ferulic acid, 
LA; linoleic acid, LP; lipid peroxidation, MDA; malondialdehyde, 1O2; singlet oxygen, OH•; hydroxylradical, p-
CMA; p-coumaric acid, t-BOOH;  t-butylhydroperoxide 
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3.3 Epidemiological studies concerning health effects of coffee 
In the recent article of Higdon and Frei [4] the results of epidemiological studies were 
summarized and the authors conclude: 
Epidemiological studies indicate a decreased risk of hepatic injury, cirrhosis and 
hepatocellular carcinoma related to coffee consumption (e.g., [206-208]). In this context it 
is notable, that oxidative damage plays a crucial role in the etiology of these diseases and 
numerous studies indicated that dietary antioxidants are preventive against the devolopment 
of these injuries [209,210]. Furthermore it is well documented that cirrhosis is associated with 
increased incidences of hepatocellular cancer. It is also assumed that ROS play a crucial role 
in this disease [211,212]. In this context it is notable that the acitivites of serum aspartate 
aminotransferase (AST) and/or alanine aminotransferase (ALT) were decreased in two 
Japanese case control studies due to coffee consumption. 
Furthermore, case control studies indicate inverse associations between coffee and 
colorectal cancer risk, but this effect has not generally been confirmed in prospective cohort 
studies [213,214]. Beside of other mechanism (e.g., insulin resistance), oxidative stress (e.g., 
via inflammation) may also play a role in the development of colorectal cancer and thus might 
be prevented via antioxidants [215].  
In several large prospective studies an inverse association between the risk of 
Parkinson disease and the caffeine consumption from coffee has been found (e.g., 
[216,217]). In the case of neurological disorders it is less clear if the antioxidant effects of 
coffee play a role as other modes of action (e.g., ability of caffeine to block adenosine A2A-
receptors) may account for its protective properties.  
Prospective cohort studies indicate a dose dependent relationship between coffee 
consumption and reduced risk of type 2 diabetes. (e.g., [179,218]). It is also unclear if 
antioxidant effects play a role in diabetes. Recent studies indicate that the impairment of 
glucose uptake by coffee components for example chlorogenic acid account for this effect 
[219]. It is notable that this phenomenon may lead to a hypocaloric state, which leads to 
changes of the mitochondria functions and as a consequence to lower release of reactive 
oxygen species. 
It is also interesting that prospective studies have not found an association between 
coffee consumption and an increased risk of cardiovascular disease or stroke [220-223]. But 
randomised controlled trials (up to 12 weeks) found an increase in cardiovascular disease risk 
factors, such as blood pressure and plasma homocystein levels [224]. 
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It has been suggested that for adults consuming moderate amounts of coffee (3-4 
cups/d), little evidence exists for health risks, but some evidence of health benefits. Some 
groups, including people with hypertension, children, pregnant women and elderly may be 
more vulnerable to the effects of caffeine. 
3.4 Human intervention studies with coffee 
Several human intervention studies have been carried out to investigate the effect of 
coffee consumption on different markers of oxidative stress and/or on detoxifying enzymes. 
The main results of these human intervention trials are summarised in Table 4.  
3.4.1 Impact of coffee consumption on DNA stability 
Hoelzl et al. [225] and Bichler et al. [226] (see publications, page 79 and 91) measured 
the influence of coffee consumption on the DNA stability in human intervention trials with 
the single cell gel electrophoresis (SCGE) technique. The SCGE assay is based on the 
determination of the migration of DNA in an electric field. Undamaged DNA retains with 
matrix proteins in the nucleus, wherease damaged cells migrate and thus form comet like 
structures (viewed by fluorescence microscopy). 
In the pilot study of Bichler et al. [226] (n=8, 200 ml French press + 400 ml 
paperfiltered coffee/d, 5 days) a significant reduction on the formation of oxidised purines and 
pyrimidines was observed after coffee intake, furthermore the sensitivity towards H2O2 
induced DNA damage was reduced (for details see paper I, page 79). 
On the contrary in the study of Hoelzl et al. [225] (n=29, 800 ml instant coffee/d, 5ds) 
no significant alterations of oxidised purines or pyrimidines and no reduction of H2O2 induced 
DNA damage was observed after the coffee drinking period. However, a slight decrease of 
these parameters was detectable but reached only in female volunteers in the case of FPG 
significance (detection of oxidised purines) after coffee consumption (for details see paper II, 
page 91).  
The article of Steinkellner et al. [227] (for details see paper III, page 121) reports on a 
reduced sensitivity of peripheral human lymphocytes against (±)-anti-B[a]P-7,8-dihydrodiol-
9,10-epoxide (BPDE) induced DNA damage attributable to coffee cosumption which might 
be due to the induction of GSTP an detoxifying enzyme of polycyclic aromatic hydrocarbons 
(PAHs). 
In an Italian questionnaire-based study (n=71) oxidised purines were determined 
(modified SCGE with formamidopyrimidine DNA glycosylase) [228] and a positive 
association with coffee consumption was detected, whereas in another questionnaire based 
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study (n=102) an inverse (but not significant) correlation between coffee consumption and 
formation of 8-OHdG in leukocytes was observed [229].  
The urinary mutagenicity of coffee drinkers (n=32, 12g instant coffee/d for 12 ds) was 
investigated by Aeschbacher and Chappuis [230] in the Salmonella/microsome assay, but no 
significant alterations were detected.  
3.4.2 Determination of lipid peroxidation products in human intervention trials 
Natella et al. [231] found in a recent study that coffee consumption (n=10, 200 ml/P, 
once) induces incorporation of phenolic acids into LDL and increases the resistance of LDL 
to ex vivo oxidation. This observation is in agreement with the findings of an earlier study of 
Yukawa et al. [232], who conducted a human intervention study with instant coffee (n=11, 8 
g/150 ml, 7 ds) and also reported on increased resistance of LDL to ex vivo oxidation, 
furthermore, a reduction of total cholesterol, LDL-cholesterol and MDA was observed after 
coffee intervention.  
A large clinical trial in which 43 healthy non-smoking men were included no effects 
on LP parameters (serum LDL conjugated dienes, plasma hydroxy fatty acids, plasma F2-
isoprostanes, serum cholesterol and triacylglycerol, serum LP resistance, LDL and HDL 
cholesterol) were detected. The participants (all males) of this study drank either 3 (450 ml) or 
6 (900 ml) cups of paper-filtered coffee for 3 weeks. Also the single dose study 1 (150 ml), 2 
(300 ml) cups of the same coffee brand did not cause any changes.  
In the clinical trial described in paper II (page 91) the participants (n=29) were asked 
to drink 800 ml instant coffee for 5 days and different LP parameters such as MDA, oxLDL 
and F2-Isoprostane levels were determined. No alterations of the MDA or oxLDL levels were 
detected, but a significant decrease of F2-isoprostane levels was detected in the urine samples 
of the participants after coffee consumption.  
3.4.3 Impact of coffee consumption on the activites of detoxifying enzymes 
Several studies investigated the impact of coffee consumption on detoxifying enzymes. 
Bichler et al. [233] (paper I, page 79) observed an increase of superoxide dismutase (SOD) 
after the coffee consumption period, whereas no increase in the activity of glutathione 
peroxidase (GPx) was detected in human peripheral lymphocytes. On the contrary, no 
changes in the levels of SOD and GPx were observed after coffee intake (800 ml/p/day, 5 ds) 
in the study of Hoelzl et al. [225] (paper II, page 91), in which the parcitipants consumed 
instant coffee. Also Mursu et al. [234] measured the GPx activities in the plasma of the 
participants before and after coffee consumption and found no significant changes. 
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Steinkellner et al. [227] (paper III, page 121) found higher levels of GST (glutathione-
S-transferase π) after coffee drinking, this phenomena was observed with both filtered and 
unfiltered coffee. An earlier human observation by Sreerama et al. [235] indicated elevated 
levels of GST (α, µ and π), aldehyde dehydrogenase (ALDH) and DT-diaphorase in salvia and 
plasma of coffee drinkers (>150 ml/d). These enzymes were also increased in an intervention 
trial with one volunteer (22 days, 1-2 l/d). In an investigation with (metal filtered) French 
press coffee no alteration of GST activity in colorectal mucosa cells was seen [236].  
3.4.4 Impact of coffee consumption on endogenous antioxidants, total antioxidant 
capacity, H2O2 formation and protein nitrosation 
In two earlier studies an increase of the endogenous formed antioxidant glutathione 
(GSH) was reported. In one of them, plasma GSH was determined [237], in the other GSH 
levels were determined in colorectal mucosa cells [236].  
Also the total antioxidant capacity (TAC) levels measured with TRAP and the crocin 
test were elevated after coffee consumption (200 ml, n=10, once) in the study of Natella et al. 
[238]. Comparison with tea consumption carried out in the same trial indicated that coffee has 
higher antioxidant potency. These measurements were carried out in the plasma of the 
participants [238]. In another study by Garsetti et al. [239] the antioxidant activity in feces of 
the volunteers was determined (with the ABTS- decolorisation assay), the results indicate that 
coffee increase the antioxidant activity.  
Elevated urinary levels of H2O2 were detected after coffee consumption in two 
intervention trials, one trial was conducted with instant coffee the other study was conducted 
with brewed or canned coffee [240,241]. Also the results of a questionnaire-based study 
(n=33) indicate that the H2O2 levels in the urine of coffee drinkers are increased [242].  
In the clinical trial described in paper II (see page 91) GSH levels were monitored in 
erythrocytes of the volunteers and no alterations due to coffee consumption were detected, 
also the TAC in plasma and the intracellular ROS levels (lymphocytes) were not altered. Due 
to our knowledge the study described in paper II is the first were protein nitrosation has been 
determined in a human intervention trial with coffee and we observed a significant decrease 
due to coffee consumption of this parameter. 
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Table 4: Human intervention studies 
Design/coffee type/dose Measurement Results and comments Ref. 
Studies indicating pro-oxidative effects of coffee consumption 
n=71 
questionnaire based  
SCGE with restriction enzyme 
(FPG) 
↑ DNA damage (low vs. high 
coffee consumers) [228] 
n=10 
1 cup of brewed (20 g/140 ml, 
without sugar and milk) or 
canned coffee (187 ml, with 
sugar and milk), once 
H2O2 concentration in urine by 
FOX assay for 200 min after 
coffee consumption 
↑ 3-10-fold of H2O2 levels after 
consumption; peak between 50 and 
100 min. 
possible H2O2 generating 
component is 1,2,4-benzenetriol 
[240] 
n=4 
1 cup of instant coffee 
(2.5 g/200 ml, with sugar and 
creamer), once 
H2O2 concentration in urine by 
FOX assay for 200 min. after 
coffee consumption 
↑ of H2O2 levels for up to 2 h. after 
coffee consumption; ≥3-fold ↑ 
after ∼30 min.;no effect of sugar 
and creamer 
[241] 
n=33 
questionnaire based 
urine was tested for clastogenicity 
in CHO-cells and for H2O2-
formation (spectrophotometrically, 
λ=575 nm) 
↑ of clastogenic effects in urine of 
coffee drinkers;  
↑ H2O2-formation (at high pH) [242] 
Studies indicating no effect of coffee consumption 
n=43 
0, 450 and 900 ml of paper 
filtered coffee, 3 wks 
 
n=35 
0, 150 or 300 ml, once 
Lipid peroxidation parameters 
(such as conjugated dienes, plasma 
hydroxy fatty acids, F2-
isoprostanes) 
Plasma total homocysteine 
Antioxidant enzymes 
GPx; SOD, PON 
↔ neither short- nor long-term 
effects on lipid peroxidation or on 
the activity of measured AO 
enzymes [234] 
n=32 
12g instant coffee/d, 4 ds or 
12 g/d, once 
urinary mutagenicity test in TA98 
and TA100 strains (± ß-
glucuronidase) 
↔ urinary mutagenicity 
[230] 
Studies indicating antioxidative effects of coffee consumption 
n=29 
800 ml/d (Instantcoffee), 5 ds, 
cross-over design 
 
SCGE under standard conditions, 
with restriction enzymes (ENDO 
III, FPG) and H2O2 sensitivity;  
 
oxLDL, MDA, 2F-isoprostane, 
SOD, GPx, GST, intracellular 
ROS, TAC, GSH, 3-NT 
RT-PCR 
↔ of DNA migration under 
standard conditions, oxidised 
purines and pyrimidines, H2O2-
sensitivity ↓ oxidised purines in 
female volunteers 
↔ oxLDL, MDA, SOD, GPx, 
GST, intracellular ROS, TAC, 
GSH, RT-PCR 
↓ F2-isoprostane, 3-NT 
[225]1 
n=8 
600 ml/d (400 ml paper 
filtered and 200 ml French 
press coffee), 5 ds 
SCGE under standard conditions, 
with restriction enzymes 
(ENDOIII, FPG) and H2O2-
sensitivity; 
GPx and SOD activity in plasma 
↔ of DNA migration under 
standard conditions;  
↓ DNA migration due to oxidised 
purines and pyrimidines; ↓ H2O2-
sensitivity ↑ SOD-  ↔ GPx-
activity 
[233]1 
n=10  
200 ml of filtered coffee 
(60 g/1000 ml), once 
LDL oxidation before, 30 and 60 
min. after coffee intake;  
ex vivo determination of 
incorporation of HCA into LDL 
↑ of lag time 30 and 60 min after 
coffee consumption by 11 and 
20%;  
↑ of CA, FA and p-CA after coffee 
consumption in LDL 
[231] 
First trial: n=10 
1l boiled coffee/d, 5 ds  
Second trial: n=7 
1l coffee/d, 3 ds (paper-
filtered vs. unfiltered coffee) 
Third trial: n=7 
1l boiled coffee/d, 5 ds 
GST activity in saliva and plasma; 
GST isozymes in plasma (ELISA) 
 
SCGE assay, comet formation 
induced by BPDE 
first trial: ↑ GST in saliva and 
blood, sign. only in plasma 
samples; ↑ of GSTpi-levels; 
↔GSTα, second trial: ↑ GSTpi 
with filtered and unfiltered coffee 
third trial: 
↓ DNA migration due to BPDE 
[227]1 
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Table 4: continued 
Design/coffee type/dose Measurement Results and comments Ref. 
n=11 
24 g instant coffee/d 
(8 g/150 ml), 7 ds 
LDL oxidation 
TBARS in blood and urine  
levels of caffeine in serum and 
CGA in urine by HPLC 
↑ of LDL-oxidation lag time (8%);  
↓ of TBARS  [232] 
 
n=23; 
5 cups/d (preparation n.s.), 7 
ds 
GSH-plasma levels by HPLC 
H2O2- plasma levels (by D-ROMS 
test), homocysteine-plasma levels 
↑ GSH levels 
↔ no significant increase of 
plasma-homocysteine levels 
↔ no effect on the oxidative status 
[237] 
n=10 
200 ml drip filtered coffee 
once 
plasma AO capacity 0,1 and 2h 
after coffee intake with TRAP and 
crocin test 
↑ AO capacity with both tests by ≥ 
4%; stronger effects with coffee 
than with tea 
[238] 
n=64, cross-over design 
1l (39g coffee/l) French press 
coffee/d, 2 wks;  
 
proliferation of colorectal cells; 
GST activity (spectro-
photometrically), GST- α, µ, π by 
Western blot; GSH levels (by 
HPLC) in mucosa cells 
↔ cell proliferation and GST-
activities;  
↑ of GSH concentrations by 8% [236] 
n=14 
participants recorded their 
food intake three 
times for a period of 2 d 
48 h dietary weighing protocol, 
subsequent 24 h collection of 
faeces;  
TAA of faeces by ABTS•+-
decolorization assay 
↑ TAA (r=0.758/p=0.002) and 
increase of faecal weight with 
coffee consumption;  [239] 
n=102 
questionnaire based 
8-OHdG measured in leukocytes 
by HPLC 
inverse relation with coffee 
consumption (not sign.) [229] 
n=25, coffee drinkers 
(>150 ml/d) vs. abstainers 
n=1, intervention with coffee 
1-2 l/d, 22 ds 
GST isozymes (α, µ, pi)  
3 aldehyde dehydrogenase  
DT-diaphorase in saliva and 
plasma 
↑ plasma and salivary content of 
all 3 enzymes  
↑ salivary enzyme levels ↓ to basal 
when coffee was removed from the 
diet (tested in one subject) 
[235] 
 
Abbreviations: ABTS•+; 2,2'-azinobis-3-ethylbenzothiazoline-6-sulfonic acid, AO; antioxidant, CA; caffeic acid, 
CGA; chlorogenic acid, CHO; chinese hamster ovary cells, ds; days, DT-diaphorase; NAD(P)H:(quinone-
acceptor) oxidoreductase, ENDOIII; endonuclease III, FA; ferulic acid, FOX; ferrous oxidation xylenol orange 
method, FPG; formamidopyrimidine DNA glycosylase, GPx; glutathione peroxidase, GSH; glutathione, GST; 
glutathione S transferase, HCA; hydroxycinnamic acids, LDL; low density lipoproteins, MDA; 
malondialdehyde, n.s.; not specified, oxLDL; oxidised low density lipoprotein, p-CA; p-cumaric acid, PON; 
paraoxonase, SCGE; single cell gel electrophoresis, SOD; superoxide dismutase, TAA; total antioxidant activity, 
TAC; total antioxidant capacity, TBARS; thiobarbituric acid reactive substances, TRAP; total radical trapping 
AO parameter, 3-NT; (±)-anti-B[a]P-7,8-dihydrodiol-9,10-epoxide, BPDE; 3-nitrotyrosine, 8-OHdG; 8-
hydroxydeoxyguanosine, ↑; increase, ↔; no change, ↓; decrease, 1 results presented in the present thesis  
3.5 Conclusion and outlook 
Taken together, the currently available data indicate, that coffee intake may protect 
humans against oxidative DNA damage and its consequences. There is some evidence that 
high coffee levels can generate hydrogen peroxide under in vitro conditions (for details see 
[243]), but it seems that these findings are not relevant for the situation in humans as the 
effects were seen under unphysiological conditions [244]. It is also notable that the detection 
of ROS in the urine (see Table 4) is not directly indicative for DNA damage in inner organs; 
and that in many of the human trials direct or indicrect evidence for antioxidant properties of 
coffee were observed. As mentioned above, the responses of the individual endpoints differed 
strongly, but this may be due to the fact that the mechanism which underly the antioxidant 
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activities are quite complex (i.e. direct scavenging, induction of tanscription factors, indirect 
mechanisms caused by reduced glucose uptake in the gastrointestinal tract).  
It has been stressed in a meta-analyses by Dotan et al. [50], that antioxidant properties 
can be not described by the measurement of individual parameters and that strong differences 
exist in the sensitivity of different endpoints. Furthermore, comparisons of the results of 
coffee studies are difficult, as the volunteers consumed different types of coffees and also the 
time schedule (duration of coffee intake) varied, which is an important for the outcome of the 
studies. 
The concentrations of putative active compounds in coffee can be modified via 
selection of the cultivars used, but also by the roasting and brewing procedures and specific 
production strategies (e.g. addition of clorogenic acid or decaffeination). This will enable to 
design coffees with increased beneficial health effects in the future. 
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The present thesis is based on orginal articles and a review. Paper I describes a pilot 
human intervention trial with a mix of paper and metalfiltered coffee. The main part of the 
thesis is a clinical human intervention trial with instant coffee (Paper II). Paper III describes a 
human intervention trail in which GST measurements were performed and also a modified 
version of the SCGE assay. The review article describes the use of single cell gel 
electrophoresis (SCGE) assays in human intervention trials. This technique is used to 
determine the DNA stability in peripheral lymphocytes of the volunteers as one of the primary 
outcomes of the studies described in paper I, II and III. 
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Aim of the study was to investigate the impact of coﬀee on DNA-stability in humans. DNA-damage was monitored in lymphocytes of
eight individuals with single cell gel electrophoresis assays before and after consumption of 600 ml coﬀee (400 ml paper ﬁltered and
200 ml metal ﬁltered/d) for ﬁve days. Under standard conditions, no alteration of DNA-migration was seen, but a strong reduction
of DNA-migration attributable to endogenous formation of oxidised purines and pyrimidines was detected with restriction enzymes;
furthermore DNA-damage caused by reactive oxygen radicals (H2O2 treatment) and by the heterocyclic aromatic amine 3-amino-1-
methyl-5H-pyrido[4,3-b]indole-acetate was signiﬁcantly reduced after coﬀee consumption by 17% and 35%, respectively. Also in
in vitro experiments, inhibition of H2O2 induced DNA-damage was observed with coﬀee at low concentrations (625 ll/ml) whereas
the diterpenoids cafestol and kahweol caused only marginal eﬀects indicating that the eﬀects of coﬀee are due to scavenging eﬀects of
other constituents. Enzyme measurements showed that additionally induction of antioxidant enzymes may play a role: while the activity
of glutathione peroxidase was only marginally increased after coﬀee consumption, a signiﬁcant (38%) increase of superoxide dismutase
activity was detected. Comparisons with results of earlier studies suggest that coﬀee consumption may prevent oxidative DNA-damage to
a higher extent as diets enriched in fruits and vegetables.
 2007 Elsevier Ltd. All rights reserved.
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811. Introduction
Coﬀee is one of the most widely consumed beverages
worldwide. The production (about 70% Arabica and 30%
Robusta) shows annual variations due to recurring calam-
ities but has generally increased by about 15–20% in the
last 20 years from 5.2 million tons per year in 1984 to
5.9–6.4 million nowadays (Clarke and Vitzthum, 2001).
J. Bichler et al. / Food and Chemical Toxicology 45 (2007) 1428–1436 1429Coﬀee contains a variety of bioactive compounds
including caﬀeine and other purine derivatives, polypheno-
lics including chlorogenic acid derivatives and its degrada-
tion product caﬀeic acid, Maillard reaction products and
speciﬁc diterpenes such as cafestol and kahweol (C + K)
(IARC, 1991). The consequences of coﬀee consumption
on human health have been studied intensely during the
last decades (for reviews see for example Stavric (1992))
and a number of epidemiological studies indicate that cof-
fee drinking is inversely related to the incidence of liver and
colon cancer in humans (Gallus et al., 2002a; Gelatti et al.,
2005; Giovannucci, 1998; Inoue et al., 2005; Kurozawa
et al., 2004; Shimazu et al., 2005).
Aim of the present investigation was to elucidate if these
protective eﬀects are causally related to prevention of
DNA-damage. It is well documented that reactive oxygen
species (ROS) play a key role in the aetiology of liver cir-
rhosis and hepatocellular carcinoma (Gebhardt, 2002;
Ichiba et al., 2003; Szuster-Ciesielska et al., 2002) and a
number of in vitro and animal studies indicate that coﬀee
and many of its constituents are protective towards ROS
(Daglia et al., 2000,2004; Devasagayam et al., 1996; Iwai
et al., 2004; Stadler et al., 1995,1996b), while results of
human studies based on food questionnaires are scarce
and controversial (Giovannelli et al., 2002; Pellegrini
et al., 2003; Svilaas et al., 2004). ROS may also play a role
in the aetiology of other forms of cancer as well as in
degenerative diseases and ageing (for reviews see Harman,
1981; Hoelzl et al., 2005; Squier, 2001).
Another potential cancer risk factor are heterocyclic
aromatic amines (HAs) which are formed during cooking
of meats. It has been shown in animal studies that the cof-
fee speciﬁc diterpenoids cafestol and kahweol (C + K)
reduce the formation of HA DNA-adducts in colonic tissue
(Huber et al., 1997), also in vitro experiments with human
derived cells provided evidence for protective eﬀects (Majer
et al., 2005), which were attributed to induction of detoxi-
fying enzymes (Cavin et al., 1998; Huber et al., 1997; Majer
et al., 2005). Over the last three decades, intense eﬀorts
have been made to identify dietary constituents which pro-
tect against HAs but evidence for eﬀects in humans are
restricted to indirect approaches, i.e. chemical analyses of
urinary metabolites and urinary mutagenicity tests (for
reviews see (Dashwood, 2002; Schwab et al., 2000).
Recently, we developed a protocol for single cell gel elec-
trophoresis (SCGE) experiments with lymphocytes which
can be used to study alterations of HA induced DNA-
damage induced by dietary factors in humans (Ho¨lzl,
2004).
To investigate the potential DNA protective eﬀects of
coﬀee in humans, we conducted an experiment in which
we monitored the eﬀects of coﬀee consumption on endoge-
nous formation of single strand breaks, oxidised purines
and pyrimidines and ROS sensitivity in single cell gel elec-
trophoresis (SCGE) assays with peripheral lymphocytes. In
addition, experiments were conducted to ﬁnd out if the
impact of coﬀee on oxidative DNA-damage is due to direct82scavenging of ROS or to induction of the antioxidant
enzymes superoxide-dismutase (SOD) and glutathione per-
oxidase (GPx).
To elucidate if coﬀee drinking aﬀects DNA-damage
caused by HAs we also monitored DNA-migration caused
by 3-amino-1-methyl-5H-pyrido[4,3-b]indole acetate (Trp-
P-2) in peripheral lymphocytes of the participants of the
intervention trial before and at the end of the study. We
showed earlier that lymphocytes are able to convert HAs
to DNA reactive metabolites and used the tryptophan
pyrolyzate in the present study as it is a more potent indu-
cer of DNA-damage as other amines (Ho¨lzl, 2004). This
compound was the ﬁrst HA detected in fried meats (Sugim-
ura et al., 1977) and is a potent carcinogen in rodents
(IARC, 1993).2. Materials and methods
2.1. Chemicals
Trp-P-2 was purchased from the Nard Institute (Nishinagasu Ama-
gasaki, Japan); hydrogen peroxide (H2O2) and dimethyl sulfoxide
(DMSO) were from Merck (Darmstadt, Germany). RPMI was from
Sigma–Aldrich (St. Louis, USA). Cafestol and kahweol (a mix of
52.5:47.5 C + K, purity >98%) were a gift from Nestle´ (Lausanne, Swit-
zerland). The RANSOD kit used to monitor superoxide dismutase (SOD)
activity was purchased from Randox Laboratories Ltd. (Ardmore, UK);
agarose from Invitrogen Life Technologies Ltd. (Paisley, Scotland).
Endonuclease III (ENDO III) and formamidopyrimidine glycosylase
(FPG) were provided by the laboratory of DNA Repair (Prague, Czech
Republic).2.2. In vitro experiments with peripheral lymphocytes
Lymphocytes were isolated from blood of a healthy donor by centri-
fugation (Collins and Dusinska, 2002), washed twice with PBS (pH 7.4)
and transferred into RPMI medium. The cells were treated in culture
ﬂasks (1.5 ml, Eppendorf, Hamburg, Germany) either with diﬀerent
amounts of coﬀee, or with the coﬀee diterpenoids C + K (dissolved in
DMSO) for 30 min. The coﬀee used in in vitro experiments was prepared
with the French Press Method (see below). In combination experiments
with hydrogen peroxide, 50 lM H2O2 were added to the cells on ice for
5 min and coﬀee concentrations were used which did not cause acute toxic
and genotoxic eﬀects. To terminate the exposure, the cells were centrifuged
and washed twice with PBS (pH 7.4).2.3. Design of the human study
In total, eight healthy, non smoking volunteers (age 20–50 years)
participated in the study. From all individuals, written consent was
obtained and the study was approved by the Austrian Ethical Commis-
sion. One week before and during the intervention, the participants con-
sumed a restricted diet (i.e. they refrained from consumption of more than
200 g of the following foods: citrus fruits, fruit juices, cabbage, onions,
whole meal products and alcoholic beverages) and did not consume
additional coﬀee, tea, cola and energy drinks. During the intervention,
each of them drank in total 600 ml coﬀee (200 ml metal ﬁltered and 400 ml
paper ﬁltered coﬀee, Brand: Brasil sanft) per day over a period of ﬁve
days. The metal ﬁltered coﬀee was prepared with the French Press Method
(Original French Press, Bodum, Triengen, Switzerland). Per liter, 50 g of
ground coﬀee were used for both preparations. At the beginning and on
the last day of the study, blood (10 ml) was aspired by venipuncture and
collected in heparinised tubes (10 ml, BD Vacutainer Systems, Plymouth,
1430 J. Bichler et al. / Food and Chemical Toxicology 45 (2007) 1428–1436UK). Lymphocytes were isolated using Histopaque-1077 (Sigma–Aldrich,
St. Louis, USA) according to the instructions of the manufacturer.
2.4. Single cell gel electrophoresis assays
The SCGE experiments were conducted according to the guidelines of
Tice et al. (2000). In the in vitro experiments, the survival of the cells was
determined with trypan blue (Lindl and Bauer, 1994), only cultures with a
viability P80% were analysed for comet formation. To compare DNA-
migration before and after coﬀee intervention, the cells were either ana-
lysed without pretreatment under standard conditions (25 V, 300 mA, and
20 min electrophoresis time), additionally nuclei were treated either with
FPG or ENDO III according to the protocol of Collins et al. (1997,1993).
To monitor alterations of the chemical sensitivity of the cells, lympho-
cyte cultures were exposed either for 5 min on ice to H2O2 (50 lM) or to
Trp-P-2 (200 lM) for 30 min in PBS. The exposure concentrations of the
chemicals were chosen on the basis of earlier experiments (Ho¨lzl, 2004).
After the treatment, the cells were washed and transferred to agarose
coated slides for comet analysis.
From each participant, three slides were prepared for each experi-
mental point and from each slide 50 cells were evaluated. Tail lengths and
tail moments were measured with a computer aided image analysis system
(Helma and Uhl, 2000).
2.5. Enzyme measurements
GPx activity was measured in cytosols of peripheral lymphocytes
according to the protocol of Gunzler et al. (1974) which is based on the
spectrophotometrical determination of reduction of NADPH (k =
340 nm). SOD activity was determined in cytosols with the RANSOD test
kit (Randox Laboratories Ltd., Ardmore, UK). The inactivation of
superoxide by SOD was determined by monitoring the formation of a red
formazan dye (k = 505 nm). Each measurement was carried out in
triplicate.2.6. Statistics
Diﬀerences in the median tail lengths were tested by analysis of vari-
ance (ANOVA). For in vitro experiments, in case of a signiﬁcant (p 6 0.05)
main eﬀect of experimental conditions, Dunnett’s tests were performed to
compare the diﬀerent test conditions with the control condition. The
results of the experiments with human volunteers were analysed with two-
factor ANOVAs with data before/after coﬀee consumption as the exper-
imental factor and subjects as a random factor. In all tests, a two-sided
p-value 6 0.05 was considered signiﬁcant.0.0 25.0 50.0 100.0 200.0 400.0 600.0
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833. Results
3.1. In vitro SCGE experiments
The results of comet assays in which the eﬀects of coﬀee
on induction of DNA-migration and cell survival were
measured in human lymphocytes are depicted in Fig. 1a
and b. It can be seen that coﬀee caused a dose dependent
decline of the viability of cells in the dose range tested
(25–600 ll coﬀee/ml medium). In the same experiment also
induction of DNA-migration was observed which was
statistically signiﬁcant at exposure concentrations P50 ll
coﬀee/ml medium. On the contrary, no DNA-damaging
eﬀect was detectable with the coﬀee diterpenoids in the
SCGE assay and the viability of the cells was not signiﬁ-
cantly aﬀected (Fig. 2a and b).
The results of combination experiments with coﬀee and
H2O2 are shown in Fig. 3a and b. In this experiment sub-
toxic concentrations of coﬀee were used which caused nei-
ther acute toxic nor genotoxic eﬀects. Over the entire dose
range, pronounced protective eﬀects were observed, which
were signiﬁcant at dose levels which caused slight cytotoxic
eﬀects whereas in parallel experiments with C + K only
moderate (27–38%) inhibition of H2O2 induced DNA-
migration was observed (Fig. 4a and b).3.2. Eﬀects of coﬀee consumption on DNA-migration in
humans
The results of the SCGE measurements in periphe-
ral lymphocytes before and after coﬀee consumption are
shown in Fig. 5a–e. DNA-migration was signiﬁcantly
increased after treatment of the nuclei with the restriction
enzymes and also after exposure of the cells to H2O2 and
Trp-P-2.
When the comet assays were carried out under standard
conditions (20 min electrophoresis time, 25 V, 300 mA), no
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Fig. 2. Eﬀect of the coﬀee speciﬁc diterpenoids cafestol and kahweol on the viability (a) and on DNA-migration (b) of human lymphocytes. The
diterpenoids were dissolved in DMSO and diﬀerent concentrations were added to the cell suspensions for 30 min. Controls were exposed to the solvent
only. Subsequently, cell viability and comet formation were determined. Per experimental point, three cultures were prepared in parallel. *Indicates
statistical signiﬁcance (p-value 6 0.05, analysis of variance ANOVA). Bars indicate means ± SD results obtained with three slides (per slide 50 cells were
evaluated).
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out as described in the legend of Fig. 1, but after exposure of the cells to subtoxic concentrations coﬀee, H2O2 (50 lM) was added to the cells for 5 min on
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(p-value 6 0.05, analysis of variance ANOVA). Bars indicate means ± SD results obtained with three slides (per slide 50 cells were evaluated).
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mined after addition of the restriction enzymes (FPG,
ENDO III), signiﬁcant alterations were detected (Fig. 5b84and c). The bars of the ﬁgures depict both, DNA-migration
due to formation of endogenous single and double strand
breaks and additionally also migration attributable to
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Fig. 5. Eﬀect of coﬀee consumption on endogenous and chemically induced DNA-damage. Eight individuals participated in the intervention trial. Each of
them consumed 600 ml coﬀee consecutively over a period of ﬁve days. Before and after the intervention lymphocytes were isolated from blood and
analysed for DNA-migration in SCGE experiments. (a) Shows the results obtained with standard electrophoresis conditions. In experiments with H2O2 (d)
and Trp-P-2 (e), three cultures per participant were prepared in PBS and the cells were treated on ice with H2O2 (50 lM) for 5 min or 30 min with Trp-P-2
(200 lM). To monitor endogenous formation of oxidised bases, FPG (b) and ENDO III (c) were added to the slides with the nuclei. From each participant
and time point three cultures were prepared and 50 cells per slide were evaluated for comet formation from each culture. Bars indicate means ± SD of
results obtained with the eight participants. Black bars: DNA-migration after coﬀee consumption, white bars: before coﬀee consumption. *Indicates
statistical signiﬁcance (p-value 6 0.05, analysis of variance ANOVA).
1432 J. Bichler et al. / Food and Chemical Toxicology 45 (2007) 1428–1436formation of oxidised purines and pyrimidines. The extent
of migration attributable solely to oxidised purines before
the intervention was on average 3.5 lm and after interven-
tion 1.2 lm, the corresponding values for DNA-migration
due to oxidised pyrimidines are 3.8 lm and 1.9 lm (data
were calculated on the basis of the diﬀerences of migration
seen in absence and presence of the restriction enzymes).
Also when DNA-migration was induced by treatment of
the cells with H2O2 (Fig. 5d), a signiﬁcant protective eﬀect
(17% reduction) was observed. The results obtained with
Trp-P-2 are shown in Fig. 5e; also with the tryptophan85pyrolyzate a signiﬁcant decrease of the tail lengths (by
35%) was observed at the end of the intervention (Fig. 5e).
In all experiments the tail moments were monitored in
addition to the tail lengths (data not show) and the evalu-
ation of this parameter led to the same conclusions.
3.3. Eﬀects of coﬀee consumption on the activities of
antioxidant enzymes
The results of the enzyme measurements with cytosolic
fractions of lymphocytes are shown in Fig. 6a and b. It
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Fig. 6. Eﬀect of coﬀee consumption on the activity of antioxidant
enzymes. The measurements were carried out with cytosolic fractions of
lymphocytes of the participants of the intervention trial. The intervention
was carried out as described in the legend of Fig. 5. GPx (a) was measured
according to the method of Gunzler et al. (1974), SOD (b) was determined
with the RANSOD test kit. Each measurement was made in triplicate.
Bars indicate means ± SD of results obtained with eight participants.
Black bars: enzyme activity after coﬀee intervention, white bars: enzyme
activity before coﬀee consumption. *Indicates statistical signiﬁcance
(p-value 6 0.05, ANOVA).
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cantly after coﬀee consumption (Fig. 6a), whereas the
activity of SOD (Fig. 6b) was increased by 38%.4. Discussion
Aim of the present study was the investigation of poten-
tial DNA protective eﬀects of coﬀee consumption in
humans, in addition also in vitro experiments with lympho-
cytes were carried out.
The ﬁndings of the in vitro experiments show that expo-
sure of the cells to high concentrations of coﬀee, but not to
coﬀee speciﬁc diterpenoids (C + K), causes induction of
DNA-migration (Fig. 1). This observation was not unex-
pected; also in several other in vitro experiments with bac-
terial and mammalian indicator cells positive results were
obtained (IARC, 1991; Stadler et al., 1994). A number of
earlier investigations indicate that generation of H2O2
accounts for the genotoxic eﬀects of coﬀee (Fujita et al.,
1985; Nagao et al., 1986; Wakabayashi et al., 1989) and
it was reported more recently that chlorogenic and caﬀeic
acids and their pyrolysis products which are contained in
coﬀee cause formation of ROS (Iwahashi et al., 1990; Tsuji
et al., 1991; Yamanaka et al., 1997), also caﬀeine was
shown to possess prooxidant properties under speciﬁc con-
ditions (Azam et al., 2003). As described above (Fig. 2), no
genotoxic eﬀects were observed with the coﬀee speciﬁc
diterpenoids C + K.
In contrast to the results obtained with coﬀee in the ﬁrst
experimental series (Fig. 1), pronounced protective eﬀects
were observed in experiments with low coﬀee concentra-
tions (Fig. 3) which caused no acute toxic and genotoxic
eﬀects in combination with H2O2. This observation is in
agreement with the results of a number of earlier in vitro86experiments and with in vivo studies with rats (Daglia
et al., 2000,2004; Pellegrini et al., 2003; Somoza et al.,
2003; Stadler et al., 1995,1996a,b). Also speciﬁc constitu-
ents of coﬀee such as caﬀeine and phenolic acids (i.e.
chlorogenic-, ferulic- and caﬀeic acid) and Maillard reac-
tion products are known to act as antioxidants (Azam
et al., 2003; Devasagayam et al., 1996; Iwai et al., 2004;
Khan et al., 2000; Kono et al., 1997; Nardini et al.,
1995,1997,1998; Stadler et al., 1995,1996a,b). The ROS
protective eﬀects of the coﬀee diterpenoids C + K have
not been investigated earlier and the results of our experi-
ments indicate that they possess only weak antioxidant
activity.
In the human study, no indication for induction of geno-
toxic eﬀects by coﬀee consumption was found. Neither with
the standard protocol (which enables the detection of single
and double strand breaks), nor with the restriction enzymes
increased DNA-migration was seen (Figs. 5 and 6). The
lack of DNA-damaging properties of coﬀee is in line with
data from animal experiments in which consistently nega-
tive results were obtained (Aeschbacher et al., 1984; Shi-
mizu and Yano, 1987). In this context it is notable that
Rinkus and Taylor (1990) emphasised that H2O2, which
causes the genotoxic eﬀects of coﬀee under in vitro condi-
tions (Stadler et al., 1994) is probably not formed after
ingestion and that it may be a confounding factor in
in vitro tests. Only a few other studies are available in which
the eﬀects of coﬀee consumption on genomic stability in
humans were investigated. Smith et al. (1990) reported a
2-fold increase of micronuclei levels in erythrocytes of
spleenectomized humans who consumed ﬁve or more cups
of coﬀee and/or tea per day but the results of this study do
not provide information which of the two beverages caused
the eﬀect. Also the reports of Chen et al. (1989) and Reidy
et al. (1988) in which increased frequencies of chromo-
somal aberrations and sister chromatid exchanges were
found in peripheral lymphocytes of coﬀee drinkers do not
allow to draw ﬁrm conclusions. The scorer eﬀects exceeded
in both studies the eﬀects seen with coﬀee and the authors
stress that the results should be interpreted with caution
due to uncertainties in the quantiﬁcation of coﬀee
consumption.
The results of the present experiments with H2O2
and with restriction enzymes show clearly that coﬀee pro-
tects human lymphocytes against oxidative DNA-damage
(Fig. 6). The formation of oxidised purines was reduced
by 64%, and damage attributable to oxidised pyrimidines
was decreased by 48%; furthermore, the extent of DNA-
migration caused by H2O2 declined by 17% (Fig. 5b–d).
Only data from few other investigations on antioxidative/
oxidative eﬀects of coﬀee consumption in humans are avail-
able. Van Zeeland et al. (1999) found decreased formation
of 8-OHdG in DNA isolated from lymphocytes of coﬀee
drinkers. In this context it is notable that a good correla-
tion was observed between 8-OHdG formation and FPG
induced DNA-migration monitored with the SCGE assay
in human lymphocytes (ESCODD, 2000). Further support
1434 J. Bichler et al. / Food and Chemical Toxicology 45 (2007) 1428–1436for the assumption that coﬀee protects against DNA-dam-
age caused by ROS comes from a human study (Natella
et al., 2002) in which a pronounced increase of the antiox-
idant capacity of plasma was found after consumption of
200 ml coﬀee; likewise also in experiments with rats an
increase of the antioxidant status (i.e. of TROLOX-equiv-
alents) was seen after administration of coﬀee extract
(Somoza et al., 2003). In contrast to these ﬁndings, a posi-
tive association between coﬀee consumption and FPG
DNA-migration was observed in an Italian study, which
was based on intake assessment with questionnaires (Gio-
vannelli et al., 2002).
As mentioned above, coﬀee contains a variety of constit-
uents, which inactivate oxygen radicals. It is likely that the
eﬀects seen in the in vitro experiments (Fig. 3) are due to
direct scavenging whereas under in vivo conditions addi-
tionally enzymatic eﬀects may be involved. As described
in Section 3, a signiﬁcant (38%) increase of SOD activity
was found after coﬀee consumption (Fig. 6b). According
to our knowledge, our coﬀee study is the ﬁrst investigation
in which induction of SOD by a dietary factor in humans
was found. Another indirect mechanism, which may
account for protection against oxidative DNA-damage is
the increase of plasma glutathione levels caused by coﬀee
drinking, which was found in an earlier study by Esposito
et al. (2003).
At present, results of 51 human trials with diets and
individual food components are available in which the
SCGE-technique was used (for reviews see Moller and
Loft, 2002,2004). In approximately 50% of the studies pro-
tective eﬀects were detected. Comparisons of the results of
the present study with data from earlier trials show that
coﬀee consumption causes eﬀects, which are similar to
those seen after intake of antioxidant vitamins. For exam-
ple, a 20% reduction of H2O2 induced DNA migration was
detected after continuous supplementation with a combina-
tion of 100 mg vitamin C, 280 mg vitamin A and 25 mg
b-carotin (Duthie et al., 1996); DNA-migration due to for-
mation of oxidised pyrimidines (FPG) was reduced by 75%
in the same experiment. It is notable, that no protection
was seen in a recent intervention trial after consumption
of large amounts of mixed fruit and vegetables (600 g/P/d
for 24 days) (Moller et al., 2003). Also in another study
in which 500 g of fruit and vegetable juice were given daily
over three weeks, no eﬀects were observed (van den Berg
et al., 2001). These comparisons suggest that coﬀee drink-
ing may contribute to a higher extent to prevention of oxi-
dative DNA-damage in humans than consumption of fruits
and vegetables. This assumption is also supported by the
ﬁndings of Svilaas et al., (2004) who postulated on the basis
of an assessment of the antioxidant properties of diﬀerent
foods and beverages that coﬀee is a greater contributor
to the total antioxidant intake in man than plant derived
foods.
The ﬁndings of the present study are of particular inter-
est in the light of recent observations which indicate an
inverse relationship between coﬀee consumption and the87incidence of liver cirrhosis (Corrao et al., 2001; Gallus
et al., 2002b) and hepatocellular carcinoma (Gallus et al.,
2002a; Kurozawa et al., 2004; Shimazu et al., 2005). It is
known that cirrhosis and other inﬂammatory liver diseases
are associated with increased incidences of HCC, and it is
assumed that ROS play a causal role (Gebhardt, 2002;
Ichiba et al., 2003; Szuster-Ciesielska et al., 2002). It can
be tentatively assumed that the protection against oxidative
DNA-damage, which we detected in the present study may
account for the prevention of these diseases. Attempts to
elucidate if coﬀee protects cirrhotic liver cells against
ROS mediated DNA damage are currently under progress.
As described in Section 3, we also observed pronounced
inhibition of Trp-P-2 induced DNA-damage by coﬀee
(Fig. 5e). We included this parameter, since several earlier
investigations indicated that coﬀee speciﬁc diterpenoids
are protective towards DNA-damage caused by HAs in ani-
mals (Huber et al., 1997) and human cells (Majer et al.,
2005). It was postulated that the prevention of DNA-
damage is due to inhibition of activation (acetylation)
and induction of detoxifying enzymes (glutathione-S-trans-
ferase and UDP-glucuronosyl transferase) (Huber et al.,
2002) and it is known that these enzymes are also induced
by coﬀee in rats (Somoza et al., 2003); furthermore, recent
ﬁndings provide evidence that also in man a pronounced
increase of GST takes place after coﬀee consumption
(Steinkellner et al., 2005). Our ﬁndings suggest that coﬀee
consumption may protect also humans against the DNA-
damaging eﬀects of heterocyclic aromatic amines.
Taken together, the results of this study support the
assumption that the inverse relationship between certain
forms of cancer and coﬀee consumption, which was found
in epidemiological studies, is causally related to prevention
of DNA-damage.Acknowledgements
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ABSTRACT 1 
Background: Coffee is among the most frequently consumed beverages worldwide. 2 
Epidemiological studies indicate that its consumption is inversely related to the incidence of 3 
reactive oxygen species (ROS) related diseases (liver cirrhosis, specific forms of cancer and 4 
neurodegenerative disorders) and it was postulated that these effects are due to antioxidant 5 
properties.  6 
Objectives: We investigated the impact of a new instant coffee which contains high levels of 7 
chlorogenic acids on DNA damage and on markers of the antioxidative status.  8 
Design: The impact of coffee consumption (800 ml/P/d, 5 days) on DNA damage was studied 9 
in single cell gel electrophoresis assays under standard conditions and with lesion specific 10 
enzymes in an intervention trial with a cross-over design (n = 29).  11 
Results: DNA migration due to formamidopyrimidine-DNA glycosylase (FPG) sensitive sites 12 
(reflecting oxidised purines) was reduced by 6.7 % and damage due to endonuclease III 13 
sensitive sites (oxidised pyrimidines) was lowered by 9.8 %. The effect was only significant 14 
with FPG in females (reduction by 23.2 %). Also, F2-isoprostane levels in urine and 3-15 
nitrotyrosine levels in plasma were clearly decreased (by 14.9 % and 17.2 %, respectively). 16 
Again the effects were more pronounced in females. Other markers (superoxide dismutase, 17 
glutathion-S-transferase and glutathione peroxidase activity, glutathione levels, total 18 
antioxidant capacity, oxidised LDL, malondialdehyde and intracellular ROS) were not 19 
significantly altered.  20 
Conclusions: Intake of the coffee reduced endogenous oxidative DNA damage, lipid 21 
peroxidation and protein nitration in women but not in men. These biomarkers are associated 22 
with pathophysiological processes, therefore the results are indicative of beneficial health 23 
effects. 24 
25 
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INTRODUCTION 1 
Numerous studies indicate that cellular damage caused by reactive oxygen species 2 
(ROS) is causally involved in the etiology of a variety of diseases (1-3). Therefore, strong 3 
attempts have been made over the last decades to identify dietary components with 4 
antioxidant properties (4).  5 
Recently, we reported the results of a small intervention trial (n=8) in which we found 6 
that consumption of a mix of metal and paper filtered coffee prevents the endogenous 7 
formation of oxidised DNA bases in peripheral human lymphocytes (5). This is an interesting 8 
observation, as coffee is the second most traded commodity after petrol and among the most 9 
frequently consumed beverages. Evidence of its antioxidant properties is also supported by 10 
results of in vitro experiments, which showed that it inactivates ROS by direct scavenging (6) 11 
and by findings showing induction of antioxidant enzymes in rodents (7, 8). In vitro analyses 12 
demonstrated that coffee possesses a higher antioxidant capacity than other beverages, e.g. 5-13 
fold higher than green tea and 3-fold higher than red wine (9). It has been stressed that coffee 14 
is one of the most important sources of phenolic compounds and that its consumption 15 
contributes to a higher extent to the intake of antioxidants than consumption of fruits and 16 
vegetables (10). In this context, it is notable that increasing evidence suggests coffee that 17 
intake is inversely related to the incidence of liver and colon cancer, liver cirrhosis, 18 
Alzheimer’s and Parkinson’s diseases, and diabetes (6, 11-13). It is assumed that ROS plays a 19 
crucial role in the etiology of all these diseases (1, 2). 20 
Aim of the present study was the investigation of the antioxidant properties of a new 21 
brand of instant coffee whose antioxidant properties were improved by addition of dried 22 
material of green beans containing chlorogenic acids (CAs). CAs are assumed to contribute 23 
substantially to the antioxidant properties of the brew (14-16).  24 
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The impact of coffee consumption on the formation of endogenous oxidised DNA 1 
bases was monitored in single cell gel electrophoresis (SCGE or comet) assays in peripheral 2 
human lymphocytes. Furthermore, we analysed alterations of the sensitivity of the 3 
lymphocytes towards ROS (H2O2) induced DNA-damage, as well as DNA-damage due to 4 
formation of single and double strand breaks. These parameters were monitored in SCGE 5 
experiments, which are based on the determination of DNA migration in an electric field and 6 
are increasingly used in dietary human intervention trials (for review see (17, 18)). 7 
Additionally, a number of other endpoints were monitored which are indicative of 8 
antioxidant effects, including oxidised low density lipoproteins (oxLDL) and 9 
malondialdehyde (MDA) levels in plasma, as well as F2-isoprostane levels in urines, which 10 
are regarded as a reliable marker for lipid peroxidation (4). Other biochemical endpoints were 11 
glutathione (GSH) concentrations in erythrocytes, 3-nitrotyrosine (3-NT) levels and the total 12 
antioxidant capacity (TAC) in plasma. Since recent findings indicate that coffee might also 13 
affect the expression of genes controlled by the transcription factor Nrf2 (7) we additionally 14 
measured the impact of coffee consumption on the expression of genes encoding for 15 
antioxidant defence mechanisms by use of real time PCR, as well as the activities of a panel 16 
of antioxidant enzymes (glutathione peroxidise (GPx), superoxide dismutase (SOD) and 17 
glutathione-S-transferase (GST)). 18 
 19 
SUBJECTS AND METHODS 20 
Subjects 21 
The study was approved by the Ethical Commission of the Medical University of 22 
Vienna and informed consent was obtained from the participants, which were recruited via a 23 
placard. Only individuals who fulfilled the inclusion criteria (no overweight, non-smokers, no 24 
intake of pharmaceutical drugs, no intake of food supplements 4 weeks prior and during the 25 
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study, no participation in another clinical trial, no pregnancy, compliance with the protocol, 1 
no blood withdrawal 3 weeks before the study) were included (n=36). At the beginning and at 2 
the end of the trial, blood pressure and the pulse frequencies were monitored. Seven 3 
participants were excluded from the data analysis because of illness or other relevant reasons. 4 
In total, samples from 13 men and 16 women were analyzed. The characteristics of the 5 
participants are summarised in Table 1. 6 
 7 
Table 1: Baseline characteristics of the participants by gender 8 
Gender male (n=13) female (n=16) 
 
mean ± SD min max mean ± SD min max 
Age (y) 25.2 ± 5.6 20 41 29.3 ± 10.9 20 55 
Weight (kg) 76.2 ± 8.6 64 92 61.8 ± 8.1 48 74 
Height (cm) 181.7 ± 7.4 173 201 168.2 ± 0.1 157 184 
BMI (kg/m2) 23.0 ± 1.7 20 26 21.8 ± 2.4 19 27 
Blood pressure  
dia (mmHg) 
78.8 ± 6.41 
74.5 ± 14.82 
81.1 ± 8.93 
651 
462 
673 
901 
982 
973 
72.9 ± 10.61 
73.7 ± 8.22 
75.4 ± 7.23 
501 
642 
673 
971 
922 
903 
Blood pressure  
sys (mmHg) 
132.3 ± 11.41 
130.2 ± 17.82 
127.1 ±14.63 
1151 
1042 
993 
1541 
1652 
1583 
118.8 ± 11.41 
116.9 ± 13.02 
115.6 ± 13.13 
1051 
982 
953 
1541 
1502 
1433 
Pulse frequency 
(P/min) 
67.5 ± 12.81 
71.7 ± 16.52 
73.3 ± 20.23 
421 
502 
503 
891 
992 
1093 
76.8 ± 9.91 
80.7 ± 20.22 
78.1 ± 13.23 
561 
632 
633 
961 
1422 
1203 
1baseline, 2water period, 3coffee period 9 
 10 
Study design 11 
Figure 1 shows the experimental design of the study. One week before the start of the 12 
intervention phase (coffee/water), the participants were asked to control their consumption of 13 
fruit juices and other dietary factors such as citrus fruits or cruciferous vegetables, which may 14 
have an impact on the outcome of the study (for details see (17)). Furthermore, they were 15 
asked to avoid excessive physical exercise, since it is known that it may cause alteration of 16 
DNA migration (19).  17 
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The participants were allocated into 2 groups (18 coffee/water, 18 water/coffee). The 1 
individuals in the coffee/water group consumed coffee (800 ml/d) after a 7-day run-in phase. 2 
Following a wash-out period (5 weeks) and a restriction phase (1 week), they drank 800 ml 3 
water/d instead of coffee. The participants in the water/coffee group followed the protocol in 4 
the reversed order.  5 
Additionally, all participants were asked to limit their coffee consumption to 1 cup per 6 
day 3 weeks before the begin of the run-in phase of the study and during the first five weeks 7 
of the wash-out period.  8 
 9 
Fig. 1 Schematic overview of the crossover design 10 
 11 
Study product 12 
The coffee was provided by the Nestlé Research Center (Lausanne, Switzerland) and 13 
distributed in pre-weighed portions (3.4 g/package) at the beginning of the intervention. The 14 
participants consumed 4 x 200 ml of 1.7 % (w/w) coffee/d without a fixed schedule.  15 
The product used in the study was a mix of green and roasted coffee. Since a large 16 
proportion of green coffee antioxidants, in particular chlorogenic acids (CAs) are destroyed 17 
during the roasting process (20), the concentration of CAs was increased by addition of dried 18 
material from green (unroasted) beans.  19 
 20 
coffee coffee
1 wk 
„dietary restriction“
1 wk 
„dietary restriction“
5 wks washout + 
1 wk „dietary restriction“
Group B (n=18)
Group A
5 days „dietary restriction“
control
5 days „dietary restriction“
control
5 days intervention + 
„dietary restriction“
Group A (n=18)
5 days intervention +
„dietary restriction“
Group B
S (B+U)
5 wks washout + 
1 wk „dietary restriction“
water water
S-sampling, B-blood, U-Urine
S (B+U)
S (B+U) S (B+U)
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Sample preparation 1 
After the intervention phase (coffee or water), blood (80 ml/P) was collected in 2 
heparinized tubes (Becton-Dickinson, Plymouth, UK) by venipuncture immediately after 3 
isolation with Histopaque-1077 (Sigma-Aldrich, Steinheim, Germany) according to the 4 
instructions of the manufacturer. Lymphocytes were analyzed immediately after collection in 5 
SCGE assays or stored in liquid nitrogen. Plasma was aliquoted in 500 µl portions and stored 6 
deep-frozen at -80°C. Furthermore, 24 hr urine samples were collected; the total amounts 7 
were recorded and subsequently the samples were aliquoted and stored at –80°C. 8 
 9 
Single-cell gel electrophoresis assays (comet assays) 10 
The SCGE experiments were carried out according to international guidelines (21, 22).  11 
To monitor single and double strand breaks and apurinic sites, the experiments were 12 
conducted under standard conditions (20 min alkaline unwinding ph > 13, 20 min 13 
electrophoresis, 25 V, 300 mA, in presence of autologous plasma (10 %)). 14 
Experiments with the DNA lesion-specific enzymes endonuclease III (Endo III) and 15 
formamidopyrimidine–DNA glycosylase (FPG), which enable the detection of endogenous 16 
formation of oxidised pyrimidines and purines were carried out as described by Collins et al. 17 
(23, 24). Lymphocytes (0.025 x 106) were transferred to agarose-coated slides, lysed (4 ˚C, 1 18 
hr) and washed (3 times with enzyme buffer) prior to incubation with 50 µl of Endo III (for 45 19 
min) or FPG (for 30 min) at 37˚C. Subsequently, the slides were placed for 40 min in a 20 
horizontal electrophoresis unit (C.B.S. Scientific Company, Del Mar, CA) filled with alkaline 21 
buffer (pH>13), subsequently electrophoresis was conducted (25 V, 300 mA, 30 min).  22 
To monitor alterations of the sensitivity of the lymphocytes towards ROS, the cells 23 
were exposed to H2O2 (15 min at 4°C, 25 µM) according to the protocol of Collins et al. (25).  24 
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After treatment, cells were mixed with low melting agarose (0.5 %, Gibco, Paisley, UK) and 1 
transferred to agarose coated slides. After lysis (4 °C, 1 hr) and unwinding in alkaline buffer 2 
(20 min, pH > 13), electrophoresis was performed (25 V, 300 mA, 20 min).  3 
DNA was stained with 40 µl ethidium bromide (20 µg/ml). For each experimental 4 
point, three slides were prepared in parallel and from each, 50 cells were analyzed by a 5 
blinded observer with a computer aided image analysis system (Comet Assay IV Perceptive 6 
Instruments Ltd., Haverhill, UK). As endpoint the percentage of DNA in tail was recorded, 7 
which is an internationally accepted parameter (26, 27).  8 
Acute toxic effects were monitored with the trypan blue exclusion technique (28) and 9 
only cells from cultures in which the viability was ≥ 80 % were analyzed for comet formation 10 
as an excess of dead cells may cause false positive results (22, 29). 11 
 12 
Determination of lipid peroxidation products 13 
Determination of malondialdehyde (MDA) 14 
MDA levels were determined according to the method of Ramel et al. (30) by use of 15 
high performance liquid chromatography (HPLC). Briefly, the samples were hydrolyzed after 16 
heating (60 min, 100˚C) with phosphoric acid. This leads to formation of a complex with 17 
thiobarbituric acid, which was determined fluorometrically after deproteinisation (excitation: 18 
λ=532nm, emission: λ=563nm). Each sample was measured in duplicate. 19 
 20 
Measurement of oxidized low density lipoproteins (oxLDL) 21 
oxLDL concentrations were measured with a commercially available enzyme-linked 22 
immunosorbent assay (ELISA) kit (Mercodia AB, Uppsala, Sweden). Absorbance of samples 23 
and standards was determined with a fluorimeter (BMG Lab Technologies, Offenburg, 24 
Germany).  25 
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 1 
Determination of 8-epi-PGF2α with LCMSMS  2 
8-epi-PGF2α was determined in plasma. 8-epi-PGF2α was extracted with commercially 3 
available immunoaffinity columns (Cayman Chemical Co., Ellsworth Ann Arbor, MI) 4 
prepared from an 8-iso PGF selective antibody. The procedure was carried out according to 5 
the instructions of the manufacturer. After centrifugation, the samples were spiked with 5.0 ng 6 
of deuterated standard of the title compound, acidified and passed through a pre-washed 7 
immunoaffinity column. After elution with 5.0 ml buffer (95 % ethanol/ 5 % water), the 8 
eluates were collected and the solvent was evaporated.  9 
8-Iso-PGF2α was determined with LC/MS/MS (Sciex API 4000 Triple Quad, Applied 10 
Biosystems, Van Allen Way Carlsbad, CA), which involves a coupled HPLC (Agilent 1100, 11 
Santa Clara, CA) separation of the sample prior to MS analysis. MSMS was operated in ESI 12 
mode (negative ionisation, -4500 electron volts). In all experiments, a stable deuterated 13 
internal was used.  14 
 15 
Measurement of antioxidant enzymes 16 
CuZn-SOD activity was determined in the cytosolic fractions of lymphocytes with the 17 
RANSOD test kit (Randox Laboratories Ltd., Ardmore, UK). The test is based on the use of 18 
the xanthine/xanthine oxidase reaction to generate O2- radicals (31). The activity of the 19 
enzyme was measured spectrophotometrically (λ=505 nm) by determination of the degree of 20 
inhibition of O2 induced formation of a red formazan dye. Each measurement was carried out 21 
in triplicate. 22 
GPx activity was determined spectrophotometrically (λ=340 nm); the assay is based 23 
on the method developed by Gunzler and Flohe (32) The results were standardized on the 24 
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basis of the protein concentrations which were measured with the Bradford method (33). Each 1 
measurement was carried out in duplicate. 2 
 3 
Intracellular ROS (DCFH-DA assay) 4 
Intracellular ROS levels were measured by flow cytometric analysis of 7-5 
dichlorofluorescein (DCFH) oxidation using DCFH-DA (Fluka, Buchs, Switzerland) as 6 
described previously (34). Isolated cells were stained with PerCP labeled anti CD-45 (pan 7 
leukocytic marker) and APC labeled anti CD-14 (monocyte/macrophage specific) antibodies 8 
(BD Phorminogen, San Jose, San Francisco) for 15 min. Afterwards, DCFH-DA (10 µM) was 9 
added to the cell suspensions in presence or absence of autologous plasma (1.0 %).  10 
Additionally lymphocyte suspensions were exposed to 50 µM H2O2 (60 min at 37oC). 11 
After treatment, the cells were analyzed by multiparametric analysis using a FACS Calibur 12 
TM system (Becton-Dickinson, San Jose, CA) with excitation and emission settings of 500 ± 13 
15 and 535 ± 15 nm, respectively. 14 
Lymphocytes, monocytes and granulocytes were discriminated by scatter gating 15 
strategy (low, moderate and high FSC/SSC, respectively) and CD staining (CD45+/CD14-, 16 
CD45+/CD14+ and CD45dim/CD14dim).  17 
Background fluorescence was determined in DCFH-delabeled cells without treatment. 18 
Each sample was measured in duplicate. Data are given as mean fluorescent peak heights in 19 
arbitrary units. 20 
 21 
Total Antioxidant Capacity (TAC) 22 
TAC in plasma was analyzed spectrophotometrically (UV/VIS Spectrometer Lamda2; 23 
Perkin Elmer; λ=734nm) after iron induced oxidation. The assay is based on the ability of an 24 
antioxidant to scavenge blue-green colored 2,2´-azinobis(3-ehtylbenzthiazoline-6-sulfonic 25 
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acid) radicals (ABTS*) which are generated by the peroxidase activity of metmyoglobin in 1 
presence of the sample (35). 2 
 3 
Glutathione (GSH) 4 
 GSH levels were determined photometrically in erythrocytes. The tripeptide was 5 
released from the cells by hemolysis (36), which leads to removal of protein and blood 6 
pigments. The remaining suspensions were mixed with 5,5'-dithiobis-2-nitrobenzoic acid 7 
(DTNB) and absorbance read at 412 nm (UV/VIS Photometer ATI-Unicam UV 4, Perkin 8 
Elmer, Waltham, MA). The measurements were carried out in duplicate. 9 
 10 
Glutathion-S-transferase (GST) 11 
GST activity was spectrophotometrically (λ=340nm) determined in the cytosols of 12 
lymphocytes according to the standard method developed by Habig et al. (37) at 37 °C, using 13 
1-chloro-2,4-dinitrobenzene (CDNB) as a substrate. The protein contents were determined 14 
with the BIORAD/Bradford assay (33). All measurements were carried out in triplicate. 15 
 16 
3-Nitrotyrosine (3-NT) 17 
The levels of 3-NT in plasma were determined by liquid chromatography-electrospray 18 
ionisation tandem mass spectrometry (LC-ESI-MS/MS). After extraction of the free and 19 
protein associated form of nitrotyrosine (for details see (38)), the eluates were injected in a 20 
HPLC system (Hewlett-Packard, Pali-Alto, CA). Detection was performed with positive 21 
electrospray ionisation tandem mass spectrometry (Finnigan MAT TSQ 7000 with API 22 
interface, San Jose, CA).  23 
 24 
25 
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Gene expression  1 
The lymphocytes for RNA preparation were separated with Vacutainer® CPT cell 2 
preparation tubes (bd, city, land), subsequently the pellets were treated with TRIZOL® 3 
Reagent (Invitrogen, city, land) according to the manufacturer´s instructions. Samples were 4 
stored at –80°C. 5 
RNA was converted to cDNA using the TaqMan Reverse transcription Kit system 6 
(Applied Biosystem, Foster City, CA). Reverse transcription was performed according to the 7 
manufacturer’s instructions (Applied Biosystems, Foster City, CA), using the random 8 
hexamers primer and 2.0 µg of pooled RNA samples. cDNA synthesis was performed in a 9 
thermal cycler (Applied Biosystems, Foster City, CA) under the following conditions: 10 min 10 
at 25 °C, 30 min at 48 °C and a final inactivation step of 5 min at 95 °C. Samples were 11 
amplified in Taqman Low Density custom Array with the ABI Prism ® 7900HT Sequence 12 
Detection System using 1.0 µl of cDNA template and the TaqMan PCR master mix 2 x 13 
(Applied Biosystems, Foster City, CA). The thermocycler conditions included two 14 
incubations (2 min at 50 °C and 10 min at 95 °C), followed by 40 cycles, each consisting of a 15 
denaturation step for 15 s at 95 °C, and a second annealing and extension step for 1 min at 16 
60 °C. Quantification of amplified PCR products was performed using ABI Prism®7900HT 17 
Sequence Detection System software Version 2.2. (Applied Biosystems, Foster City, CA), 18 
normalized to the GAPDH gene as an internal control. All rat PCR probes and primers used in 19 
this study were obtained from the Low Density custom array of Applied Biosystems.  20 
 21 
Statistical analyses 22 
Statistical analyses of the comet assay data were performed with the following 23 
procedures. From each slide, 50 cells were evaluated and the medians were calculated, which 24 
were arcsine transformed in order to obtain homogeneity of variance. Outliers among 25 
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triplicates were removed with the Dixon’s test. The means of triplicates within each condition 1 
were computed, and these values submitted to Grubb’s test. Outliers among subjects within 2 
conditions were removed with this procedure. Analysis of variance was conducted by 3 
application of a mixed model with subjects as random factor, gender as between subjects 4 
factor, period (first/second) and condition (coffee/water) as within subjects factors.  5 
In addition, interactions between gender and condition as well as sequence and 6 
conditions were evaluated. By this procedure, a potential seasonal effect was removed from 7 
the other effects. Main effects and interactions were considered significant if p values were ≤ 8 
0.05. Homogeneity of variances was tested by Levene’s test. Residuals were assessed for 9 
normality by Lilliefors tests. For these tests, the significance level was set to 0.01. The 10 
statistical analyses were performed using the Statistica 8.0 (StatSoft GmbH, Hamburg, 11 
Germany) software. The gene expression data were log transformed and analyzed by 12 
Wilcoxon sign-rank tests. Statistical significance of all other parameters was analyzed by use 13 
of the Wilcoxon signed ranks test (significance level P ≤ 0.05). 14 
15 
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RESULTS 1 
The impact of coffee consumption on different parameters of DNA migration, which 2 
was measured with the SCGE technique, is summarized in Table 2. Comet formation under 3 
standard conditions (which reflects single and double strand breaks and apurinic sites) was 4 
reduced after coffee intake, but the effect did not reach statistical significance. Treatment of 5 
the cells with the enzymes lead to a strong (ca. 3-fold) increase of DNA-migration attributable 6 
to FPG-sensitve sites (reflecting oxidised purines) and Endo III-sensitve sites (reflecting 7 
oxidised pyrimidines). The results obtained with the enzymes are also shown graphically in 8 
Figure 2. In the case of Endo III a borderline effect was detected in the entire study group (P 9 
= 0.050019), while in the case of FPG a significant decrease of DNA-migration was found 10 
only in females. 11 
Table 2: Effects of coffee consumption on different endpoints carried out with the SCGE 12 
(Comet) assay 1, 2 13 
SCGE assay (% DNA in tail) water period coffee period ∆ (%)3 p-value4 
Treatment with lesions specific enzymes     
Endonuclease III 9.79±3.43 8.82±4.14 -9.88 0.05 
Formamido pyrimidine glycosylase 14.96±5.95 13.95±5.38 -6.74 0.62 
Hydrogen peroxide induced DNA damage  17.94±11.08 16.84±9.05 -6.09 0.77 
Endogenous DNA damage 1.60±1.67 1.13±0.77 -29.09 0.13 
 14 
1All values represent means ± SD. SCGE; single cell gel electrophoresis. DNA damage was measured as 15 
percentage DNA in the tail. All measurements were carried out in triplicate in peripheral human lymphocytes. 16 
2n=29, expect for Endo III n=27 17 
3
∆ (%) values were calculated from the raw data; 18 
4p-values were calculated with ANOVA and linear contrast 19 
20 
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 2 
 3 
 4 
 5 
 6 
Fig. 2 A-F Impact of coffee consumption on DNA migration after treatment of nuclei with the 7 
lesion specific enzyme endonuclease III (1 A-C, treated for 45 min at 37˚C) and with 8 
formamido pyrimidine glycosylase (1 D-E, treated for 30 min at 37°C). From each participant 9 
three slides were made per experimental point in parallel and from each 50 cells were 10 
analysed for the comet formation as described above. Bars represent the mean ± SEM. 11 
Asterisks indicate statistical significance, P ≤ 0.05 (ANOVA and linear contrast). 12 
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The results of the measurements of different biochemical parameters are summarized 1 
in Table 3. All endpoints, which are indicative for lipid peroxidation were reduced after 2 
intake of coffee, but the effect reached significance only in the case of the F2-isoprostanes. 3 
Figure 3 depicts the gender specificity of the effect and it can be seen that the overall 4 
decrease is due to the strong effect in females. 5 
 6 
Table 3: Effects of coffee consumption on different biochemical parameters1 7 
 8 
Parameters (unit) water period coffee period ∆ (%)2 p-value3 
Lipidperoxidation Products     
oxLDL (U/L)4  40.05 ± 11.41 38.05 ± 13.48 -4.98 0.421 
MDA (µM/L)4  1.16 ± 0.68 1.07 ± 0.59 -7.57 0.365 
8-epi-PGF2α (ng/mg Cr)5 0.09 ± 0.04 0.07 ± 0.03 -14.93 0.001* 
Enzymes6     
SOD (U/mg/protein) 7.60±2.66 7.32 ± 2.40 -3.68 0.585 
GPx (U/mg protein) 0.56±0.19 0.58 ± 0.26 +4.17 0.513 
GST (nmol/min/mg protein) 277.58±86.90 288.36 ± 78.38 +3.88 0.233 
Intracellular ROS6 
    
without challenge (- plasma)  10.66±4.19 10.25 ± 2.61 -3.76 0.693 
without challenge (+ plasma) 9.00±3.25 9.21 ± 2.27 +2.33 0.758 
with H2O2 (- plasma) 151.89±92.74 166.92 ± 99.84 +9.90 0.384 
with H2O2 (+ plasma) 57.10±42.91 42.93 ± 30.39 -24.81 0.291 
Other parameters 
    
TAC (mM TE)4 0.71 ± 0.16 0.76 ± 0.15 +6,61 0.253 
GSH (mg/dl)7 72.52 ± 9.41 72.43 ± 11.28 -0.12 0.772 
3-NT pg/µg tyrosine4 8.47 ± 3.08 7.01 ± 2.28 -17.24 0.011* 
 9 
1All values are means ± SD. 8-epi-PGF2α, 8-epi-prostaglandin F2α; GSH; glutathione, GPx; glutathione 10 
peroxidase, GST; glutathione-S-transferase, MDA, malondialdehyde; oxoLDL, oxidised low density lipoprotein; 11 
ROS; reactive oxygen species; SOD; superoxide dismutase, TAC; total antioxidant capacity, TE; trolox 12 
equivalent,  13 
2
∆ (%) values were calculated from raw data  14 
3 Statistical analyses were performed with the Wilcoxon signed-ranks test;  15 
*
 stars indicate statistical significance (p ≤ 0.05) 16 
4
 Measurements were performed in plasma, 5 in urine, 6 in lymphocytes, 7 in erythrocytes 17 
 18 
19 
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 1 
Fig. 3 A-C Impact of coffee consumption on the levels of 8-iso PGFα concentrations in the 2 
urines measured with LCMSMS. Bars represent the mean ± SEM. Asterisks indicate 3 
statistical significance, P ≤ 0.05 (Wilcoxon signed-rank test). 4 
 5 
 6 
The overall 3-NT levels were reduced by 17.2 % after coffee intake and it can be seen 7 
in Figure 4, that the protective effect was again due to the strong effect in females. None of 8 
the other endpoints except 3-nitrotyrosine (3-NT) was affected by coffee consumption. 9 
10 
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 1 
Fig. 4 A-C Impact of coffee consumption on the levels of 3-nitrotyrosine determined by LC-2 
ESI-MS/MS. Bars represent the mean ± SEM. * Asterisks indicate statistical significance 3 
P ≤ 0.05 (Wilcoxon signed-rank test). 4 
 5 
Intracellular ROS levels were increased after treatment of the cells with H2O2 and the 6 
levels were in general lower when the cells were cultivated in plasma, which contains a 7 
variety of antioxidants. No significant changes were seen after coffee consumption in these 8 
experiments. 9 
The expression of a variety of genes was analysed by RT-PCR; some of them 10 
NQO1 (7.8 %), SOD1 (22.2 %), UGT2A1 (125.4 %), UGT2A3 (14.4 %), UGT2B15 (20.6 %), 11 
UGT2B17 (15.0 %), GSTA1 (24.8 %), GSTA2 (45 %), GSTA5 (19.5 %) were increased after 12 
coffee consumption. (Numbers in parenthesis indicate the increase in percent). Also the 13 
expression of Nrf2 was increased (by 9.9 %). However, none of these effects reached 14 
statistical significance.  15 
16 
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DISCUSSION 1 
Overall, the results of the present study show, that consumption of instant coffee rich 2 
in chlorogenic acids (CAs) resulted in a significant protection towards DNA migration 3 
attributable to formation of oxidized bases, reduced the 3-NT levels in plasma and decreased 4 
the concentrations of F2-isoprostanes in urine, while other biomarkers of oxidative stress 5 
were not altered.  6 
The protection of oxidative DNA damage was not unexpected as we observed (in a 7 
small (n=8) recent pilot study with coffee) a reduction of FPG and Endo III sensitive lesions 8 
(5). In this earlier trial, the participants consumed a mix of paper and metal filtered coffee, 9 
while, in the present study, we used instant coffee containing high levels of hydroxycinnamic 10 
acids. This may explain why the effects we observed were less pronounced. However, as 11 
described above, the observation of a significant decrease of endogenous formation of FPG-12 
sensitive sites was restricted to female participants. Furthermore, it is notable that comet 13 
formation was decreased in the present study also under standard conditions (which reflect 14 
single and double strand breaks), however this effect did not reach significance.  15 
Also a number of earlier investigations are indicative of DNA protective effects of 16 
coffee. For example, van Zeeland et al. (39) reported lower levels of 8-OHdG in peripheral 17 
leukocytes of coffee drinkers. Furthermore, a large number of in vitro experiments with 18 
different types of coffee and with coffee constitutents such as CAs, caffeine and Maillard 19 
products provided evidence of antimutagenic properties (for review see (6)).  20 
Recently we reviewed the results of human intervention trails in which the SCGE 21 
technique was used to monitor the effects of dietary components on DNA stability (17). It is 22 
notable that in a large study no significant protection was observed after consumption of high 23 
levels of fruits and vegetables (600g/P/d) (40), while strong effects were seen with specific 24 
items, such as Brussels sprouts (41), watercress (42) and also with the common spice sumach 25 
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(43). These findings indicate that only specific food items protect against oxidative DNA 1 
damage.  2 
Another relevant marker of oxidative damage, which was decreased in the present trial 3 
are the F2-isoprostane concentration in urines. On the contrary, no such effect was seen in a 4 
study with paper filtered ground coffee (n=43, uptake of 450/900 ml for 3 weeks or n=35, 5 
uptake of 150/300 ml single dose) by Mursu et al. (44). The reason for this discrepancy may 6 
be that another type of coffee was used and/or that they monitored the isoprostanes in plasma 7 
and not in urine. F2-Isoprostanes are regarded as a reliable marker for lipid peroxidation (4) 8 
and high levels are associated with increased risk of a number of diseases, including 9 
neurological disorders, coronary heart and lung diseases, and renal dysfunction, to name only 10 
a few (for review see (45)). It has been shown in human intervention trails that dietary factors 11 
such as vitamin C (in smokers) (46), genistein (47) as well as specific foods such as legumes 12 
(48) and yam (49) decrease F2-isoprostane levels, while no such effects were seen with other 13 
dietary components, such as chocolate (50), tomato based drink (51) and blueberries (52). 14 
Another endpoint, which was affected by coffee intake are the 3-NT levels in plasma, 15 
which are indicative of pathological conditions, such as inflammation, neurodegenerative 16 
diseases and cardiovascular disorders (for review see (53)). Protein alterations, which are 17 
characterised by higher NT levels, are also characteristic for artheriossclerotic lesions (54) 18 
and it is known that they are associated with a number of functional consequences, such as 19 
modifications of the activities of specific enzymes (53). Weight loss in overweighted 20 
Caucasian women (55) and also the glycemic index of food items (56) affect human NT 21 
levels but no results from intervention trials with specific dietary factors have been published 22 
according to our knowledge. However, a number of in vitro studies showed that a citrus 23 
flavone (hesperitin) (57), tomato extracts (58) and hydroxycinnamic acids inactivate 24 
peroxynitrite (59, 60), which is responsible for the nitration of tyrosine (61). The latter 25 
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observation is of particular importance since the coffee that we used was rich in CAs. In this 1 
context, it is notable that chlorogenic acid (5-caffeoylquinic acid) reduced the NT levels in the 2 
aorta of rats. This effect was paralleled by the attenuation of hypertension and improvement 3 
of endothelial function (62).  4 
In the RT-PCR we detected alterations of the activities of some enzymes involved in 5 
antioxidant defence such as NQO, SOD1 and specific forms of UGT and GST. None of these 6 
changes was significant, but nevertheless they suggest a trend towards a specific pattern of 7 
transcriptional changes. Interestingly, Cavin et al. (7) found that coffee and coffee 8 
diterpenoids activate the transcription factor Nrf2 in the liver of rats, which controls the 9 
aforementioned genes and we detected also in the present study a moderate activation of this 10 
transcription factor in the lymphocytes (which was statistically not significant). 11 
None of the other markers, which we monitored in the present study, such as GSH, 12 
MDA, oxoLDL, SOD, GPx and intracellular ROS formation was altered after coffee intake. 13 
These findings are partly in contrast to results of other coffee studies. For example, Esposito 14 
et al (63). found increased GSH levels after intake of espresso. Bichler et al. (5) detected an 15 
increase of SOD activities with a mix of metal and paper-filtered coffee and Steinkellner et al. 16 
(64) found a strong enhancement of the levels of GST isoenzymes after intake of metal 17 
filtered coffee. On the contrary, no changes of most of these markers were found by Mursu et 18 
al. (44), who conducted a clinical trial with paper filtered ground coffee containing low 19 
amounts of cafestol and kahweol. These diterpenoids are known to interact with cell 20 
signalling pathways (65, 66).  21 
Dotan et al. (67) compared the association between several markers of oxidative stress 22 
used in human trials and/or in animal studies. The authors found that no or only weak 23 
correlations exist between different groups of endpoints, for example between markers of 24 
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lipid peroxidation and oxidative DNA damage and emphasize that oxidative stress and 1 
protection against it can not be defined in universal terms. 2 
In the case of the instant coffee we used, it is possible that indirect effects may account 3 
for its antioxidant properties. It was shown recently that green tea increased the uptake of 4 
glucose in the gastrointestinal tract which leads to a hypocaloric status associated with 5 
decreased ROS production in mitochondria. This effect was not paralleled by changes in the 6 
TAC (68). Also with coffee reduced glucose uptake was found in a recent human study and 7 
the authors suggest an antagonistic effect of CAs on glucose transport (69). 8 
The most pronounced antioxidant effects were seen in the present study consistently in 9 
females. Overall the gender specificity of the oxidant status in humans is a controversial issue. 10 
A number of comet studies indicate that the extent of DNA damage is lower in females than 11 
in males (70, 71). However, Moller et al. (72) found no clear sex differences in a recent meta-12 
analysis. 13 
According to our knowledge, no gender specific differences were reported in earlier 14 
dietary intervention trails (17). In this context, it is notable that the lack of an effect of coffee 15 
on a panel of different lipid peroxidation parameters reported by Mursu et al. (44) may be due 16 
to the fact that only males participated in this trial while in the SCGE study of Bichler et al. 17 
(5, 73), who found pronounced reduction of DNA damage, only females were enrolled. 18 
Interestingly, the results of some epidemiological studies indicate that coffee consumption is 19 
more protective in women. For example, a stronger inverse association between coffee intake 20 
and the incidence of liver cirrhosis was found in an Italian case control study (in males 21 
OR 0.6 and in females OR 0.2) (74). Also a recent meta-analysis concerning the correlation 22 
between coffee and colorectal cancer showed stronger effects in females (75) and in a large 23 
prospective Japanese study (76), a significant risk was only seen in females. It is also notable 24 
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that the inverse association of caffeine intake and diabetes type 2, which was described by Iso 1 
and coworkers in a Japenese study was less pronounced in males (77). 2 
Take together our results suggest that coffee consumption may contribute substantially 3 
to the improvement of the antioxidant status in humans and to the prevention of ROS-related 4 
diseases. 5 
 6 
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AbstractA number of animal studies indicate that coffee protects against chemical induction of cancer; also human studies suggest that
coffee consumption is inversely related with the incidence of different forms of cancer. The protective effects were attributed to
induction of glutathione-S-transferases (GSTs) and aim of the present human study was to find out if coffee causes induction of
GSTs and protects against DNA-damage caused by (±)-anti-B[a]P-7,8-dihydrodiol-9,10-epoxide (BPDE), the DNA-reactive
metabolite of benzo(a)pyrene. Ten participants consumed 1 L unfiltered coffee/d over 5 days. Before and after the intervention,
saliva and blood were collected and the overall GST activity was measured with 1-chloro-2,4-dinitrobenzene (CDNB).
Additionally, GSTP and GSTA were determined in plasma with immunoassays. In blood, only weak (p = 0.042) induction of
GST (CDNB) was found. Furthermore, pronounced (three-fold) induction of GSTP was observed in blood, whereas GSTA was
not altered. No correlations were seen between induction of GST (CDNB) and GSTP activities and the GSTP1 genotypes of the
participants. Also clinical parameters (creatinine, alanine, aminotransferase, aspartate aminotransferase, alkaline phosphatase),
which are markers for organ damage, were monitored. None of them was altered by coffee, but serum cholesterol levels were
slightly (not significantly) enhanced. In a second trial (n = 7), GSTP induction by unfiltered and paper filtered coffees, differing
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in cafestol and kahweol contents, were compared. The participants consumed 1 L coffee/d over 3 days. Again significant (three-
fold) induction of GSTP was observed. The effects seen with the two coffees were identical, indicating that the diterpenoid
concentrations are not responsible for the effects. In a further trial (n = 7), the effect of coffee (unfiltered, 1 L/d, 5 days) on BPDE
induced DNA-migration was studied in comet assays. A 45% reduction effect was observed. Our findings show that coffee
induces GSTP in humans and indicate that consumption may lead to protection towards polycyclic aromatic hydrocarbons.
© 2005 Elsevier B.V. All rights reserved.
Keywords: Coffee; Glutathione-S-transferase; Human intervention; SCGE; BPDE; DNA protection
1. Introduction
Coffee is among the most widely consumed be-
verages and its annual production is increasing [1]. As
coffee contains a broad variety of potentially bioactive
compounds, strong efforts have been made to study its
effects on human health. A number of epidemiolog-
ical studies indicate, that the consumption of coffee
is inversely related to the incidence of colon cancer
[2–5], additionally also protection towards other forms
of cancer has been reported [6,7].
These observations are supported by data from ani-
mal studies which showed that coffee protects against
dietary carcinogens such as nitrosamines and poly-
cyclic aromatic hydrocarbons (PAHs) [8,9]. One of
the most important mechanisms by which coffee and
the coffee specific dipterpenoids cafestol and kahweol
(C + K) protect against cancer appears to be induction
of glutathione-S-transferases (GSTs) [10]. GSTs are a
humans. It was shown that consumption of Brassica
vegetables causes induction of overall GST and of spe-
cific isozymes in plasma of humans [21–23]. Only
one comprehensive study on the effect of coffee is
available: Grubben et al. [24] monitored the effect
of unfiltered coffee on GST levels in colon mucosa
cells. Neither the overall GST activity nor any of
the isozymes GSTA, GSTP, GSTM were significantly
induced, but a slight increase in the glutathione lev-
els in the colorectal mucosa (8%) and plasma (15%)
was found. Sreerama et al. [25] reported on induc-
tion of GST activity in saliva after coffee consump-
tion but only one individual was monitored, there-
fore no firm conclusions can be drawn from this
observation.
In the present study we investigated the effect of
unfiltered coffee on the GST levels in serum and saliva
in a controlled study. The activity of the enzyme was
measured with 1-chloro-2,4-dinitrobenzene (CDNB)family of phase II enzymes which inactivate a broad
variety of environmental and dietary toxins [11,12]
including food carcinogens such as PAHs, aflatox-
ins and heterocylic aromatic amines (HAAs). Recent
studies indicate that the isozyme GSTP is highly pro-
tective towards (±)-anti-B[a]P-7,8-dihydrodiol-9,10-
epoxide (BPDE) which is the most important DNA
reactive metabolite formed from benzo[a]pyrene (BaP)
which is a substrate for several isozymes [26], and
provides information on the overall GST status. Fur-
thermore, we also measured GSTA and GSTP with
ELISAs, two important isozymes which can be induced
by vegetables [23,27,28]. To elucidate if the inducibi-
lity of GST depends on the genetic background, the
GSTM1 and GSTP1 genotypes of the participants
were determined by PCR, furthermore several clini-[13–15]. In a number of animal studies as well as in
experiments with human derived cells [16], induction
of GSTs by coffee and C + K was found and these
e
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cal parameters were measured in the serum to exclude
that the induction effects are a consequence of toxicity
and organ damage. In an additional trial we compared
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124ffects were paralleled by protection towards chemical
nduction of tumors and DNA-damage [16–18]. Fur-
her evidence for the important role of GSTs in human
ancer comes from a number of studies which show that
unctional polymorphisms of GST isozymes play a role
n the aetiology of different forms of cancer [19,20].
Only a few studies are available in which the induc-
ion of GSTs by dietary factors was investigated inhe effects of unfiltered and paper filtered coffee on
STP induction to find out if the effects depend on
he diterpenoid contents. With paper filtered coffee, the
mounts of lipids are normally below 0.2% (<0.6 mg
otal diterpenes/cup), whereas levels up to 20% of oil
6–20 mg diterpenes/cup) have been reported for boiled
Scandinavian), French Press and metal filtered coffees
29–33].
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Fig. 1. Design of the first intervention study.
As mentioned above, it is known that GSTs play a
key role in the detoxification of PAHs which are an
important class of DNA-reactive carcinogens. There-
fore, we conducted a further trial in which the impact
of coffee consumption on the sensitivity of peripheral
lymphocytes towards BPDE induced DNA-damage
was monitored in single cell gel electrophoresis assays
(SCGE, comet assay).
2. Materials and methods
2.1. Design of the study
Ten healthy, non-smoking, non-vegetarians (three
males, seven females) participated in the first trial. The
design of the study is depicted in Fig. 1. Fourteen days
before the start and during the study, the volunteers
(mean age: 26 ±4 years, b.w.: 75 ± 9 kg) had to refrain
from consumption of cruciferous vegetables, coffee
and tea. The participants were also asked to reduce
the consumption of alcoholic beverages and fruit juices
(not more than 200 mL/d), to consume limited amounts
of fruits and vegetables (not more than 200 g/d) and
not to perform physical exercises. 500 g of ground cof-
fee (“Brasil sanft”, Eduscho-Kaffee GmbH, Vienna,
Austria) were boiled in 10.0 L tap water for 5 min, sub-
sequently, the coffee (designated as “unfiltered coffee”)
was pressed through a metal mesh (Phillips, Vienna,
Austria). All individuals consumed seven cups (in total
1
d
o
y
t
c
sumed coffee which had been filtered through a paper
filter (“Melitta Aromapor”, Melitta Haushaltsprodukte
GmbH&Co. KG, Minden, Germany) for three days.
Before and at the end of the interventions, blood and
saliva were collected. The study was approved by the
Austrian Ethical Commission and informed consent
was obtained from all participants.
The third trial was conducted under identical con-
ditions as the first study but peripheral lymphocytes
were used in this experiment for single cell gel elec-
trophoresis assay and other participants were involved.
The average age of the participants was 26 ± 6 years
and their average body weight was 72 ± 8 kg.
2.2. Preparation of samples
A 4.0 mg DTT (Sigma–Aldrich, St. Louis, MO,
USA) were added to 5.0 mL of sputum in plastic
vials which were centrifuged at 9000 × g for 15 min.
A 10.0 mL of blood were aspired by venipuncture
and centrifuged in heparinised glass vials (Becton-
Dickinson, Plymouth, UK) at 760 × g for 10 min. The
saliva supernatants and the plasma samples were stored
in liquid nitrogen. For single cell gel electrophoresis
assays, the lymphocytes were isolated by Ficoll cen-
trifugation [35].
2.3. Enzyme measurements
Protein contents of saliva and plasma were deter-
m
[
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w
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S
125.0 L) of coffee daily over 5 consecutive days. The
esign of the second intervention was identical as that
f the first. Fourteen individuals (mean age: 25 ± 6
ear, b.w.: 74 ± 10 kg) different from those involved in
he first trial participated. Seven consumed unfiltered
offee (prepared as described above) and seven con-ined spectrophotometrically according to Bradford
36] with the BIO-RAD® Protein Assay (BIO-RAD®,
unich, Germany). GST activity in saliva and plasma
as determined according to Habig et al. [37] with
DNB as substrate. The chemicals were obtained from
igma–Aldrich (St. Louis, MO, USA). Spectrophoto-
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metrical measurements were carried out in triplicate
(Beckman DU 640 spectrophotometer, Fullerton, CA,
USA). GSTA and GSTP contents were determined in
plasma with quantitative immunoassays (HEPKITTM-
Alpha and HEPKITTM-Pi, Biotrin International Ltd.,
Dublin, Ireland).
2.4. Determination of GSTM1- and GSTP1
genotypes
DNA was isolated from buccal cells with the QIA-
GEN blood kit (QIAGEN, Hilden, Germany) and
stored in elution buffer (Perkin Elmer Cetus, Nor-
walk, USA) at −20 ◦C. Polymorphisms in the GSTM1
gene locus were determined with PCR as described by
Bell et al. [38] in which -globin was co-amplified as
an internal standard. Amplification products (-globin
268 bp, GSTM1 215 bp) were resolved on 2% ethidium
bromide-stained gel with minor modifications [39].
For the determination of the GSTP1 polymorphism
PCR/FLP assays, with separation of PCR products on
a 3% ethidium bromide-stained gel were carried out
according to Harries et al. [40] with minor modifica-
tions [39].
2.5. Blood parameters
Spectrophotometrical determinations of creatinine-
, cholesterol-, alanine aminotransferase-, aspartate
aminotransferase- and alkaline phosphatase contents
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analysis system (for details see Helma and Uhl [45]).
Per experimental point, three cultures were prepared
and from each 50 cells were analysed. Only cul-
tures were evaluated in which the viability of the
cells was ≥80% compared to untreated controls. The
viability of the cells was determined with trypan
blue [46].
2.7. Statistical analyses
To determine statistical differences of the enzyme
activities before and after the interventions, analyses
of variance (ANOVA) and Wilcoxon tests were car-
ried out. Correlations between gender, genotype, blood
parameters, body weight and GST induction were ana-
lysed with Spearman’s rank correlation test.
Comet tests in vitro with BPDE were tested by
analysis of covariance, comparisons of doses against
control were done by Dunett’s test. For statistical anal-
yses of the SCGE intervention study, the median and
90th percentiles of the distribution of the tail lengths
were calculated and subjected to an analyses of vari-
ance with control versus BPDE and time points (before
coffee consumption and after consumption) as experi-
mental factors and subjects of random factor. Although
the data showed no significant deviation from norma-
lity they were log-transformed to reach homogeneity
of variances. Post hoc tests of means of experimen-
tal conditions were done by Tukey’s HSD tests. For
all comparisons a p-value below 0.05 was considered
s
3
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126ere performed with an automated spectrophotometer
SYS 3 BM/Hitachi 747/737, Boehringer Mannheim,
ermany) according to standard protocols [41–43].
.6. Single cell gel electrophoresis assays
The lymphocytes were resuspended in phos-
hate buffered saline (pH = 7.4) and exposed to
.4M (±)-anti-B[a]P-7,8-dihydrodiol-9,10-epoxide
BPDE, obtained from Biochemisches Institut fu¨r
mweltkarzinogene, Germany, CAS: 58917-67-2)
issolved in DMSO (containing 0.1% trietylamine,
igma, St. Louis) at 37 ◦C for 30 min. Subsequently
he cells were washed with PBS, centrifuged (8 min,
10 × g) and transferred to agarose coated slides,
hich were prepared and further processed accord-
ng to the protocol of Collins et al. [44]. Comet for-
ation was monitored with a computer aided imageignificant.
. Results
.1. GST (CDNB) measurements in blood and
aliva
The results of GST measurements in saliva are
hown in Fig. 2a. Before the intervention, the average
ctivity was 29.47 ± 14.00 mIU/mg. At the end of the
tudy a 1.13-fold (not significant, p = 0.290) increase
as detected.
The results obtained with the plasma samples
re depicted in Fig. 2b. The enzyme activities were
pproximately three orders of magnitude lower than
n saliva. The background activity before the interven-
ion was 0.037 ± 0.011 mIU/mg, after the intervention,
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Fig. 2. (a) and (b) Effect of consumption of unfiltered coffee (1 L/P/d)
on GST activities (mIU/min/mg) in saliva (a) and plasma (b). The
enzyme activities were determined according to Habig et al. [37],
protein contents were determined according to Bradford. [36]. Num-
bers on the x-axis are codes of the different participants. Striped bars:
GST activity before coffee consumption, black bars: activity after
consumption, Bars indicate mean ± S.D. of three measurements in
parallel, numbers indicate codes of the different participants.
it was significantly increased (0.040 ± 0.017 mIU/mg,
p = 0.042). It is notable that the inter-individual fluctu-
ations were smaller than in saliva.
3.2. Measurement of GSTA and GSTP
To find out which GST isozymes were induced,
immunoassays for GSTA and GSTP were conducted
with the plasma samples. It can be seen in Fig. 3a
that GSTA was not affected (p = 0.440) whereas a
pronounced, highly significant (p = 0.005) increase in
GSTP was observed (Fig. 3b). Before the intervention,
Fig. 3. (a) and (b) Effect of consumption of unfiltered coffee (l L/P/d)
on GSTA (a) and GSTP (b) in plasma over three days. The isozymes
were determined with ELISA. Striped bars: GSTA and GSTP activity
before coffee consumption, black bars: activity after consumption,
Bars indicate mean ± S.D. of three measurements in parallel, num-
bers indicate codes of the different participants.
the mean GSTP content was 16.34 ± 6.11 ng/mL, at the
end of the study it was 50.06 ± 12.53 ng/mL.
3.3. Genotyping of the participants
From the ten participants of the first study, four had
an intact GSTM1 gene (participant numbers 4, 9, 12,
13), six were GSTM*0 (6, 7, 15, 16, 17, 18), four (12,
13, 16, 17) had the wildtype GSTP1 gene, the others
(4, 6, 7, 9, 15, 18) were heterozygous.
The results of Spearman’s rank correlation tests
showed no significant correlations between induction
of GST activity in plasma and increased GSTP contents
(p = 1.0) and also no relation between induction of over-
all GST, GSTP and GSTA and the different genotypes
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(the p values for induction of GST and GSTP1 geno-
type was 0.046, for GSTP and GSTP1 the value was
0.51).
3.4. Clinical blood parameters
Data of the measurements of the blood parameters
(creatinine-, cholesterol-, alanine aminotransferase,
aspartate aminotransferase and alkaline phospatase)
are not shown in detail. With exception of serum
cholesterol, none of them was enhanced after
coffee consumption. The cholesterol level was
195.2 ± 37.7 mg/100 mL before the begin of the study
and was increased by 6.5% after the intervention (mean
207.3 ± 25.7 mg/100 mL). However, this effect was not
statistically significant (p = 0.06).
3.5. Comparison of GSTP induction by ﬁltered
and unﬁltered coffee
The results of the second trial in which the effects
of unfiltered and paper filtered coffee on GSTP induc-
tion were compared are depicted in Fig. 4a and b. It is
known that the bioactive coffee compounds C + K are
retained by paper filtration [33,34]. Both types of cof-
fee were prepared from the same brand and boiled for
5 min. As mentioned above, the C + K values are sub-
stantially lower in paper filtered coffee. Nevertheless,
identical GSTP induction effects were seen with both
preparations.
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Fig. 4. (a) and (b) Effect of consumption of paper filtered (a) and
unfiltered (b) coffee (1 L/P/d) on the induction of GSTP in plasma.
The measurements were carried out with ELISA. The bars show
mean ± S.D. of results obtained with seven individuals per group.
Striped bars: GSTP activity before coffee consumption, black bars:
activity after consumption, Bars indicate mean ± S.D. of three mea-
surements in parallel, letters indicate the codes of the participants.
4. Discussion
More than 20 years ago Wattenberg [9] showed
that feeding of coffee beans to rodents leads to an
increase of the GST activity in different organs and
protects against tumor induction by PAHs [9]. Also
for green tea which is rich in phenolics, protective
effects towards dietary carcinogens via this mechanism
is well documented [47]. The results of the present
study show that consumption of coffee leads also in
humans to a pronounced increase in the activity of this
detoxifying enzyme. Furthermore, we demonstrated
that this effect is paralleled by substantial protection
128.6. Results of SCGE experiments
In order to define the optimal concentration of BPDE
or the intervention trial, a dose response experiment
as carried out with lymphocytes from one individual.
he results are depicted in Fig. 5. It can be seen that
he diol induced DNA-migration over the entire range
ested; already at the lowest dose (0.25M) a signifi-
ant effect was observed.
The results of the intervention trial are summarised
n Fig. 6. In all participants the DNA-damage induced
y BPDE was substantially reduced after coffee con-
umption. Overall the protection effect caused by cof-
ee was 45% and highly significant (p = 0.0001). In
ontrol cultures (i.e. in cells which were not treated
ith the diol), no difference in DNA migration was
een before and after the invention (p = 0.84).
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Fig. 5. Induction of DNA migration in human lymphocytes by
BPDE. The cells were exposed for 30 min (at 37 ◦C) to different
concentrations of BPDE. Per experimental point three cultures were
prepared and from each 50 cells were analysed. Stars indicate statis-
tical significance (p≤ 0.05).
towards DNA-damage caused by BPDE in peripheral
lymphocytes.
The present study was conducted under controlled
dietary conditions. This has the advantage that indi-
vidual fluctuations can be minimized. We found in
earlier investigations that GST levels as well as DNA
migration vary strongly when the measurements are
conducted without dietary control. Due to the reduc-
tion of these fluctuations and the design of the study
as an intervention trial it is possible to get meaningful
results with a lower number of participants as those
required in studies which are based on comparisons
of different groups. Also in earlier human studies in
which the impact of dietary factors on GST levels and
on DNA-damage in lymphocytes were measured, sim-
ilar or even smaller group sizes as in the present study
were used [27,28,44,48–51]. The induction of GSTP
as well as the protective effect towards DNA-damage
caused by BPDE was seen in ≥90% of the participants
and are statistically highly significant. For the negative
results (lack of GST (CDNB) induction in saliva and
lack of GSTA induction in plasma) we calculated the
statistical power of our study to detect a 25% alter-
ation (increase or decrease) of these parameters; for
GST (CDNB) it was 84% and for GSTA it was 88%,
respectively. This shows that the number of participants
in our experiments was sufficient to detect relevant
alterations.
Only a few earlier studies on the induction of GSTs
in humans by dietary factors are available. Apart from
Fig. 6. Impact of coffee consumption on induction of DNA migration by
unfiltered coffee per day over a period of 5 days, before and after the inte
or with the solvent (DMSO) only for 30 min. Subsequently, the viability a
in all cases ≥80% (data not shown). Bars indicate mean ± S.D. of three c
DNA migration. Numbers on the x-axis indicate individual participants. W
cultures, shaded bars: DNA migration in control cultures after coffee consu
consumption, black bars: DNA migration induced by BPDE after coffee con
129BPDE in human lymphocytes. The participants consumed 1 L of
rvention, the cells were isolated and treated with BPDE (0.4M)
nd DNA migration were monitored. The survival of the cells was
ultures in parallel. From each culture, 50 cells were analysed for
hite bars: DNA migration before coffee consumption in control
mption, grey bars: DNA migration induced by BPDE before coffee
sumption.
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the coffee study by Grubben et al. [19] who did not
find an effect on GSTs in colon mucosa after cof-
fee consumption, all other investigations concerned the
effects of vegetables. For example Nijhoff et al. [27,28]
reported induction of GSTA with Brussels sprouts in
males but not in females, more recently Lampe et al.
[52] found induction effects by Brassica and Allium
diets. Also with these vegetables, cancer protective
effects were seen in animal experiments which were
attributed to induction of GSTs [53].
The human glutathione biotransformation system
consists of four major classes of GSTs namely GSTA,
GSTM, GSTP and GSTT which differ in their tissue
distribution and also in their substrate specificity [54].
In the aforementioned vegetable studies, the increase
in overall GST was found in spectrophotometric assays
with CDNB which is a substrate for different isozymes
except GSTT [54]. Immunoassays showed induction of
GSTA in the plasma [28,52] whereas GSTP levels were
not altered [28], only in an experiment with intestinal
biopsies, a significant induction of both isozymes was
observed in rectal cells after consumption of Brussels
sprouts [27]. In the present study, a different induc-
tion pattern was observed, i.e. the GSTA levels were
not affected whereas a drastic increase in GSTP was
observed.
GSTP is the most widely distributed enzyme of
all GSTs and the most abundant form in many tis-
sues except in the liver [55]. It is dominating for
example in the lungs [56] and in the rectum [27],
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the GSTP status has an impact on cancer risks in
humans.
The observation that coffee consumption reduces
BPDE induced DNA-damage was not unexpected. The
protective effect of GSTP towards chemical carcino-
gens was shown earlier in a number of genotoxicity
studies which indicated that this enzyme detoxifies re-
presentatives of different classes of DNA-reactive
carcinogens. Ryberg et al. [62] found increased
hydrophobic DNA-adducts in lung tissues of cancer
patients (smokers) who had the GG phenotype.
The GG phenotype (GSTP1-valin variant) causes
formation of an altered enzyme protein which has
lower affinity to CDNB, but a greater affinity towards
other substrates (bromosulfophtalein and ethacrynic
acid) [71]. In another study with smokers, no effect of
GSTP1 mutations on adduct formation in peripheral
white blood cells was found, but in combination
with GSTM1 null genotypes a significant increase
was detected [72]. No such combination effects
were seen in a similar study in lung cells, but again
in blood cells the adduct levels were increased in
smokers with the GSTM1 null genotype and GSTP1
(Ile105/Val105 or Val105/Val105). These findings
were explained by the fact that GSTP catalyses the
detoxification of BPDE (the ultimate DNA-reactive
metabolite of 3,4-benzo[a]pyrene (B(a)P) and other
diols [73–75]). Consistent with these biochemical data
it was shown that GSTP transfected cells are more
resistant towards BPDE induced DNA-damage than
n
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130lso in lymphocytes its activity is higher as that of
ther GSTs [54]. Approximately 50% of the Cau-
asians carry a mutation in the GSTP gene [40] and
t is known that polymorphisms exist in humans in
xons 5 and 6 which have functional effects on the
ene product resulting in decreased enzyme activity
57–60]. A number of studies indicate that these poly-
orphisms are associated with increased risks for
ifferent forms of cancer in humans for example in
he lung [61–64], breast [65,66], oesophagus [67],
rostate [40,68], bladder [40], testes [40] and colon
69]. It is notable that some other studies failed to
nd correlations between GSTP polymorphisms and
pecific forms of cancer, for example no associa-
ions were seen in two other studies on colon cancer
61,70] and two Swedish investigations did not detect
ssociations with prostate cancer incidence. Never-
heless, the overall evidence strongly suggests thatormal cells [13–15] and enhanced skin tumorigenesis
y 7,12-dimethylbenz[a]anthracene (DMBA) was
ound in knockout mice lacking class GSTP [76].
STP plays also an important role in protection
owards other DNA-reactive carcinogens. In work-
rs exposed to styrene oxide, a higher number of
PRT mutations was found in individuals with
eterozygosity of the GSTP1 gene [77]. These
ffects towards styrene oxide were further confirmed
n in vitro micronucleus experiments with human
ymphocytes [78]. Protective effects of GSTP were
lso reported against the heterocylic aromatic amine
-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine
PhIP) in experiments with human liver and prostate
ells [79,80], towards the UV mimetic compound
-nitroquinoline-1-oxide (4-NQO), alkylating agents
81–84] and against different DNA-reactive anticancer
rugs such as cis-platin, carbo-platin and thiotepa [85].
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The results described in the last paragraphs indi-
cate that GSTP plays an important role in the protec-
tion towards DNA-reactive carcinogens (in particular
towards PAHs) and that altered activity (due to poly-
morphisms) is associated with increased cancer risks.
The strong increase in the activity of this isozyme
(two- to six-fold) seen in the present study supports
the assumption that coffee consumption has beneficial
effects in humans in terms of reducing their cancer risks
and is supported by the results of the SCGE experi-
ments which clearly show a protective effect of coffee
consumption towards BPDE induced DNA-damage in
peripheral human lymphocytes. It is notable, that we
observed also pronounced enzyme induction effects in
individuals who were heterozygous in the GSTP1 gene.
This indicates that the upregulation is not affected by
base mutations in the GSTP1 allele.
In the present study we were interested initially in
overall GSTP induction effects in the body and not
in the alterations of this enzyme in the lymphocytes.
However, it is not possible to rule out on the basis
of the present findings in which cells/organs induction
effects take place. This question will be clarified in fur-
ther animal studies which are in progress. It is known
that extracellular GSTP induction may be due to toxic
effects but since no alterations in the clinical parame-
ters were seen and no changes of the viability of the
lymphocytes before and after coffee consumption were
observed, this possibility can be excluded. As men-
tioned above, strong protective effects towards BPDE
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studies, it was claimed that the DNA- and cancer pro-
tective effects of coffee as well as the induction of GST
and other enzymes might be due to the coffee specific
diterpenoids C + K [17]. However, it was also shown by
Wattenberg and Lam [18] that C + K account only for
40% of GST (CDNB) inducing activity of coffee in the
mouse liver and Esposito et al. [86] found induction
of glutathione after consumption of coffees with low
C + K contents. Since C + K leads to hypercholester-
aemic effects [29,30] it is important that the increase
in the cancer protective enzyme system was also seen
after consumption of a coffee preparation which had
low diterpenoid levels. In this context, it is notable
that it has been postulated that, apart from C + K other
coffee components, in particular polyphenols such as
chlorogenic acids and melanoidins produced during the
roasting process, may also account for GSH and GST
induction [86–88].
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A B S T R A C T
This article summarises the results of human dietary intervention trials employing the comet assay
(single cell gel electrophoresis, SCGE), which have been published in the last few years (i.e., between 2005
and 2008) and describes new trends and developments aswell as current problems concerning the design
of intervention trials and the interpretation of the results. Most new studies were carried out with
complex plant derived foods and juices; only a few were conducted with individual food constituents.
With speciﬁc vegetables, for example with water cress and Brussels sprouts, potent antioxidant effects
were observed; also coffee caused a protective effect and it is notable that it was more effective than
consumption of a diet containing increased levels of fruits and vegetables. Interesting recent
developments include the development of protocols which enable us to monitor protection towards
genotoxic chemicals contained in the human diet, and it was shown in preliminary studies that
alterations of the activities of drug metabolising enzymes by dietary factors lead to altered sensitivity of
lymphocytes against DNA damage caused by certain dietary carcinogens. Another novel approach is the
development of methods to monitor the effects of dietary factors on DNA repair. The development of
protocols for experiments with exfoliated buccal cells is another potentially valuable innovation. The
adequate experimental design of SCGE trials is still a matter of debate and the evaluation of the available
data shows that there is an urgent need to develop guidelines concerning the number of participants,
sampling periods, duration of trials, use of placebos, and deﬁnition of adequate run-in and wash-out
phases. Recent studies showed that the results of dietary studies could be biased by factors such as age,
sex, body mass index and life style habits and by seasonal effects. Another still unsolved problem is the
interpretation of the results of SCGE trials in regard to potential beneﬁcial health effects. The use of –
omics techniques may contribute to provide mechanistic explanations in addition to conventional
approaches (such as enzyme measurements). Information on health effects of dietary factors and on
prevention of diseases related to DNA damage can also be obtained in experiments with animals, using
SCGE to detect decreases in DNA damage in inner organs.
 2008 Elsevier B.V. All rights reserved.
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intervention trails. SC: standard conditions, ROS: damage induced by reactive
oxygen species (H2O2 treatment or radiation); white bars: positive results, grey
bars: negative results.
Fig. 2.Overlap of positive results obtained in different endpoints. In total, 32 studies
were found in which DNA-migration was measured under standard conditions,
after ROS challenge and also treatment of the nuclei with EndoIII, FPG or with both
enzymes.1. Introduction
Since the ﬁrst use of the single cell gel electrophoresis (SCGE, or
cometassay) techniqueinaninterventiontrialwithvitamins in1996
by Duthie and co-workers [1], this method has increasingly been
employed to investigate the impact of dietary factors on DNA
stability inhumansas it is less labour-intensiveandcostly thanother
methods such as chromosomal aberration analysis or the micro-
nucleus assay. Brieﬂy, cells (such as peripheral lymphocytes) are
embeddedinagaroseonamicroscopeslide,andlysedwithdetergent
and 2.5 M NaCl to removemembranes and soluble cytoplasmic and
nuclear constituents, includingmost histones. This leaves nucleoids,
in which the DNA is still attached to the nuclear matrix and
supercoiled. Electrophoresis at high pH (>13) draws the DNA
towards the anode – but only if its supercoiling has been relaxed by
DNA breaks. Thus comet like structures (viewed by ﬂuorescence
microscopy) are formed, inwhich the relative intensity of the comet
tail reﬂects the number of relaxed DNA loops and therefore the
number of strand breaks (including alkali-labile sites) in the DNA.
To date, results of 84 intervention trials using SCGE have been
published. As this technique may be useful for the justiﬁcation of
health claims made on foods that are requested by authorities in
theUSA and in Europe it has gained importance in the last years [2–
4]. A recent comprehensive review evaluating methods which are
currently used to monitor antioxidant effects of dietary factors led
us to the conclusion that the SCGE assay and isoprostane
measurements are among the most reliable approaches [5].
Møller and Loft [6–8] evaluated and summarised in several
reviews the results of earlier human SCGE studies. In the present
article, we give a short overview on recent investigations (not
included in their papers) and describe new developments, i.e.,
protocols which enable the identiﬁcation of food components that
interact with repair processes, attempts to use indicator cells other
than peripheral blood lymphocytes and the design of modiﬁed
versions of the SCGE assay which provide information on
protective effects of dietary factors towards representatives of
different classes of food-related DNA-reactive carcinogens. The last
paragraphs concern the experimental design of SCGE trials and
describe further perspectives of their use in food research.
2. Conventional SCGE trials with complex foods and individual
food constituents—an update
The majority of investigations have been carried out according
to protocols developed by Collins and co-authors (for reviews see
[9,10]) either with untreated peripheral lymphocytes under
standard electrophoresis conditions, after exposure of the cells
to reactive oxygen species (ROS), or after treatment of nuclei with
lesion-speciﬁc enzymes. Comets which are formed under standard
conditions reﬂect endogenous DNA damage (single and double
strand breaks, apurinic/apyrimidinic sites) whereas experiments
with the lesion-speciﬁc enzymes endonuclease III (EndoIII) and
formamidopyrimidine DNA glycosylase (FPG) provide information
on endogenous formation of oxidised pyrimidines and purines,
respectively. The yield of DNA breaks after exposure of intact cells
to ROS (either by treatment with hydrogen peroxide or other ROS-
forming chemicals or by exposure to ionizing radiation) is
indicative for changes of the sensitivity of the cells towards138exogenous oxidative DNA damage [11] and thus gives information
on antioxidant status.
Inapproximatelyhalfof thestudies conductedso far, a signiﬁcant
decrease in the formation of oxidised bases and/or protection
towards ROS-mediated DNA damage was seen, while only in one
third a decrease in DNA migration was found under standard
conditions (i.e., measuring endogenous DNA breaks alone, Fig. 1).
It can be seen in Fig. 2 that the overlap of the different endpoints
is quite poor, i.e., only in about 10% of the studies a signiﬁcant
protective effect was detected in all parameters.
Table 1
Results of human intervention trials, which were published since 2005
Dietary factor Design of the study SCGE resultsa Remarks Ref.
Complex foods
Almond consumption Randomised, crossover %DNA Serum: a-tocopherol (+), " SOD (++),
" GPX (+) (only in smokers)
[27]
84 g/p/d n = 60 < smokers,
control n = 30 < non-smokers
# SC (+)
4 w intervention,
4 w wash-out period
Sampling: weeks 0 and 4
Almond consumption Sequential %DNA Plasma: $ SOD, $ GPx, # MDA (++)
and (+++) in low and high consumption groups
[40]
84 g/p/d or n = 20 < smokers,
10 in each group,
control n = 10 smokers
# SC (++) in high
consumption
group only
Urine: # 8-OH-dG (+++) in both group168 g/p/d
4 w intervention
Sampling: weeks 0 and 4
Apples Double-blind, randomised,
cross-over n = 6 <
%DNA Plasma: $ antioxidant capacity
of low-density lipoproteins
[28]
1000 g/p/d either
organically or
conventionally
produced
3 d run-in, 1 d intervention,
1 w wash-out
$ SC, $ FPG
Sampling: 0 h, 1–6, 9, 12 and 24 h
# EndoIII (+++)
# FeCl3b (++)
$ H2O2
Brussels sprouts Sequential TL LY: # SULT1A1 (++, which activates PhIP), $ GPx, [18]
300 g/p/d n = 8 <+,, $ SC, # H2O2 (++) Plasma: " vitamin C (++)
5 d run-in, 6 d intervention # FPG (++),
Sampling: 0 d, 6 d # EndoIII (++)
Raw watercress Single-blind, randomised, cross-over %DNA Beneﬁcial changes were signiﬁcantly higher
in smokers than in nonsmokers;
[19]
85 g/p/d n = 30 < + 30 , # SC (+), # FPG (+)
Plasma: " lutein (+++) and "b-carotene (++)8 w intervention, 7 w wash-out $ H2O2
Sampling: weeks 0, 8, 15 and 23
Sumach (Rhus coriaria L) Placebo- controlled, randomised TL Plasma: " SOD (+), # GPX (+), " GST (++) [31]
3 g/p/d n = 16 (8 sumach, 8 placebo) # SC (+), # FPG (++) " GST-pi (+)
3 d intervention # EndoIII (++)
Sampling: 0 d, 3 d # H2O2 (++)
Virgin olive oil (high
phenol extra virgin)
50 g/p/d (equals
30 mg phenols/p/d)
Randomised cross-over
(high phenol oil vs low phenol oil)
%DNA High phenol oil: [32]
n = 10 ,, post-menopausal
High phenol
oil: # SC (++)
Plasma: $ antioxidant capacity
8 w intervention, 8 w wash-out # FPG (++)
" (+++) Olive oil phenolics in urine
(hydroxytyrosol, homovanillyl alcohol)
Sampling: 2 w (5 times ﬁrst period,
5 times second period)
$ H2O2
Wheat sprouts Sequential TL In parallel CBMN assay in LY was carried out [37]
70 g/p/d n = 13 < + , $ SC # Apoptosis (+), $ MN, $ NPB
5 d run-in, 5 d intervention,
10 d wash out
# FPG (++) $ Nbud, $ necrosis, $ NDI
Sampling: 0 d, 5 d, 10 d
Beverages
Breast or cow’s milk Sequential Arbitrary units [39]
n = 35 <+, breast milk fed,
n = 35 <+,
# SC (++) in
breast milk fed
6 m intervention
Sampling: at age 10 m
Coffee Sequential TL/TM LY: " SOD (++), $GPx [12]
600 ml/p/d (150 ml
metal ﬁltered +
450 ml paper
ﬁltered)
n = 9 < + , $ SC
5 d run in, 5 d intervention # FPG (++)
Sampling: 0 d, 5 d # EndoIII (++)
# H2O2 (+)
Coffee Sequential TL LY: " SOD (++), $ GPx [13]
600 ml/p/d (200 ml
metal ﬁltered +
400 ml paper
ﬁltered)
n = 8 < + , $ SC
5 d run-in, 5 d intervention # FPG (++)
Sampling: 0 d, 5 d # EndoIII (++)
# H2O2 (++)
Coffee Sequential TL Plasma and salvia: $ overall GST [14]
1 l/p/d n = 7 <+,, $ SC Plasma: " (+++) GST-pi,
$ plasma GST-aMetal ﬁltered 14 d run in, 6 d intervention
Sampling: 0 d, 6 d
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Dietary factor Design of the study SCGE resultsa Remarks Ref.
Juices
Blueberry/apple juice Sequential n = 168 (54 <+114 ,) TM Plasma: " quercetin (+++),
" (+) vitamin C and " TEAC (+)
[29]
1000 ml/p/d 5 d wash-out, 4 w intervention # H2O2 (+)
Sampling: 0 d and 28 d < Stronger
effect than ,
Blood orange juice Sequential LC/%DNA Plasma: " (++) vitamin C content
after orange and supplemented
drink till 8 h after consumption
[17]
300 ml/p/d or drink
supplemented
with the same amount of
vitamin C (150 mg), or
sugar drink (control)
n = 7 , received each drink on
3 different occasions 2 w apart
$ SC
Sampling: every h till 8 h and
24 h after the intake of each drink
# H2O2 (+)
Red mixed berry juice
(rich in polyphenols
TEAC 19:1)
Placebo-controlled parallel LC/%DNA Plasma: $ malondialedehyde [16]
700 ml/p/d
n = 27 < (treatment:18, placebo: 9) # SC (++) Blood: " (+) total glutathione,
" (+) reduced glutathione,
$ oxidised glutathione
3 w run-in, 4 w intervention or
placebo, 3 w wash out
# FPG (++)
Sampling: 0 d, after
each week, from 1 to 9
Tomato-drink
(rich in caroteniods)
Double-blind, placebo-
controlled cross-over
%DNA Blood: " (+) INF-g after placebo
intake, $ after tomato drink,
[33]
250 ml/p/d n = 13 <+13 ,
$ SC
# (++) TNF-a
26 d placebo, 26 d
intervention, 26 d wash-out
Sampling: 26 d per phase
(placebo/wash out/intervention)
Individual food components
Carotenoids: lutein,
lycopene or ß-carotene
Blinded, placebo-controlled parallel VIS Plasma: " (++) caroteinoids [38]
12 mg/p/d of each or
4 mg each in a mix/p/d
n = 37 ,, postmenopausal, # SC (+)
57 d intervention $ H2O2
Sampling: 0 d, 15 d, 29 d, 43 d, 57 d
Coenzyme Q Sequential TM Plasma: # (+) redox-status,
" coenzyme Q (+++),
[30]
3 mg/kg/p/d n = 10 , # FPG (+)
Platelets: # (+) redox-status,
" coenzyme Q (+),
28 d intervention
White blood cells:
" coenzyme Q (+)
Sampling: 0 d, 14 d, 28 d, 12 w
Gallic acid (GA), Sequential, placebo-
controlled, randomised
TL Plasma: " SOD (++),
" GPX (+), $ GST, " GST-pi (+++)
[20]
0.2 mg/kg/kg/p/d
3 d intervention
# SC (+),
n = 16 <+, (8 GA, 8 placebo)
# (++) FPG
Sampling: 0 d, 3 d
# (++) EndoIII
# (++) H2O2
Vitamins C and E Sequential VIS No other investigations [34]
500 + 300 mg/p/d n = 17 <+, exposed
to anaesthetic gases,
# (++) SC
n = 19 <+, control
12 w intervention
Sampling: 0 d, 12 w
Vitamins C and E Randomised placebo-controlled LC/%DNA Plasma: $ TBARS [35]
9 pts – vit E 400 mg/p/d, n = 27 < and 9 ,, pts with COPD $ SC
9 pts – vit E 200 mg/d, 9 pts 12 w intervention # (++) H2O2
– vit C 250 mg/d, 8 - placebo Sampling: 0 d, 12 w
Vitasay, complex of
10 vitamins + 10 minerals
Double-blind randomised %DNA No effect of age and gender [36]
4 w intervention # SC
n = 80 (40 < + 40 ,) # H2O2
Sampling: weeks 0 and 4
Abbreviations: d, days; COPD, chronic obstructive pulmonary disease; EndoIII, endonuclease III; FPG, formamidopyrimidine glycosylase; GPx, glutathione peroxidase; GST,
glutathione-S-transferase; INF-g, interferon-g; LC, leucocytes; L, liter; m, months; Nbud, nuclear buds; NDI, nuclear division index; NPB, nucleoplasmatic bridges; p, person;
pts, patients; SC, standard conditions of the comet assay (single strand breaks; double strand breaks; alkali-labile sites); SOD, superoxide dismutase; SULT –sulfotransferase;
TEAC, trolox equivalent antioxidative capacity; TL, tail length; TM, tail moment; VIS, visual score of comets; TNF-a, tumor necrosis factora; w, weeks; # decrease; " increase;
$ no alteration; + either increase or decrease of 25%; ++ either increase or decrease less than 50%; +++ either increase or decrease less than 75% compared to control.
a Unless otherwise indicates, lymphocytes were used as indicator cells.
b FeCl3 was used to induce oxidative damage of DNA.
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formation of oxidised purines and pyrimidines were evaluated in
parallel. In total, 16 studies were identiﬁed, and in 50% of them,
protection was seen in both endpoints.
The results of 20 newer studies are summarised in Table 1. One
of the interesting ﬁndings is the observation of a signiﬁcant
protective effect of coffee consumption [12–14] (600–1000 ml/
day, 5–7 days), and it is notable that no protective effectswere seen
in earlier trials after consumption of 600 g of a mixed fruit/
vegetable diet [15] or consumption of fruit/vegetable juice [16,17].
Newer studies with cruciferous vegetables [18,19] yielded
evidence for strong protective properties; and gallic acid, which
occurs in speciﬁc plant foods (e.g., mangos and rhubarb), was also
extremely effective [20,21]. Comparisonswith the results obtained
in human studies with vitamin C under similar conditions showed
that gallic acid is more active in regard to prevention of oxidative
damage [20]. These results suggest that only certain plant derived
foods and beverages demonstrate protective effects as indicated by
the comet assay. It is notable that Giovannelli et al. [22] reported
on the basis of a questionnaire-based study that coffee consump-
tion is associated with increased DNA migration attributable to
FPG lesions. However, in the same study also lycopene consump-
tion was found to cause DNA damage due to formation of oxidised
purines, and it is likely that the outcome of the studywas biased by
confounding factors as tomatoes as well as lycopene were found to
be active in a number of earlier controlled intervention trials in
which the SCGE technique was used [8]. Furthermore, the
observation of protective effects of coffee consumption towards
FPG-induced lesions could be conﬁrmed in two large follow-up
studies (forty individuals per study) with different types of coffee
(Knasmu¨ller et al., unpublished). However, it is also notable that
coffee may also cause adverse effects, for example, an increase of
DNA damage induced by the heterocyclic aromatic amine PhIPwas
seen in a small trial which may be due to its interaction with
enzymes involved in the activation of this amine [21].
Other potential adverse effects of coffee may be increased risks
for cardiovascular diseases and increased probability of sponta-
neous abortions or impaired fetal growth [23]. As described in a
recent review [24], it may be possible to design coffees with
increased beneﬁcial health effects on the basis of the identiﬁcation
of the speciﬁc components which account for its antioxidant and
DNA-protective effects which were not only found in human trials
but also in a number of in vitro studies [25,26] (see Table 1 [12–
14,16–20,27–40]).
3. Correlations with other markers of damage
In several SCGE experiments additional parameters that are
indicative for antioxidant effects were measured. Overall, the
ﬁndings are inconsistent: in a study by Bub et al. [41] with fruit
juices, the thiobarbituric acid reactive substance (TBARS) level was
signiﬁcantly reduced in plasma whereas no changes were seen in
ferrous oxidation of xylenol orange (version 2, FOX2) and ferric-
reducingantioxidantpower (FRAP)measurements.Weisel et al. [16]
investigated the effect of an anthocyanin-rich juice and found
protection in SCGE assays and increased glutathione levels but no
impact on plasma malondialdehyde (MDA) concentrations or on
urinary isoprostane excretion. In a trialwitholiveoil, DNAmigration
was reducedwhen the experimentswere conductedunder standard
conditions and with FPG and the effects were paralleled by an
increase of the total antioxidant capacity (TAC) of plasma [32].
In some of the studies, the impact of dietary factors on the
activities of antioxidant enzymes was monitored. For example, the
activity of superoxide dismutase (SOD) was found to be elevated
after consumption of sumach [31], Brussels sprouts [42], coffee14[13] and gallic acid [20,21], whereas no alterations of the
glutathione peroxidase activity (GPx) were observed in any of
these trials.
Another relevantmarker of DNA oxidation that has been used in
a number of human studies is the excretion of 8-oxoguanine (8-
oxoGua) in urine. According to our knowledge, no results are
available from intervention trials in which the urine levels of
oxidised deoxyguanosine and lymphocyte comets were compara-
tively evaluated. However, Gedik et al. [43] compared in a small
study the occurrence of 8-oxoGua in urine and in lymphocytes (by
HPLC) and FPG-induced comet formation in lymphocytes. Over-
night urinary 8-oxoGua concentrations correlated both, with the
overall 8-oxoGua levels in lymphocytes measured by HPLC, and
with FPG-sensitive sites in these cells, although individual values
of DNA base oxidation from HPLC and the comet assay did not
correlate with each other.
Dotan et al. [44] compared the results of numerous studies in
which different endpoints of oxidative stress were measured in
parallel. They concluded that different markers of lipid peroxida-
tion correlate well among themselves (e.g., F2-isoprostanes, MDA
and lipid hydroperoxides), but failed to ﬁnd correlations between
these parameters and DNA migration. A recent biomonitoring
study [45] on 141 subjects (43 controls and 98 exposed) also
demonstrated no correlation of MDA levels with DNA strand
breaks or oxidative DNA damage although there was a positive
correlation of DNA damage with cholesterol and triglycerides.
On the other hand, this study revealed a strong inverse
correlation of oxidised purines and pyrimidines with glutathione
S-transferase activity, that was signiﬁcant in almost all groups and
subgroups. Associations of oxidative DNA damage with plasma
concentrations of antioxidant vitamins (a- and b-tocopherol, b-
carotene and retinol) were also found.
In a recent comprehensive evaluation of techniques used to
monitor antioxidant effects of food components, we suggested that
methodswhich enable the detection of oxidative DNA damage (i.e.,
DNA migration and also other endpoints such as 8-OH-dG
measurements) may be in particular highly relevant since DNA
damage is considered to be a key mechanism which is associated
with the aetiology of a number of diseases. Other potentially
valuable endpoints are probably the measurement of oxidised LDL
and of isoprostanes levels which are also considered to be related
to risks of cardiovascular disorders (for review see Knasmu¨ller
et al., 2008 [5]).
4. Use of SCGE trials to detect protection against DNA-reactive
carcinogens
Humans are exposed to a broad variety of genotoxic carcino-
gens either via environmental contamination or by consumption of
foods which contain various groups of DNA-reactive carcinogens
[46]. Over the last few years, we attempted to develop protocols for
SCGE experiments that can be used to detect alterations of the
sensitivity of lymphocytes towards speciﬁc genotoxic carcinogens.
DNA-reactive carcinogens which can be used in experiments
with human lymphocytes are for example heterocyclic aromatic
amines (PhIP; 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyri-
dine; IQ; 2-amino-3-methylimidazo[4,5-f]-quinoline, MeIQx; 2-
amino-3,8-dimethylimidazo[4,5-f]quinoxaline; AaC—2-amino-
9H-pyrido[2,3-b]-indole; Trp-P-2; 3-amino-1-methyl-5H-pyrido-
[4,3-b]indole), thermal degradation products (acrylamide, furan,
glycidamide), metals (V5+, Cd3+, Cr6+), methylating agents (methyl
methanesulfonate, N-methyl-N-nitrosourea, N-methyl-N-nitroso-
dimethylamine) and also other compounds such as the mycotoxin
ochratoxin A or the cytostatic drug cyclophosphamide (for a
complete list see Nersesyan et al. [21]).1
Table 2
Results of human intervention trials in which alterations of the sensitivity of peripheral lymphocytes towards DNA-damage induced by different carcinogens were
investigated
Model carcinogen/treatment Intervention trial Result Ref.
BPDE (0.40 mM, 30 min) Coffee (unﬁltered) # (45%) TL [14]
1.0 l/d, 5 d $ Plasma and salvia overall GST
n = 7 " (206%) plasma GST-pi
$ Plasma GST-a
Sumach # (59%) TL [31]
3.0 g/d, 3 d " (85%) plasma GST-a
n = 4 < + 4 , " (39%) total GST
" (48%) GST-pi
Trp-P-2 (0.20 mM, 30 min) Brussels sprouts $ TL [18]
300 g/d, 6 d # (23%) SULT1A1 (which activates PhIP)
n = 4 < + 4 , $ SOD, $ GPx
" (37%) plasma vitamin C
Coffee (metal ﬁltered) # (35%) TL [13]
600 ml/d, 5 d, " (38%) SOD
n = 4 < + 4 ,
PhIP (0.70 mM, 30 min) Brussels sprouts # (97%) TL [18]
300 g/d, 6 d # (23%) SULT1A1 (which activates PhIP)
n = 4 < + 4 , $ SOD, $ GPx
" (37%) plasma vitamin C
Coffee (metal ﬁltered, French press) " (22%) TL [12]
600 ml/d, 5 d, " (38%) SOD
n = 4 < + 4 ,
MNU (0.55 mM, 30 min) Coffee (metal ﬁltered, French press) # (19%) TL [21]
800 ml/d, 5 d
n = 5 < + 10 ,
DMNA (0.40 mM, 30 min) Coffee (metal ﬁltered, French press) # (23%) TL [21]
800 ml/d, 5 d
n = 5 < + 10 ,
Abbreviations: BPDE, benzo(a)pyrene-7,8-diol-9,10-epoxide; DNMA, N,N-dimethyl-N-nitrosoamine; MNU, N-methyl-N-nitrosourea; PhIP, 2-amino-1-methyl-6-phenylimi-
dazo[4,5-b]pyridine; TL, tail length; Trp-P-2, 3-amino-1-methyl-5H-pyrido[4,3-b]indole; SULT, sulfotransferase; SOD, superoxide dismutase; GPx, glutathione peroxidase;
GST, glutathione S-transferase.
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activation of procarcinogens are quite low in peripheral lympho-
cytes [47], therefore negative results are obtainedwith compounds
such as benzo(a)pyrene and also with the mycotoxin aﬂatoxin B1.
In order to detect protective effects towards these carcinogens, it is
possible to use their DNA-reactive metabolites, for example
benzo(a)pyrene-7,8-diol-9,10-epoxide (BPDE) [48]. In the case of
aﬂatoxin B1, its DNA-reactive metabolite (the exo isomer of AFB1
8,9-epoxide) is highly unstable [49], but it is possible to activate
themycotoxin by preincubationwith exogenous liver homogenate
(S9 mix) [50]. Also heterocyclic aromatic amines (HAs) can be
activatedwith this procedure [51], butwe, aswell as others [52,53]
showed that positive effects can be obtained in lymphocytes also
with high concentrations of the parent compounds.
Table 2 summarises the results of intervention studies with
selected genotoxic carcinogens which we conducted in recent
years. It can be seen, that in some cases protective effects were
observed which could be explained by alterations of the activities
of activating and/or detoxifying enzymes. For example, the
attenuation of DNA damage by PhIP after consumption of Brussels
sprouts could be attributed to inhibition of sulfotransferase
(SULT1A1) that is required for the activation of this heterocyclic
aromatic amine [18]. Interestingly, no protective effect was
observed in the same study towards Trp-P-2, which is structurally
related but does not require activation by SULT [18]. On the
contrary, a signiﬁcant increase of PhIP-induced DNAmigrationwas
observed in a recent coffee study (consumption of 600 ml/d during
5 days) [12]. The reason for this adverse effectmay be the induction
of enzymes such as CYP1A1 and CYP1A2whichwas found in earlier
experimentswith rats byHuber et al. [54]. In the same intervention142study, changes of the sensitivity of the cells towards the alkylating
agent methyl methanesulfonate were also found, whereas no clear
effect was seen with dimethylnitrosamine. It was shown recently
in animal experiments that the coffee diterpenoids kahweol and
kafestol induce the activity of the enzyme O6-methylguanine DNA
methyltransferase which removes methyl groups from guanosine
[54], and it is possible that the induction of this repair enzymemay
account for the protective effect towards methyl methane
sulfonate [12].
5. Effects of dietary interventions on DNA repair
In 2001, Collins et al. [55] published a protocol for an SCGE-
based in vitro assay for repair of oxidative DNA damage, which can
be applied to human lymphocytes collected in dietary intervention
studies. Cell free extracts of lymphocytes are incubated with
agarose-embedded nucleoids from cells previously treated with
photosensitiser plus light to induce elevated levels of 8-oxoGua.
Accumulation of breaks resulting from incision at oxidised bases
by the repair enzyme 8-oxoguanine DNA glycosylase (OGG1) leads
to increased comet formation. In two human intervention studies,
one with coenzyme Q10 [56], and one with kiwifruit [57], an
increase of the DNA repair capacity was seen. Recently we found a
similar effect in the Oslo Antioxidant Study, in which volunteers
took a diet high in antioxidant-rich foods for several weeks [58]. In
the kiwifruit study,mRNA levels weremeasured for OGG1 and also
for the enzyme that follows OGG1, AP endonuclease 1 (APE1);
there was no sign of a change in gene expression being responsible
for the increased enzyme activity. Also several other studies with
dietary components failed to ﬁnd an increase of OGG1 at the
Table 3
Design of human intervention trialsa
Design Sequential (%) Crossover (%)
Simple 28 (33.3) 4 (4.9)
Placebo 27 (32.1) 2 (2.5)
Run-in period 5 (6.0) –
Wash-out period 6 (7.1) 7 (8.4)
Placebo + run-in 1 (1.1) –
Placebo + wash-out 1 (1.1) 1 (1.1)
Run-in + wash-out 1 (1.1) –
Placebo, run-in + wash-out 1 (1.1) –
Total 70 (83.3) 14 (16.7)
a In total 84 studies have been published.
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differences in OGG1 enzyme activity are poorly reﬂected in gene-
expression levels [59].
More recently we developed an analogous assay for nucleotide
excision (NER) repair, in which UV-irradiated cells provide the
substrate DNA and are currently applying this protocol in human
nutritional studies [60]. The further validation of the different
repair protocols is currently under progress.
It is theoretically possible to monitor cellular repair more
directly, by treating cells with DNA-damaging agents and
incubating them in medium at 37 8C, measuring the residual
damage at intervals. In an early experiment [61], we gave
volunteers 1 g of vitamin C and, 2 h later, isolated lymphocytes;
and incubated them upto 24 h. Rejoining of strand breaks in
lymphocytes is slow, taking several hours (comparedwithminutes
in standard cultured cell lines such as HeLa). Eight volunteers
varied in their response to vitamin C. Two, who showed the largest
increase in plasma concentration, also showed an apparent
acceleration of repair, whereas the others did not. We also
performed similar trials with b-carotene (waiting 24 h after
supplementation, since it is slowly absorbed compared to vitamin
C) [62]. Again, the responses varied, but cells from some volunteers
appeared to rejoin breaks more quickly if isolated after the b-
carotene supplementation.
However, we later concluded [63] that this apparent stimula-
tion of repair probably has another explanation. Immediately after
isolation, the blood cells show a transient increase in strand breaks
(in the absence of H2O2) that might reﬂect the effect of sudden
exposure to atmospheric oxygen. In the case of cells treated with
H2O2, a continuing input of oxidative damage, working against the
removal of the H2O2-induced breaks, would give an impression of
slow repair; and carotenoids or vitamin C, by protecting against
atmospheric oxygen, would appear to speed up repair. Lympho-
cytes show much faster rejoining if incubated for 24 h before
challenging with H2O2 [64]; but we have not pursued this
approach to the nutritional modulation of repair, since the
experimental results are hard to interpret and the in vitro approach
seems more reliable.
6. Indicator cells and media
The majority of investigations (90%) were carried out with
peripheral lymphocytes whereas only in a few studies leucocytes
were used.
When cells are treated with ROS-generating chemicals or
radiation they are inmost cases kept in artiﬁcialmedia. However, it
is also possible to conduct experiments in which cells are
maintained in the plasma of the donors. The latter protocol
detects extracellular ROS-scavenging effects caused by a dietary
factors, whereas the ﬁrst reﬂects changes of intercellular ROS
defence system and both approaches should be used in human
studies in order to obtain a more complete picture [21].
In a few intervention trials, buccal cells have been used in SCGE
experiments. Szeto et al. [65] described recently the development
of an improved protocol in which agarose embedded cells of
epithelial origin from the mouth were digested with trypsin and
proteinase K. In the same study, a small intervention trial with
carotene rich berry juice was included and a signiﬁcant reduction
of comet formation was observed. According to these authors [65]
it is not possible to use an earlier protocol developed by Rojas et al.
[66] as it leads to extremely high background levels.
Another approach was followed by Osswald et al. [67] who
isolated lymphocytes from suspensions of cells collected from the
mouth and developed a technique for SCGE analyses which was
used successfully in an intervention trial with supplemented bread14by Glei et al. [68]. More recently, it was shown by Kleinsasser and
co-workers [69,70] that it is possible to establish mini organ
cultures with oral mucosal cells and use them to study the DNA-
damaging effects of dietary genotoxins in SCGE trials. This
approach may be also useful to monitor protective effects of
dietary compounds.
One of the advantages of the use of buccal cells is that they can
be collected with non-invasive methods. Since more than 90% of
human cancers arise from epithelial cells it has been postulated
that experiments with these cells may have particular relevance
for the detection of cancer preventive effects [71]. In this context it
is also notable that micronucleus assays with exfoliated oral cells
have been successfully used to predict health risks due to
occupational exposure, life style factors and also to identify
protective factors in the human diet [72–74].
7. Experimental design of human studies
One of the most problematic issues of human SCGE trials
concerns the adequate design of the studies. Table 3 shows that a
broad variety of different protocols has been used in earlier
investigations.
The experimental design of intervention trials has been
critically discussed by Møller and Loft [6], who attempted to
deﬁne criteria for the quality of such studies. They stressed that the
experiments should have a placebo-controlled, parallel design.
However, in studies with fruits and vegetables, it is problematic to
design adequate placebos. A crossover design, in which the
subjects are randomly split into two (or more) groups, receiving
supplement(s) or baseline diet in different orders, allows for the
possibility of ‘seasonal changes’ affecting results, as the groups
(control diet and supplemented) are compared at the same time.
Sequential and crossover trials have the advantage that the
subjects can be used as their own controls, which reduces the
interindividual variations of the study.
In studies with a crossover design, it is important to include
wash-out periods between the different phases. Møller and Loft [6]
emphasise that positive results of some poorly controlled earlier
studies may have been biased by seasonal variations or by changes
of the lifestyle of the subjects over time. An evaluation of currently
available reports shows that approximately 70% of all investiga-
tions published so far lasted less than 4 weeks. Therefore, it is
unlikely that such changes would have had a substantial impact on
the results of these trials. However, in longer studies such effects
may be relevant; for example, Verschaeve et al. [75] found higher
basal values of DNA damage (strand breaks) in summer than in
other seasons in a Belgian study, whereas Smolkova et al. [76]
failed to detect such effects in Slovakia.
The time factor can be excluded in ‘ecological’ or questionnaire-
based studies in which the aim is to seek correlations between
general nutritional habits and DNA damage. Krajcovicova-3
Fig. 3. (a–c) Experimental design of intervention trials. The bars are based on the evaluation of results published in peer-reviewed journals between 1996 and 2008. (a)
Number of studies different intervention periods; (b) number of participants in intervention trials; (c) number of blood samplings.
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which they found more oxidative DNA damage in older women
than in young ones and lower levels of DNA damage in older
vegetarians compared to non-vegetarians. The same group
reported also a clear protective effect of consumption of fruits,
vegetables and cereals towards formation of oxidised purines [78].
Giovannelli et al. [22] found correlations between both coffee
consumption and tomato intake and the formation of oxidised
purines—contrasting with intervention studies in which inverse
associations were seen [13,21].
In a number of experiments [13,16,18,37,79,80] run-in-phases
were included in which the participants consumed a controlled
diet and did not consume the items under study. We strongly
recommend the use of such phases in which the intake of dietary144factors that are known to cause protective effects is controlled and
in which the participants are asked to avoid physical exercise that
may lead to comet formation [81,82]. Also wash-out periods will
increase the quality of intervention studies, but the deﬁnition of
their duration is problematic. In this context it is notable that Bub
et al. [41] showed that the reversal of protective effects of a
polyphenolics enriched diet takes several weeks. Also the duration
of the intervention period itself is problematic and Fig. 3 shows
that the periods used in previous studies vary over a broad range.
It can be expected that direct acting antioxidants cause effects
already after few hours whereas compounds that act via induction
of protective enzymes require longer periods to elicit protective
effects. In the case of phenolics it was shown that the decrease in
oxidative DNA damage occurs with some delay [83]. Boyle et al.
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plasma ﬂavonoids at 4 h, whereas DNA oxidation reached the
lowest level 4 h later.Multiple samplingwhichwas used in a few of
the studies [8,16,38,85,86] may help to solve the problem of
deﬁning the ideal intervention time, but usually ﬁnancial
limitations as well as the capacity of the laboratories are limiting
factors. The number of participants that should be included in
intervention trials is a further crucial question. Fig. 3 shows the
numbers of participants enrolled in previous intervention trials. An
adequate strategy to determine the ideal number of subjects is the
calculation of the statistical power. Møller and Loft [8] compared
the number of participants required to detect a 50% reduction of
DNA migration on basis of earlier studies and found extremely
strong variations, i.e., between 14 and 49 individuals.
The quality of intervention trials can be increased when factors
are taken into consideration which may affect their outcome such
as age [8,87,88], gender [87,89–91], body weight [92], seasonal
effects [75,93], the lifestyles of the participants (nutritional habits,
alcohol and tobacco consumption) [22,94–96] and physical
activity [97], and also the latitude [89] and ethnicity may affect
the results of SCGE trials [98]. According to a recent analysis by
Møller [89] the most important factor is the age.
Most dietary studies were carried out with healthy individuals.
However, some of the newer investigations were conducted with
participants who suffered from diseases associated with oxidative
stress (such as diabetes and renal failure) or had increased
oxidative DNA damage due to physical exercise [99–103]. The
results of some of these studies indicate that protective effects of
speciﬁc dietary factors are more pronounced in individuals under
oxidative stress; for example, Glei et al. [68] found protective effect
with supplemented bread in smokers but not in non-smokers.
8. Unsolved problems and future perspectives
As described above, one of the problems associatedwith the use
of SCGE assays in human intervention trials aimed to detect dietary
protective factors concerns their experimental design. No efforts
have been made so far to establish an international consortium
which develops and validates appropriate strategies. The activities
of the European Standards Committee on Oxidative DNA Damage
(ESCODD) concerned primarily the standardisation of 8-oxoGua
measurements, whereas groups concerned with the development
of standardised SCGE guidelines [104–106] have addressed the
problems associated with the adequate design of animal and in
vitro studies, rather than human dietary intervention studies.
Recommendations on how to carry out human studies using the
comet assay tomonitor DNA damage and repair have recently been
published by Dusˇinska and Collins [107]. The major critical steps,
summarised below, have been addressed. As was already
mentioned, the careful design of the study and the use of ‘power
calculations’ are crucial to obtain statistically meaningful results.
Inclusion and exclusion criteria have to be clearly deﬁned and
confounding factors (age, sex, physiological and clinical state,
alcohol consumption, smoking, etc.), which may inﬂuence the
background level and may bias the study, should be taken into
consideration. A control group, either taking placebo or not
(according to the type of study), carefully matched to the
investigated groups, should be included and the control subjects
should be sampled over the same period. The study must be
ethically approved. To avoid subjectivity as much as possible,
samples have to be coded, and analyses should be randomised and
blinded wherever possible. Time and conditions of sampling,
seasonal and geographical details, and other operational aspects
including transport, storage and retrieval should be recorded as all
these might increase the variability. Effects of individual differ-14ences in lifestyle and diet should be recorded (a detailed
questionnaire is strongly recommended) together with individual
and family history, and possible environmental or occupation
exposure. Sampling of subjects should be performed at the same
time of day, and in the same way throughout the study (if possible
by taking fasted blood), sampling of subjects and controls should
be done simultaneously (e.g., include at least a few subjects from
the control group and if possible from each investigated group on
the same day), rather than in consecutive phases. Even if it is
possible to carry out the comet assay on the day the samples are
collected, it is advisable also to freeze and store aliquots of
lymphocytes at 80 8C or in liquid nitrogen. It is also necessary to
consider whether to select frozen samples for the comet assay
analysis completely randomly, or in batches (e.g., all samples from
one subject together in the same comet assay experiment).
For each measured endpoint (strand breaks, FPG-sensitive sites,
etc.), at least twoparallels fromeach sample are recommended tobe
analysed. To control the standard experimental conditions, the use
of ‘reference standards’—the samecells (e.g., untreated lymphocytes
from a single source, frozen in aliquots) in each comet assay
experiment, is recommended. Inclusionofpositive control cells (e.g.,
lymphocytes treated with H2O2) is also advisable.
As there are multiple factors that may increase the variation
and modify ﬁnal results, it is essential to employ the principles of
Good Laboratory Practice and to follow the same procedure and the
same protocol during the entire study. Furthermore, it is suggested
to archive slides for possible future reanalysis. Several aspects of
the planning and execution of trials and the analysis of data have
been thoroughly discussed in a paper by Lovell and Omori [108].
Recently Møller [89] published a meta-analysis in which he
calculated the baseline values of endpoints on the basis of earlier
human studies (i.e., experiments conducted under standard
conditions and after FPG and EndoIII treatment). The data he
collected provide useful information if results obtained in future
investigations lie in the normal range, but more information is
required concerning the time and design of run-in and intervention
phases, the duration of wash-out periods, the calibration of
enzymes and other important factors which may inﬂuence the
outcome of the experiments. One of the striking results obtained in
the aforementioned analysis is, that neither alkali treatment nor
the duration of the electrophoresis, had a signiﬁcant impact on the
levels of DNA damage.
One of the shortcomings associated with the interpretation of
SCGE results in human trials is that we do not know whether a
decrease in the level of DNA damage is translated into a beneﬁcial
effect on health. In the case of micronucleus assays, chromosomal
aberration analysis and sister chromatid exchange tests, the efforts
of Bonassi et al. [109,110] and Norppa et al. [111] showed that the
ﬁrst two endpoints, but not the last, correlate with the incidence of
cancer in human populations indicating that dietary factors which
reduce the number of micronuclei and/or chromosomal aberra-
tions in humans lower the cancer risks. In the case of SCGE assays
no results of long-term studies and meta-analyses to show
whether comet formation correlateswith cancer risks are available
and it is questionable if the results of short-term interventions
(which last only few days) indeed reﬂect long-term effects. It is,
however of interest that increased comet formation was observed
in patients with diabetes type 2 [112–114], hepatitis B and C
[115,116], chronic inﬂammations such as rheumatoid arthritis
[117,118], hyperlipidemic patients [118], obstructive pulmonary
disease [119], renal dialysis patients [120], in Down syndrome
[121] and in patients with psoriasis [121,122]. Most of these
disorders are associated with increased cancer risks and preven-
tion of DNA migration (seen in SCGE trials) may be taken
tentatively as indicative for potential protective effects against5
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them. The latter assumption is also supported by a publication of
Dusinska et al. [123] who found in an occupational study with
ﬁber-exposed individuals that the MN-frequencies correlate well
with levels of FPG- and EndoIII-sensitive sites in DNA.
However, it should be kept in mind, that the mechanisms of
breaks leading to comet formation are not fully understood at
present and that substantial further experimental evidence is
required to draw ﬁrm conclusions between disease prevention and
the reduction of comets by dietary factors.
The combination of SCGE experiments with omics-techniques
which have been developed in the last decade and also with
conventional biochemical methods may help to provide mechan-
istic explanation for DNA-protective effects [5,21]. A typical
example is the explanation of the protective effects seen after
Brussels sprouts consumption towards PhIP-induced DNA damage
which is due to inhibition of sulfotransferases involved in the
activation of this amine [42].
In a recent study, Hoelzl et al. found a signiﬁcant increase of
SOD in lymphocytes of individuals after consumption of Brussels
sprouts in a proteomic study [42] which may explain the
antioxidant effects (prevention of formation of oxidised DNA
bases) which they found in a preceding SCGE trial with these
vegetables in the same target cells [18].
One of the advantages of the SCGE technique is that it also can
be used to monitor prevention of DNA damage in a variety of
different tissues in laboratory rodents. This offers the possibility to
investigate if protective effects seen in peripheral lymphocytes in
humans are paralleled by a reduction of DNA damage in inner
organs under identical experimental conditions. Furthermore,
animal models can also provide valuable information concerning
prevention of speciﬁc diseases associated with DNA damage. We
have shown recently that gallic acid which is highly effective as
antioxidant in peripheral lymphocytes of humans also protects
against oxidative damage in inner organs of rats including brain,
liver and lungs [21]. Subsequently, we could also demonstrate that
the ROS-protective effect in the liver leads to reduction of
radiation-induced preneoplastic hepatic lesions [21].
Despite all the different problems described above, the SCGE
technique is probably one of the most effective methods for the
detection of DNA-protective and antioxidant effects of dietary
compounds in humans and it can be expected that the numbers of
SCGE studies will increase in the near future.
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